<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7195975\results\search\tropicalVirus\results.xml">
   <result pre="following H1N1 (2009), polio (2014), Ebola in West Africa (2014)," exact="Zika" post="(2016) and Ebola in the Democratic Republic of Congo"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7196187\results\search\tropicalVirus\results.xml">
   <result pre="Drug Products: Chloroquine Phosphate Oral tablets) and prophylaxis caused by" exact="Zika" post="virus (20, 21). The anti-malarial drugs hydroxychloroquine and chloroquine"/>
   <result pre="an animal modelCell Res2330030210.1038/cr.2012.16523208422 20LiCZhuXJiXet al.2017Chloroquine, a FDA-approved drug, prevents" exact="Zika" post="virus infection and its associated congenital microcephaly in miceEBioMedicine2418919410.1016/j.ebiom.2017.09.03429033372"/>
   <result pre="in miceEBioMedicine2418919410.1016/j.ebiom.2017.09.03429033372 21ShiryaevSAMesciPPintoAet al.2017Repurposing of the anti-malaria drug chloroquine for" exact="Zika" post="virus treatment and prophylaxisSci Rep71577110.1038/s41598-017-15467-629150641 22YaoXYeFZhangMet al.2020In vitro antiviral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7196923\results\search\tropicalVirus\results.xml">
   <result pre="infectious disease outbreaks. Ebola, Influenza A (H1N1), SARS, MERS, and" exact="Zika" post="virus have had a massive global impact in terms"/>
   <result pre="Rubin, 2020). Azithromycin has been displayed an antiviral property against" exact="Zika" post="and Ebola virus in vitro (Bosseboeuf et al., 2018;"/>
   <result pre="M., RaoultD., &amp;amp; MussoD. (2018). Azithromycin inhibits the replication of" exact="Zika" post="virus. Journal of Antivirals &amp;amp; Antiretrovirals, 10(1), 6â€&quot;11. 10.4172/1948-5964.1000173"/>
   <result pre="A., Mandel-BrehmC., NowakowskiT. J., KriegsteinA. R., &amp;amp; DeRisiJ. L. (2016)." exact="Zika" post="virus cell tropism in the developing human brain and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7197250\results\search\tropicalVirus\results.xml">
   <result pre="fever, Ebola, Lassa fever, Marburg virus, SARS- CoV, MERS-CoV, Nipah," exact="Zika" post="virus, Rift Valley fever virus and COVID-19 are some"/>
   <result pre="concern, H1N1 (2009), Polio (2014), Ebola in West Africa (2014)," exact="Zika" post="(2016) and Ebola in Congo (2019). Just recently, in"/>
   <result pre="only the choice. The outbreaks of MERS, SARS, Nipah [30]," exact="Zika" post="[31], give a lesson to us that social distance,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7198427\results\search\tropicalVirus\results.xml">
   <result pre="emergency intervention in several pandemics, including the Spanish flu, SARS-CoV," exact="West Nile" post="virus, and more recently, Ebola virus [[20], [21], [22],"/>
   <result pre="Dis196200743544010.1086/51939217597458 23HaleyM.RetterA.S.FowlerD.Gea-BanaclocheJ.Oâ€™GradyN.P.The role for intravenous immunoglobulin in the treatment of" exact="West Nile" post="virus encephalitisClin Infect Dis372003e88e9010.1086/37717212955669 24ShimoniZ.NivenM.J.PitlickS.BulvikS.Treatment of West Nile virus"/>
   <result pre="treatment of West Nile virus encephalitisClin Infect Dis372003e88e9010.1086/37717212955669 24ShimoniZ.NivenM.J.PitlickS.BulvikS.Treatment of" exact="West Nile" post="virus encephalitis with intravenous immunoglobulinEmerg Infect Dis7200175910.3201/eid0704.010432 25van GriensvenJ.EdwardsT.de"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7198842\results\search\tropicalVirus\results.xml">
   <result pre="is permitted which does not comply with these terms. Abstract" exact="Chikungunya" post="disease (CHIKD) is a viral infection caused by an"/>
   <result pre="cell-mediated activation of B cells leads to the formation of" exact="CHIKV" post="specific antibodies. Increase in titres of neutralizing IgG/IgM antibodies"/>
   <result pre="and Biotechnology10.13039/100007675Core Fund fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Chikungunya" post="disease (CHIKD), caused by an arthritogenic alphavirus, chikungunya virus"/>
   <result pre="several years (Figure 1). Figure 1 Sequence of events during" exact="CHIKV" post="infection: infected Aedes mosquito deposits the virus into the"/>
   <result pre="months/years. Acute Phase Early Events Leading to the Establishment of" exact="CHIKV" post="Infection The pre-acute phase or the incubation period of"/>
   <result pre="thus can react to the unprocessed antigens (43). Infection of" exact="CHIKV" post="in mice (footpad) led to a significant increase in"/>
   <result pre="immune response (39, 47, 51, 52). One such study of" exact="CHIKV" post="infection in mice models observed changes in cutaneous cytokine"/>
   <result pre="during early infection is evidenced by IFNAR-deficient mice models of" exact="CHIKV" post="infection in which mice died within 3 days post"/>
   <result pre="CHIKV infection in which mice died within 3 days post" exact="CHIKV" post="infection. Skin fibroblast cells upon infection by CHIKV virus"/>
   <result pre="days post CHIKV infection. Skin fibroblast cells upon infection by" exact="CHIKV" post="virus were found to be major producers of type"/>
   <result pre="infection, thus leading to a strong anti-viral defense early during" exact="CHIKV" post="infection (57). Establishment of the Acute Phase of Infection"/>
   <result pre="the local site of replication to the primary sites of" exact="CHIKV" post="infection in the host body (24). Hallmarks of the"/>
   <result pre="the NLR family were associated with peak inflammatory symptoms during" exact="CHIKV" post="infection and these effects could be reversed upon the"/>
   <result pre="or NLRP3 inhibitors (65). Previously, the role of inflammasomes in" exact="CHIKV" post="infection was explored through in-vitro studies using siRNA targeting"/>
   <result pre="in-vitro studies using siRNA targeting caspase-1 that showed enhancement in" exact="CHIKV" post="replication with silencing (66). Members of RIG-1-like helicase families"/>
   <result pre="stimulation with 5â€²-triphosphate RNA generates a robust antiviral response against" exact="CHIKV" post="through RIG-1 pathway with the help of transcription factor"/>
   <result pre="IFN-Î², and TFN-Î± production (68). An association of TLR3 with" exact="CHIKV" post="replication was shown by an agonist of TRIF-dependent signaling"/>
   <result pre="controlling viral dissemination (57). Transcriptional analyses of peripheral blood from" exact="CHIKV" post="infected patients showed a high expression of viperin in"/>
   <result pre="and rapid immune response against the virus in permissive cells," exact="CHIKV" post="effectively evades the cellular control mechanisms. In fibroblast cells,"/>
   <result pre="evades the cellular control mechanisms. In fibroblast cells, for example," exact="CHIKV" post="dodges the interferon response by inducing a translational shut"/>
   <result pre="a translational shut off (27). Additionally, the cytopathic nature of" exact="CHIKV" post="induces apoptosis (72). Fibroblast and stromal cells, for example,"/>
   <result pre="vessels. Evidence has demonstrated the infection of blood monocytes by" exact="CHIKV" post="virus (75). The virus continues replication, achieving a peak"/>
   <result pre="viremia during the acute phase. Immunopathology of Acute Phase As" exact="CHIKV" post="infection spreads, host immune responses are activated by engaging"/>
   <result pre="CCR2âˆ’/âˆ’ mice exhibited increased foot swelling and cartilage erosion upon" exact="CHIKV" post="infection (83). Macrophages are also known to be the"/>
   <result pre="(83). Macrophages are also known to be the reservoirs of" exact="CHIKV" post="in later stages of infection (24), which possibly plays"/>
   <result pre="neutrophil infiltration to the infected tissues (83). CCR2âˆ’/âˆ’ mice upon" exact="CHIKV" post="infection showed enhanced arthritic symptoms without any significant change"/>
   <result pre="the key mediators of arthritic symptoms and tissue damage in" exact="CHIKV" post="infection by releasing granules carrying antimicrobial molecules and producing"/>
   <result pre="extracellular traps (NETs) through a process called NETosis. In vitro" exact="CHIKV" post="infection in neutrophils isolated from mice resulted in the"/>
   <result pre="viral load has been shown in IFNARâˆ’/âˆ’ mice model and" exact="CHIKV" post="infected patients, respectively, suggesting the anti-CHIKV role of NETosis"/>
   <result pre="cells, which secrete high levels of IFN-I (87, 88). In" exact="CHIKV" post="infection, the virus is sensed by pDCs in an"/>
   <result pre="inflammatory cytokine responses (89). Figure 2 Immune cell infiltration in" exact="CHIKV" post="infected tissues: the primary target organs during CHIKV infection"/>
   <result pre="infiltration in CHIKV infected tissues: the primary target organs during" exact="CHIKV" post="infection include liver, spleen, joints, and kidney. As the"/>
   <result pre="have recently been shown to contribute toward the pathogenesis during" exact="CHIKV" post="infection in mice without altering much of the viral"/>
   <result pre="of anti-CHIKV antibodies along with significantly reduced neutralizing activity (100)." exact="CHIKV" post="infected cells are killed by the induction of cytolytic"/>
   <result pre="cells may have a role in mediating cytolytic killing of" exact="CHIKV" post="infected cells during the acute phase of CHIKD (103)."/>
   <result pre="exhaustion during the later stages of the disease. Post-Acute Phase" exact="CHIKV" post="Clearance Clearance of CHIKV from blood paves the path"/>
   <result pre="stages of the disease. Post-Acute Phase CHIKV Clearance Clearance of" exact="CHIKV" post="from blood paves the path to recovery in CHIKD"/>
   <result pre="CHIKD. This phase is marked by complete clearance of active" exact="CHIKV" post="from the body by neutralizing antibodies in the blood"/>
   <result pre="and development of IgG antibodies with age. It suggests that" exact="CHIKV" post="neutralization and IgG titres were higher in 8-week-old mice"/>
   <result pre="were higher in 8-week-old mice during the acute phase, whereas" exact="CHIKV" post="clearance was not observed until post-acute phase in 20"/>
   <result pre="and persists for months or even years (108). Persistence of" exact="CHIKV" post="specific IgM antibodies in the blood and synovial fluid"/>
   <result pre="the major class of antibody produced in the case of" exact="CHIKV" post="infected mice model due to IFN-Î³ produced from CD4+"/>
   <result pre="Numerous reports have sought to characterize the neutralizing ability of" exact="CHIKV" post="specific antibodies, and it has been reported in mice"/>
   <result pre="immune cells (119). Administration of polyclonal anti-CHIKV virus antisera in" exact="CHIKV" post="infected RAG1âˆ’/âˆ’ and B cell-deficient Î¼MT mice resulted in"/>
   <result pre="(C3) (120â€&quot;122). However, a recent study reports that clearance of" exact="CHIKV" post="and RRV remains unaffected in the C3âˆ’/âˆ’ and B"/>
   <result pre="SR-A6 (MARCO) was identified as the key factor responsible for" exact="CHIKV" post="clearance (123). Disease Resolution Chikungunya disease resolution is a"/>
   <result pre="the key factor responsible for CHIKV clearance (123). Disease Resolution" exact="Chikungunya" post="disease resolution is a combination of viral clearance from"/>
   <result pre="inflammation (134). In the case of CHIKV, proteomic profiling of" exact="CHIKV" post="infected patients revealed a number of factors that mediate"/>
   <result pre="2 (TGFB2) are significantly downregulated mediators of inflammation found in" exact="CHIKV" post="patients with 1â€&quot;10 days post-onset of symptoms (133). However,"/>
   <result pre="symptoms (133). However, a phase-specific analysis of these mediators in" exact="CHIKV" post="patients would provide better insight into the mechanism underneath"/>
   <result pre="insight into the mechanism underneath the resolution of inflammation upon" exact="CHIKV" post="infection. Also, RNA-seq analysis of feet and lymph nodes"/>
   <result pre="infection. Also, RNA-seq analysis of feet and lymph nodes of" exact="CHIKV" post="infected mice highlighted granzyme A as a major promoter"/>
   <result pre="(136). Macrophages exhibiting M2-like activation patterns are found in the" exact="CHIKV" post="induced musculoskeletal inflammatory lesions (138) and are known to"/>
   <result pre="the same time M2 macrophages might support the persistence of" exact="CHIKV" post="in the system leading to chronic disease. This hypothesis"/>
   <result pre="performed on a non-human primate model that suggests long term" exact="CHIKV" post="persistence in the macrophages (24). RNA interference (RNAi) controls"/>
   <result pre="and host immune factors (141â€&quot;144). A recent report suggested that" exact="CHIKV" post="establishes infections by regulating miRNA expression profile (145). miR15,"/>
   <result pre="miR-16, miR-17, let-7e, miR-125, miR-99, and miR-23a are altered during" exact="CHIKV" post="infection which indicates that these act as biomarkers in"/>
   <result pre="receptor interactions, and Fc gamma R-mediated phagocytosis (145). In addition," exact="CHIKV" post="infection in human synovial fibroblasts triggers the expression of"/>
   <result pre="of NF-ÎºB pathway by a negative feedback loop and promotes" exact="CHIKV" post="replication (147, 148). Likewise, miRNAs are also known to"/>
   <result pre="IL-1Î², IL-6, and IL-17 associated with Th17 cells in both" exact="CHIKV" post="infected humans and CHIKD mice models (92, 93, 162,"/>
   <result pre="and CXCL-10 (26, 92, 103, 162, 179â€&quot;182). At this stage," exact="CHIKV" post="virus particles/viral RNA is cleared from the blood; however,"/>
   <result pre="from the blood; however, studies have reported the persistence of" exact="CHIKV" post="RNA in the macrophages (24) and fibroblast during chronic"/>
   <result pre="Apart from RNA intermediates, studies have reported the persistence of" exact="CHIKV" post="specific proteins in host cells over an extended period"/>
   <result pre="(33), while in another study, CHIKV-capsid proteins were evident in" exact="CHIKV" post="infected mice as late as 60 days post-infection, suggesting"/>
   <result pre="may also be a contributing factor toward the persistence of" exact="CHIKV" post="(26). Another hallmark of the chronic phase is bone"/>
   <result pre="in the joints, osteoblast cells (Bone-forming cells) are susceptible to" exact="CHIKV" post="infection causing over-expression of IL-6 and RANKL and inhibition"/>
   <result pre="secrete enhanced levels of RANKL, IL-6, IL-8, and (MCP-1), upon" exact="CHIKV" post="infection resulting in higher RANKL: OPG ratio, which favors"/>
   <result pre="K, and Î²3 integrin. Secretion of IL-1 and TNF-Î± by" exact="CHIKV" post="infected resident macrophages phosphorylate JNK and ERK which in"/>
   <result pre="role of mosquito saliva is strikingly an understudied phenomenon in" exact="CHIKV" post="infection. Does the mosquito saliva possess factors that can"/>
   <result pre="does the presence of viral antibodies from previous bites affect" exact="CHIKV" post="pathogenicity during the next bite to a naÃ¯ve individual?"/>
   <result pre="inflammation that have not been studied in the context of" exact="CHIKV" post="chronic infections. This review has strived to emphasize the"/>
   <result pre="zoonotic arbovirus. J Genrl Virol. (2007) 88:2363â€&quot;77. 10.1099/vir.0.82858-017698645 4.Leparc-GoffartINougairedeACassadouSPratCde LamballerieX." exact="Chikungunya" post="in the Americas. Lancet. (2014) 383:514. 10.1016/S0140-6736(14)60185-924506907 5.RaoTRCareyDEPavriKM. Preliminary"/>
   <result pre="of La Reunion. PLoS Med. (2008) 5:e60. 10.1371/journal.pmed.005006018351797 24.LabadieKLarcherTJoubertCManniouiADelacheBBrochardPet al.." exact="Chikungunya" post="disease in nonhuman primates involves long-term viral persistence in"/>
   <result pre="host immune response. J Immunol. (2010) 184:5914â€&quot;27. 10.4049/jimmunol.090025520404278 27.WhiteLKSaliTAlvaradoDGattiEPierrePStreblowDet al.." exact="Chikungunya" post="virus induces IPS-1-dependent innate immune activation and protein kinase"/>
   <result pre="of the T cell responses against E2, nsP1 and capsid" exact="CHIKV" post="proteins in recovered and chronic patients after the epidemics"/>
   <result pre="containing nonstructural protein 3. J Virol. (2018) 92:e00477â€&quot;18. 10.1128/JVI.00477-1829875241 34.StaplesJEBreimanRFPowersAM." exact="Chikungunya" post="fever: an epidemiological review of a re-emerging infectious disease."/>
   <result pre="Topics in Neglected Tropical Diseases.Colombia: Intechopen (2019). p. 34â€&quot;57. 38.PaulBJSadanandS." exact="Chikungunya" post="infection: a re-emerging epidemic. Rheumatol Ther. (2018) 5:317â€&quot;26. 10.1007/s40744-018-0121-730047016"/>
   <result pre="Virology. (2014) 464:26â€&quot;32. 10.1016/j.virol.2014.06.02325043586 40.StyerLMKentKAAlbrightRGBennettCJKramerLDBernardKA. Mosquitoes inoculate high doses of" exact="West Nile" post="virus as they probe and feed on live hosts."/>
   <result pre="with recombinant mosquito salivary protein D7 enhances mortality from subsequent" exact="West Nile" post="virus infection via mosquito bite. PLoS Neglect Trop Dis."/>
   <result pre="Hyg. (2008) 102:400â€&quot;8. 10.1016/j.trstmh.2008.01.02418342898 51.StyerLMLimPYLouieKLAlbrightRGKramerLDBernardKA. Mosquito saliva causes enhancement of" exact="West Nile" post="virus infection in mice. J Virol. (2011) 85:1517â€&quot;27. 10.1128/JVI.01112-1021147918"/>
   <result pre="of reemerging chikungunya virus. PLoS Pathog. (2007) 3:e89. 10.1371/journal.ppat.003008917604450 73.WikanNSakoonwatanyooPUbolSYoksanSSmithDR." exact="Chikungunya" post="virus infection of cell lines: analysis of the East,"/>
   <result pre="South African lineage. PLoS ONE. (2012) 7:e31102. 10.1371/journal.pone.003110222299053 74.Krejbich-TrototPGayBLi-Pat-YuenGHoarauJJJaffar-BandjeeMCBriantLet al.." exact="Chikungunya" post="triggers an autophagic process which promotes viral replication. Virol"/>
   <result pre="double-stranded (viral) RNA. J Immunol. (2004) 172:5656â€&quot;63. 10.4049/jimmunol.172.9.565615100310 77.Dupuis-MaguiragaLNoretMBrunSLe GrandRGrasGRoquesP." exact="Chikungunya" post="disease: infection-associated markers from the acute to the chronic"/>
   <result pre="cell activation. J Infect Dis. (2011) 204:115â€&quot;23. 10.1093/infdis/jiq00621628665 93.GardnerJAnrakuILeTTLarcherTMajorLRoquesPet al.." exact="Chikungunya" post="virus arthritis in adult wild-type mice. J Virol. (2010)"/>
   <result pre="infection in mice. J Immunol. (2013) 190:259â€&quot;69. 10.4049/jimmunol.120217723209328 96.PanningMGrywnaKVan EsbroeckMEmmerichPDrostenC." exact="Chikungunya" post="fever in travelers returning to Europe from the Indian"/>
   <result pre="and Medicine. J Infect Chemother. (2011) 17:419â€&quot;3. 10.1007/s10156-010-0124-y20862507 111.SchilteCStaikowskyFCoudercTMadecYCarpentierFKassabSet al.." exact="Chikungunya" post="virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS"/>
   <result pre="infection in human cells. PLoS ONE. (2013) 8:e79886. 10.1371/journal.pone.007988624278205 147.SelvamaniSPMishraRSinghSK." exact="Chikungunya" post="virus exploits miR-146a to regulate NF-ÎºB pathway in human"/>
   <result pre="Role of proinflammatory cytokines and chemokines in chronic arthropathy in" exact="CHIKV" post="infection. Viral Immunol. (2011) 24:265â€&quot;71. 10.1089/vim.2010.012321830898 163.NgLFChowASunYJKwekDJLimPLDimatatacFet al.. IL-1beta,"/>
   <result pre="184.DanksLTakayanagiH. Immunology and bone. J Biochem. (2013) 154:29â€&quot;39. 10.1093/jb/mvt04923750028 185.AmdekarSParasharDAlagarasuK." exact="Chikungunya" post="virus-induced arthritis: role of host and viral factors in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7199731\results\search\tropicalVirus\results.xml">
   <result pre="genome projectNat. Genet.23199915115710508510 22WichapongK.PianwanitS.SipplW.KokpolS.Homology modeling and molecular dynamics simulations of" exact="Dengue" post="virus NS2B/NS3 protease: insight into molecular interactionJ. Mol. Recogn.:"/>
   <result pre="Interdiscipl. J.232010283300 23EkinsS.LieblerJ.NevesB.J.LewisW.G.CoffeeM.BienstockR.Illustrating and homology modeling the proteins of the" exact="Zika" post="virusF1000Research52016 24DavisF.P.BarkanD.T.EswarN.McKerrowJ.H.SaliA.Hostâ€&quot;pathogen protein interactions predicted by comparative modelingProtein Sci.1620072585259617965183"/>
   <result pre="influenza proteomePloS One82013 34WangL.ValderramosS.G.WuA.OuyangS.LiC.BrasilP.From mosquitos to humans: genetic evolution of" exact="Zika" post="virusCell Host Microbe19201656156527091703 35PatelH.KukolA.Prediction of ligands to universally conserved"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7199921\results\search\tropicalVirus\results.xml">
   <result pre="to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms Abstract SUMMARY The recent" exact="Zika" post="virus (ZIKV) and chikungunya virus (CHIKV) epidemics highlight the"/>
   <result pre="increases the competence of this species for dengue virus and" exact="CHIKV" post="as well as Ae. albopictus for ZIKV, suggesting that"/>
   <result pre="helps explain how Ae. aegypti can sustain explosive epidemics like" exact="ZIKV" post="despite relatively poor vector competence in single-feed laboratory trials."/>
   <result pre="of dengue virus (DENV; Flaviviridae), chikungunya virus (CHIKV; Togaviridae), and" exact="Zika" post="virus (ZIKV; Flaviviridae)5,6. These three arboviruses are transmitted by"/>
   <result pre="received a single bloodmeal (Fig. 1a). Midgut infection prevalence of" exact="ZIKV" post="was similar in the single- and double-feed groups, but"/>
   <result pre="and double-feed groups, but the percentage of mosquitoes with disseminated" exact="ZIKV" post="infection to leg tissues was significantly higher in mosquitoes"/>
   <result pre="mosquitoes were fed a non-infectious bloodmeal prior to receiving a" exact="ZIKV" post="infectious bloodmeal (Extended Data 1). This suggests that an"/>
   <result pre="a non-infectious bloodmeal. Temporal examination of this observation revealed that" exact="ZIKV" post="disseminated more rapidly in the double-feed group than the"/>
   <result pre="1c). The increase in dissemination correlated with an increase of" exact="ZIKV" post="positive saliva samples as the transmission rate regression line"/>
   <result pre="aegypti were orally-exposed to dengue virus type 2 (DENV-2) and" exact="CHIKV" post="and then given a second bloodmeal. As with ZIKV,"/>
   <result pre="mosquitoes with disseminated infections for both DENV-2 (Fig. 1e) and" exact="CHIKV" post="(Fig. 1f) were significantly increased compared to single-feed controls."/>
   <result pre="with double-feeding resulted in a higher proportion of mosquitoes transmitting" exact="CHIKV" post="to mice (Fig. 1h). This demonstrates that the serial"/>
   <result pre="whether our findings were unique to Ae. aegypti, we tested" exact="ZIKV" post="rates of dissemination in a low-generation (F5) colony of"/>
   <result pre="competent and could have contributed more to transmission during the" exact="ZIKV" post="epidemic than previously thought. To ascertain the basis of"/>
   <result pre="disseminated infection) (Extended Data 4). Our data indicates that once" exact="ZIKV" post="has established an infection in the gut, its ability"/>
   <result pre="might affect virus transit, we performed a retrograde infection assay." exact="ZIKV" post="was intrathoracically inoculated into a cohort of Ae. aegypti"/>
   <result pre="3 days post-inoculation. Nine days post-bloodmeal, mosquito midguts were removed," exact="ZIKV" post="antigen was detected by immunofluorescence, and ZIKV genome equivalents"/>
   <result pre="midguts were removed, ZIKV antigen was detected by immunofluorescence, and" exact="ZIKV" post="genome equivalents were quantified by RT-qPCR. ZIKV titers were"/>
   <result pre="by immunofluorescence, and ZIKV genome equivalents were quantified by RT-qPCR." exact="ZIKV" post="titers were significantly higher in those provided a bloodmeal"/>
   <result pre="infection could be detected in those provided a bloodmeal, whereas" exact="ZIKV" post="antigen could not be detected in the epithelium of"/>
   <result pre="To quantify how a second bloodmeal would affect transmission of" exact="ZIKV" post="by Ae. aegypti as measured by the basic reproductive"/>
   <result pre="reproductive number (R0), we first modeled the distributions of the" exact="ZIKV" post="EIP when mosquitoes were fed only one bloodmeal and"/>
   <result pre="derived from a meta-analysis of published studies that temporally assessed" exact="ZIKV" post="infection rates (Fig. 3a). Based on our single-feed empirical"/>
   <result pre="second bloodmeal may help explain the magnitude of Ae. aegypti-vectored" exact="ZIKV" post="epidemics despite the relatively low competence observed experimentally (after"/>
   <result pre="vector. Furthermore, our model predicted a greater epidemic potential of" exact="ZIKV" post="(as indicated by R0&amp;gt;1) in regions where the daily"/>
   <result pre="is lower (Extended Data 8). Thus, the potential range of" exact="ZIKV" post="persistence may be slightly greater than previously estimated34. This"/>
   <result pre="for convenience and for arboviruses such as ZIKV, DENV, and" exact="CHIKV" post="that do not produce infectious-level viremias in easy to"/>
   <result pre="than after feeding on viremic hosts36,37. To overcome this impediment," exact="ZIKV" post="and DENV were grown in mosquito cell culture rather"/>
   <result pre="feeding on viremic hosts36,37. To overcome this impediment, ZIKV and" exact="DENV" post="were grown in mosquito cell culture rather than mammalian"/>
   <result pre="Culture, Mosquitoes, and Mice Viruses used in this study included" exact="ZIKV" post="(PRVABC59; GenBank: KU501215), DENV-2 (125270/VENE93; GenBank: U91870), and CHIKV"/>
   <result pre="included ZIKV (PRVABC59; GenBank: KU501215), DENV-2 (125270/VENE93; GenBank: U91870), and" exact="CHIKV" post="(R99659; GenBank: KX713902). C6/36 Ae. albopictus cells were used"/>
   <result pre="GenBank: KX713902). C6/36 Ae. albopictus cells were used to amplify" exact="ZIKV" post="(final passage history= Vero-3, C6/36â€&quot;1) and DENV-2 (C6/36â€&quot;3), CHIKV"/>
   <result pre="amplify ZIKV (final passage history= Vero-3, C6/36â€&quot;1) and DENV-2 (C6/36â€&quot;3)," exact="CHIKV" post="(Vero-2) were grown in Vero E6 cells, and BHK-21"/>
   <result pre="samples, the right front leg of euthanized mice exposed to" exact="CHIKV" post="infected mosquitoes were collected by one group and provided"/>
   <result pre="were used to complete the studies. Initially, all of the" exact="ZIKV" post="studies were performed with frozen stocks of ZIKV (4.8"/>
   <result pre="of the ZIKV studies were performed with frozen stocks of" exact="ZIKV" post="(4.8 Ã— 106 plaque forming units (pfu)/ml); however, in"/>
   <result pre="with multiple bloodmeals. For comparison, mean human viremia titers of" exact="ZIKV" post="were estimated in the 104-105 genome equivalents/ ml range41,42."/>
   <result pre="106 â€&quot; 3 Ã— 107 pfu/ml) and frozen aliquots of" exact="CHIKV" post="(4 Ã— 106 pfu/ml) were used. To evaluate ZIKV"/>
   <result pre="of CHIKV (4 Ã— 106 pfu/ml) were used. To evaluate" exact="ZIKV" post="transmission by mosquitoes, saliva was collected in individual glass"/>
   <result pre="maximum speed for 5 min. Outbred mice are susceptible to" exact="CHIKV" post="infection43 and were used as host animals in CHIKV"/>
   <result pre="to CHIKV infection43 and were used as host animals in" exact="CHIKV" post="transmission experiments based on a previously published protocol44. Individual"/>
   <result pre="mouse, homogenized in 500 ul of PBS-G, and tested for" exact="CHIKV" post="infection by RT-qPCR. Infection rates were determined and reported"/>
   <result pre="the manufacturerâ€™s instructions. Samples were eluted in 50 Î¼l ddH2O." exact="ZIKV" post="RNA was detected in mosquito tissues using a previously"/>
   <result pre="using a previously described primer-probe set spanning the 3â€™-UTR46 and" exact="CHIKV" post="RNA was detected using the previously described 6856F/6981c/6919-FAM primer-probe"/>
   <result pre="Bio-Rad CFX Manager 3.1 software. The cut-off value used for" exact="ZIKV" post="exposed samples to be considered positive by RT-qPCR was"/>
   <result pre="(Table S5). Ct values &amp;lt;35 cycles were considered positive for" exact="CHIKV" post="and &amp;lt;33 cycles for DENV-2. The use of RT-qPCR"/>
   <result pre="(Table S6). RNA standards were generated in order to quantify" exact="ZIKV" post="RNA from mosquito midguts. Briefly, an ~ 680 bp"/>
   <result pre="achieve serial 10-fold genome equivalent (GE) dilutions. We detected 102â€&quot;107" exact="ZIKV" post="GE/ reaction with a primer efficiency of 78.4% with"/>
   <result pre="Assay Ae. aegypti mosquitoes were intrathoracically inoculated with approximately 70" exact="ZIKV" post="PFUâ€™s. Three days post-inoculation (dpi), half of the individuals"/>
   <result pre="were determined by calculating the standard error of sample proportions." exact="ZIKV" post="transmission rate data was analyzed by linear regression and"/>
   <result pre="legends. All analyses were performed using GraphPad Prism Statistical software." exact="ZIKV" post="Plaque Assay In addition to RT-qPCR, salivary secretions from"/>
   <result pre="crystal violet, and plaques enumerated. Estimates of EIP distributions for" exact="Zika" post="virus We developed models to estimate the distribution of"/>
   <result pre="estimate the distribution of the extrinsic incubation period (EIP) of" exact="Zika" post="virus (ZIKV) under both single-feed and double-feed scenarios. Because"/>
   <result pre="attempted to quantitatively describe the distribution of the EIP for" exact="ZIKV" post="using our experimental results, and compare these results to"/>
   <result pre="during the incubation period. Published data on the EIP of" exact="ZIKV" post="were collected by searching the relevant literature using Web"/>
   <result pre="â€œsalivary gland infectionâ€� OR â€œcompetenceâ€� OR â€œtransmissionâ€�). We required that" exact="ZIKV" post="infection data were collected on mosquitoes at three or"/>
   <result pre="We attempted to account for sources of study variability (e.g." exact="ZIKV" post="strain, utilization of fresh or frozen virus stock, and"/>
   <result pre="effect. We identified nine papers in total that experimentally assessed" exact="ZIKV" post="EIP in Aedes aegypti using traditional single-feed methodology (Table"/>
   <result pre="for studies in which temporal infection data were collected on" exact="ZIKV" post="dissemination to legs, wings or heads, including our own"/>
   <result pre="for studies in which temporal infection data were collected on" exact="ZIKV" post="dissemination to heads, salivary glands or in salivary secretions."/>
   <result pre="or in salivary secretions. We assumed that the EIP for" exact="ZIKV" post="was gamma distributed and that the data on the"/>
   <result pre="to obtain estimates needed to parameterize the EIP distribution for" exact="ZIKV" post="according to the formula below: p t , i"/>
   <result pre="parameterized our model for R0 according to current understanding of" exact="ZIKV" post="transmission dynamics. When parameters specific to ZIKV transmission were"/>
   <result pre="current understanding of ZIKV transmission dynamics. When parameters specific to" exact="ZIKV" post="transmission were not available or as yet understood, we"/>
   <result pre="understood, we informed the ranges from dengue virus studies, as" exact="Zika" post="and dengue are arboviruses of the same Flavivirus genus,"/>
   <result pre="from the literature. We identified 41 estimates of R0 for" exact="ZIKV" post="from 22 studies. Studies were identified by searching Web"/>
   <result pre="a wide variation in estimates of the generation interval of" exact="ZIKV" post="(Table S4), which is positively correlated with estimates of"/>
   <result pre="be a major source of uncertainty in R0 estimates for" exact="ZIKV" post="55,56. Our results suggest that estimates of the generation"/>
   <result pre="Our results suggest that estimates of the generation interval of" exact="ZIKV" post="based on natural history models may be upwardly biased,"/>
   <result pre="setting. At lower values of p, within the range where" exact="ZIKV" post="epidemics have been observed, R0 is slightly higher under"/>
   <result pre="in a natural setting may lead to greater persistence of" exact="ZIKV" post="on the edges of observed transmission zones. Finally, we"/>
   <result pre="dissected from both cohorts and tested for the presence of" exact="ZIKV" post="RNA by RT-q-PCR. (â—�) single feed; (â—�) double feed."/>
   <result pre="of sample proportions. Extended Data Fig. 2 Increased transmission of" exact="ZIKV" post="RNA and infectious virions associated with acquisition of an"/>
   <result pre="an additional non-infectious bloodmeal. Aedes aegypti mosquitoes were offered a" exact="ZIKV" post="infectious bloodmeal and at 3 dpi individuals in the"/>
   <result pre="bloodmeal. 10 dpi mosquito saliva was collected and assayed for" exact="ZIKV" post="RNA and infectious virions by RT-qPCR and plaque assay"/>
   <result pre="Trop166, 155â€&quot;163, doi:10.1016/j.actatropica.2016.11.020 (2017).27876643 2FariaNRet al.Establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the Americas. Nature546, 406â€&quot;410, doi:10.1038/nature22401nature22401"/>
   <result pre="of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit" exact="Zika" post="virus. BMC Infect Dis15, 492, doi:10.1186/s12879-015-1231-2[pii] (2015).26527535 15Chouin-CarneiroTet al.Differential"/>
   <result pre="of Aedes aegypti and Aedes albopictus from the Americas to" exact="Zika" post="Virus. PLoS Negl Trop Dis10, e0004543, doi:10.1371/journal.pntd.0004543 (2016).26938868 16DiagneCTet"/>
   <result pre="Asian tiger mosquito Aedes albopictus of La Reunion Island for" exact="Zika" post="virus. Med Vet Entomol, doi:10.1111/mve.12284 (2017). 23Oâ€™DonnellKL, BixbyMA, MorinKJ,"/>
   <result pre="a Northern Population of Aedes vexans (Diptera: Culicidae) to Transmit" exact="Zika" post="Virus. J Med Entomol54, 1354â€&quot;1359, doi:10.1093/jme/tjx0873797264 [pii] (2017).28499036 24OkudaKet"/>
   <result pre="doi:10.1371/journal.pntd.0005976 (2017).28961239 26KantorAM, GrantDG, BalaramanV, WhiteTA &amp;amp; FranzAWEUltrastructural Analysis of" exact="Chikungunya" post="Virus Dissemination from the Midgut of the Yellow Fever"/>
   <result pre="(1988).2896802 28DelatteHet al.Blood-feeding behavior of Aedes albopictus, a vector of" exact="Chikungunya" post="on La Reunion. Vector Borne Zoonotic Dis10, 249â€&quot;258, doi:10.1089/vbz.2009.0026"/>
   <result pre="163â€&quot;171 (1981).6115555 34PerkinsTA, SirajAS, RuktanonchaiCW, KraemerMUG &amp;amp; TatemAJModel-based projections of" exact="Zika" post="virus infections in childbearing women in the Americas. Nature"/>
   <result pre="41WaggonerJJet al.Viremia and Clinical Presentation in Nicaraguan Patients Infected With" exact="Zika" post="Virus, Chikungunya Virus, and Dengue Virus. Clin Infect Dis63,"/>
   <result pre="and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus," exact="Chikungunya" post="Virus, and Dengue Virus. Clin Infect Dis63, 1584â€&quot;1590, doi:ciw589"/>
   <result pre="in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and" exact="Dengue" post="Virus. Clin Infect Dis63, 1584â€&quot;1590, doi:ciw589 [pii] 10.1093/cid/ciw589 (2016).27578819"/>
   <result pre="Dis63, 1584â€&quot;1590, doi:ciw589 [pii] 10.1093/cid/ciw589 (2016).27578819 42MussoDet al.Molecular detection of" exact="Zika" post="virus in blood and RNA load determination during the"/>
   <result pre="J Med Virol89, 1505â€&quot;1510, doi:10.1002/jmv.24735 (2017).27859375 43HaeseNNet al.Animal Models of" exact="Chikungunya" post="Virus Infection and Disease. J Infect Dis214, S482â€&quot;S487, doi:jiw284"/>
   <result pre="&amp;amp; FikrigEExtrinsic incubation periods for horizontal and vertical transmission of" exact="West Nile" post="virus by Culex pipiens pipiens (Diptera: Culicidae). J Med"/>
   <result pre="Med Entomol45, 445â€&quot;451 (2008).18533438 45LanciottiRSet al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
   <result pre="Dis13, 764â€&quot;767, doi:10.3201/eid1305.070015 (2007).17553261 48ChanM &amp;amp; JohanssonMAThe incubation periods of" exact="Dengue" post="viruses. PLoS One7, e50972, doi:10.1371/journal.pone.0050972 (2012).23226436 49FergusonNMet al.Countering the"/>
   <result pre="Dengue viruses. PLoS One7, e50972, doi:10.1371/journal.pone.0050972 (2012).23226436 49FergusonNMet al.Countering the" exact="Zika" post="epidemic in Latin America. Science353, 353â€&quot;354, doi:10.1126/science.aag0219 (2016).27417493 50rjags:"/>
   <result pre="to Characterize Transmissibility and Forecast Patterns and Final Burden of" exact="Zika" post="Epidemics. PLoS Curr8, doi:10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583 (2016). 56FunkSet al.Comparative Analysis of"/>
   <result pre="Zika Epidemics. PLoS Curr8, doi:10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583 (2016). 56FunkSet al.Comparative Analysis of" exact="Dengue" post="and Zika Outbreaks Reveals Differences by Setting and Virus."/>
   <result pre="PLoS Curr8, doi:10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583 (2016). 56FunkSet al.Comparative Analysis of Dengue and" exact="Zika" post="Outbreaks Reveals Differences by Setting and Virus. PLOS Neglected"/>
   <result pre="Multiple feeding events increase dissemination and transmission rates of ZIKV," exact="DENV" post="and CHIKV in Aedes aegypti. (a) Schematic of experimental"/>
   <result pre="events increase dissemination and transmission rates of ZIKV, DENV and" exact="CHIKV" post="in Aedes aegypti. (a) Schematic of experimental design. (b)"/>
   <result pre="and legs were collected and assayed for the presence of" exact="ZIKV" post="RNA by RT-qPCR (MGI (midgut infection rates) and DI"/>
   <result pre="RT-qPCR (MGI (midgut infection rates) and DI (disseminated infection). (c)" exact="ZIKV" post="dissemination rates of paired bodies and legs 5â€&quot;14 dpi"/>
   <result pre="rates of paired bodies and legs 5â€&quot;14 dpi assayed for" exact="ZIKV" post="RNA; only DI rates are presented. (d) 6, 8"/>
   <result pre="and 10 dpi paired bodies and saliva were assayed for" exact="ZIKV" post="RNA; only transmission rates (TR) are presented. TR data"/>
   <result pre="by linear regression and analysis of covariance. (e,f) DENV-2 and" exact="CHIKV" post="infection and dissemination rates, respectively. (g) Schematic of mouse"/>
   <result pre="respectively. (g) Schematic of mouse transmission studies. (h) TR of" exact="CHIKV" post="infected Ae. aegypti transmitting to suckling mice. (â—�) single-feed;"/>
   <result pre="(d) Viral genome equivalents/ midgut of individuals intrathoracically inoculated with" exact="ZIKV" post="(n=14) or inoculated and provided a bloodmeal 3 dpi"/>
   <result pre="and statistically analyzed with a two-tailed t-test. (e) Midguts from" exact="ZIKV" post="inoculated individuals with or without a bloodmeal assayed for"/>
   <result pre="ZIKV inoculated individuals with or without a bloodmeal assayed for" exact="ZIKV" post="antigen 12 dpi. Representative images of two experimental replicates"/>
   <result pre="the parameters of the CDF. For reference, we also estimated" exact="ZIKV" post="dissemination rates in Aedes aegypti mosquitoes offered only one"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7200052\results\search\tropicalVirus\results.xml">
   <result pre="the analysis includes other positive-sense RNA virus, namely HCV, Dengue," exact="West Nile," post="Zika and Yellow Fever viruses (Fig.Â 1b). In particular,"/>
   <result pre="includes other positive-sense RNA virus, namely HCV, Dengue, West Nile," exact="Zika" post="and Yellow Fever viruses (Fig.Â 1b). In particular, HCV"/>
   <result pre="in (a) with the addition of positive-sense viruses HCV, Dengue," exact="West Nile," post="Zika and Yellow Fever viruses; c Sequences from positive-sense"/>
   <result pre="with the addition of positive-sense viruses HCV, Dengue, West Nile," exact="Zika" post="and Yellow Fever viruses; c Sequences from positive-sense coronaviruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7202844\results\search\tropicalVirus\results.xml">
   <result pre="doi: 10.1016/S1473-3099(20)30360-1 : Article Vaccine development during global epidemics: the" exact="Zika" post="experience CastanhaPriscila M SaMarquesErnesto T Amarques@pitt.edua[a], pmc-release: 2020-5-5epub: 2020-5-5(C)"/>
   <result pre="North and South American continents experienced a major epidemic of" exact="Zika" post="virus in 2015â€&quot;16, which infected up to 70% of"/>
   <result pre="to 70% of the population in some areas.1 Until then," exact="Zika" post="virus infection had been considered a benign viral infection"/>
   <result pre="consequences. However, during the 2015â€&quot;16 epidemic, it was recognised that" exact="Zika" post="virus infection can lead to neurological diseases of the"/>
   <result pre="characterised by microcephaly. The spectrum of clinical presentations of congenital" exact="Zika" post="syndrome is still not fully described. Studies have shown"/>
   <result pre="shown that about 20% of babies of mothers exposed to" exact="Zika" post="virus during pregnancy who were born with no initial"/>
   <result pre="cognitive development and other neurological abnormalities later in life.2, 3" exact="Zika" post="is endemic in all tropical areas of the world,"/>
   <result pre="of the global population lives in areas at risk of" exact="Zika" post="transmission, and the chance for future Zika epidemics remains"/>
   <result pre="at risk of Zika transmission, and the chance for future" exact="Zika" post="epidemics remains very real. 5 years after the 2015â€&quot;16"/>
   <result pre="the 2015â€&quot;16 outbreak, we still do not have a licensed" exact="Zika" post="vaccine despite substantial efforts throughout this time period.4 In"/>
   <result pre="1 clinical trial on the safety and immunogenicity of a" exact="Zika" post="purified inactivated virus vaccine given via standard, accelerated, or"/>
   <result pre="standard, accelerated, or shortened schedules. The authors showed that their" exact="Zika" post="vaccine formulation was well tolerated, immunogenic, and did not"/>
   <result pre="an accelerated schedule (weeks 0 and 2), elicited a robust" exact="Zika" post="virus neutralising antibody response that peaked 2 weeks after"/>
   <result pre="than 100 by study week 16. The sharp decay in" exact="Zika" post="virus neutralising antibody titres might be linked to poor"/>
   <result pre="an ideal vaccine, and efforts to develop or refine promising" exact="Zika" post="vaccine candidates must remain a priority. However, because of"/>
   <result pre="made we might be somewhat better prepared should a new" exact="Zika" post="outbreak occur. Despite low antibody durability after boost, it"/>
   <result pre="would allow for a quicker humoral immune response to a" exact="Zika" post="infection, as has been shown for other flavivirus vaccines.7,"/>
   <result pre="of dengue infection. Anti-dengue antibodies have been shown to enhance" exact="Zika" post="virus infection in in-vitro, ex-vivo, and animal models, but"/>
   <result pre="dengue.10 This potential risk could probably be mitigated by administering" exact="Zika" post="vaccine to individuals who have already been exposed to"/>
   <result pre="We have learned a lot from efforts to develop a" exact="Zika" post="vaccine, and the experience acquired during the Zika outbreak"/>
   <result pre="develop a Zika vaccine, and the experience acquired during the" exact="Zika" post="outbreak is reflected by the rapid response to the"/>
   <result pre="a sprint race, it is a marathon. Efforts to develop" exact="Zika" post="vaccines must continue to be supported financially if we"/>
   <result pre="future outbreaks. References References 1Rodriguez-BarraquerICostaFNascimentoEJMImpact of preexisting dengue immunity on" exact="Zika" post="virus emergence in a dengue endemic regionScience363201960761030733412 2EinspielerCUtschFBrasilPAssociation of"/>
   <result pre="a dengue endemic regionScience363201960761030733412 2EinspielerCUtschFBrasilPAssociation of infants exposed to prenatal" exact="Zika" post="virus infection with their clinical, neurologic, and developmental status"/>
   <result pre="toolJAMA Netw Open22019e187235 3MulkeySBArroyave-WesselMPeytonCNeurodevelopmental abnormalities in children with in utero" exact="Zika" post="virus exposure without congenital Zika syndromeJAMA Pediatr2020published online Jan"/>
   <result pre="in children with in utero Zika virus exposure without congenital" exact="Zika" post="syndromeJAMA Pediatr2020published online Jan 6.10.1001/jamapediatrics.2019.5204 4PolandGAOvsyannikovaIGKennedyRBZika vaccine development: current"/>
   <result pre="development: current statusMayo Clin Proc9420192572258631806107 5StephensonKETanCSWalshSRSafety and immunogenicity of a" exact="Zika" post="purified inactivated virus vaccine given via standard, accelerated, or"/>
   <result pre="NgonoAYoungMPBunzMCD4+ T cells promote humoral immunity and viral control during" exact="Zika" post="virus infectionPLoS Pathog152019e1007474 7CapedingMRAlbertoERBouckenoogheAFive-year antibody persistence following a Japanese"/>
   <result pre="IC51Vaccine2820105197C202 9LangerakTMumtazNTolkVIThe possible role of cross-reactive dengue virus antibodies in" exact="Zika" post="virus pathogenesisPLoS Pathog152019e1007640 10CastanhaPMSErdosGWatkinsSCFaloLDMarquesETABarratt-BoyesSMReciprocal immune enhancement of dengue and"/>
   <result pre="Zika virus pathogenesisPLoS Pathog152019e1007640 10CastanhaPMSErdosGWatkinsSCFaloLDMarquesETABarratt-BoyesSMReciprocal immune enhancement of dengue and" exact="Zika" post="virus infection in human skinJCI insight52020133653 We declare no"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7203554\results\search\tropicalVirus\results.xml">
   <result pre="MartÃ­n-AcebesM. A.GabandÃ©-RodrÃ­guezE.GarcÃ­a-CabreroA. M.SÃ¡nchezM. P.LedesmaM. D.SobrinoF.et al. (2016). Host sphingomyelin increases" exact="West Nile" post="virus infection in vivo.J. Lipid Res.57422â€&quot;432. 10.1194/jlr.M06421226764042 MillerM. E.AdhikaryS.KolokoltsovA."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7204673\results\search\tropicalVirus\results.xml">
   <result pre="neuropsychiatric sequelae While several recent infectious diseases such as Ebola," exact="Zika" post="and HIV are well known to affect the brain,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7204720\results\search\tropicalVirus\results.xml">
   <result pre="the middle ages, to the flu, pertussis, malaria, AIDS, SARS," exact="Zika" post="and now COVID-19, our urban life is susceptible to"/>
   <result pre="and 1957 Asian flu pandemics, and the AIDS, SARS and" exact="Zika" post="epidemics of the 1980s and 2010s, respectively, transmissions of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7205198\results\search\tropicalVirus\results.xml">
   <result pre="epidemics, LACâ€™s poor were more likely to become infected with" exact="Zika" post="and more likely bear children with microcephaly [20], suggesting"/>
   <result pre="MendesA da CG, LyraTM, et al.Microcephaly epidemic related to the" exact="Zika" post="virus and living conditions in Recife, Northeast Brazil. BMC"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7207108\results\search\tropicalVirus\results.xml">
   <result pre="interferon-stimulated genes [92]. Additionally, its antiviral activity was reported against" exact="Zika" post="virus in human glial cells, where it prevented the"/>
   <result pre="Neomycin, Kasugamycin, and Streptomycin inhibited herpes simplex, influenza A and" exact="Zika" post="virus replication by upregulating the interferon-stimulated genes (ISGs) [97]."/>
   <result pre="and vaccinia virus [201] 6. Doxycycline Inhibits the viral replication" exact="Chikungunya" post="virus [114] The US-FDA approved antihelmintic drug Niclosamide is"/>
   <result pre="and cancer [149]. It has shown the antiviral activity against" exact="Dengue" post="virus by inhibiting the viral replication without affecting its"/>
   <result pre="Exhibits virucidal activity and suppresses the viral adsorption and replication" exact="Dengue" post="virus [213] 13. Raoulic (Raoulia australis) Broad spectrum antiviral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7211204\results\search\tropicalVirus\results.xml">
   <result pre="with recombinant human hyaluronidase (HylenexÂ®) in non-human primates [43]. The" exact="Zika" post="DMAb phase I trial is utilizing this co-formulated approach."/>
   <result pre="A and B viruses [36, 37, 97], Ebolavirus [36, 42]," exact="Zika" post="virus [38], CHIKV [121], rabies [15], and HIV [49]."/>
   <result pre="viruses [36, 37, 97], Ebolavirus [36, 42], Zika virus [38]," exact="CHIKV" post="[121], rabies [15], and HIV [49]. Anti-Dengue Virus pDNA-mAbs"/>
   <result pre="Virus pDNA-mAbs Over 2 billion people are at risk for" exact="Zika" post="virus infection [125]. Building on the early studies with"/>
   <result pre="Both anti-Zika virus wt-DMAb and LALA-DMAb protected AG129 mice against" exact="Zika" post="virus challenge and, in addition, protected against Zika-related damage"/>
   <result pre="a sequential administration strategy on daysâ€‰âˆ’â€‰10,â€‰âˆ’â€‰7, andâ€‰âˆ’â€‰4 before challenge with" exact="Zika" post="virus PRVABC59 on day 0. Macaques expressed on average"/>
   <result pre="time of challenge, and four out of five animals controlled" exact="Zika" post="virus infection. This was the first demonstration that a"/>
   <result pre="translation of the DMAb platform for administration in people. This" exact="Zika" post="virus DMAb candidate is now in a human trial"/>
   <result pre="LNP, have been evaluated targeting rabies [15], HIV [49], and" exact="CHIKV" post="[127]. Human anti-rabies immunoglobulin and the rabies vaccine must"/>
   <result pre="et al. delivered an anti-CHIKV DMAb in combination with a" exact="CHIKV" post="DNA vaccine, demonstrating both immediate and persistent protection against"/>
   <result pre="the safety, tolerability, and pharmacokinetic expression of the anti-E protein" exact="Zika" post="virus DMAb (INO-A002) is currently underway (NCT03831503; trial start"/>
   <result pre="delivery of a DNA-encoded monoclonal antibody protects non-human primates against" exact="Zika" post="virusMol Ther201927597498510.1016/j.ymthe.2019.03.00530962164 39.PatelADiGiandomenicoAKellerAESmithTRFParkDHRamosSet al.An engineered bispecific DNA-encoded IgG antibody"/>
   <result pre="plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or" exact="West Nile" post="virus is similar despite differing plasmid backbones or gene-insertsToxicol"/>
   <result pre="plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or" exact="West Nile" post="virus is similar, without integration, despite differing plasmid backbones"/>
   <result pre="Med.2016375151448145610.1056/NEJMoa160433027732819 125.AlanizAJBacigalupoACattanPESpatial quantification of the world population potentially exposed to" exact="Zika" post="virusInt J Epidemiol201746396697510.1093/ije/dyw36628338754 126.SokDBurtonDRRecent progress in broadly neutralizing antibodies"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7212070\results\search\tropicalVirus\results.xml">
   <result pre="(JE), La Crosse encephalitis, St. Louis encephalitis, western equine encephalitis," exact="West Nile" post="virus encephalitis), ii. Enteroviruses (e.g., coxsackievirus, polioviruses), iii. Herpes"/>
   <result pre="genus Flavivirus, which also includes the dengue, yellow fever and" exact="West Nile" post="viruses and is transmitted by Culex mosquitoes. In northern"/>
   <result pre="al.Cross-protection induced by Japanese encephalitis vaccines against different genotypes of" exact="Dengue" post="viruses in mice Scientific reports2016611928442746 11LiuBLiNLWangJShiP-YWangTMillerMAet al.Overlapping and distinct"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7213670\results\search\tropicalVirus\results.xml">
   <result pre="severe hemorrhagic disease 25. Notably, the possibility of ADE between" exact="Zika" post="virus (ZIKV), the causative agent of ZIKV congenital syndrome"/>
   <result pre="of ADE between Zika virus (ZIKV), the causative agent of" exact="ZIKV" post="congenital syndrome 26, and DENV has been intensely debated"/>
   <result pre="(ZIKV), the causative agent of ZIKV congenital syndrome 26, and" exact="DENV" post="has been intensely debated recently 27-29. Moreover, ADE has"/>
   <result pre="stimulation of the innate antiviral responseJ Virol201488(8)41809410.1128/JVI.03114-1324478443 26CugolaFRFernandesIRRussoFBFreitasBCDiasJLGuimarÃ£esKPet al.The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental modelsNature2016534(7606)2677110.1038/nature1829627279226 27BardinaSVBunducPTripathiSDuehrJFrereJJBrownJAet"/>
   <result pre="strain causes birth defects in experimental modelsNature2016534(7606)2677110.1038/nature1829627279226 27BardinaSVBunducPTripathiSDuehrJFrereJJBrownJAet al.Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunityScience2017356(6334)1758010.1126/science.aal436528360135 28DejnirattisaiWSupasaPWongwiwatWRouvinskiABarba-SpaethGDuangchindaTet al.Dengue virus"/>
   <result pre="Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed" exact="Zika" post="Virus-Infected PatientsClin Infect Dis201765(8)1260510.1093/cid/cix55829017246 30KuzminaNAYounanPGilchukPSantosRIFlyakAIIlinykhPAet al.Antibody-Dependent Enhancement of Ebola"/>
   <result pre="autologous non-neutralising antibodies at early stages of infectionRetrovirology201181610.1186/1742-4690-8-1621401915 32KuczeraDAssoliniJPTomiotto-PellissierFPavanelliWRSilveiraGFHighlights for" exact="Dengue" post="Immunopathogenesis: Antibody-Dependent Enhancement, Cytokine Storm, and BeyondJ Interf Cytokine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7213748\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : People and places : Geographical locations :"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences: Epidemiology : Biology"/>
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Infectious Diseases:"/>
   <result pre="Sciences : Infectious Diseases: Vector-Borne Diseases New estimates of the" exact="Zika" post="virus epidemic attack rate in Northeastern Brazil from 2015"/>
   <result pre="A modelling analysis based on Guillain-BarrÃ© Syndrome (GBS) surveillance data" exact="Zika" post="versus Guillain-BarrÃ© Syndrome http://orcid.org/0000-0003-3253-654XHeDaihaiConceptualizationFormal analysisMethodologyProject administrationSupervisionWriting â€&quot; review &amp;amp;"/>
   <result pre="Between January 2015 and August 2016, two epidemic waves of" exact="Zika" post="virus (ZIKV) disease swept the Northeastern (NE) region of"/>
   <result pre="Guillain-BarrÃ© Syndrome (GBS) were observed concurrently. The mandatory reporting of" exact="ZIKV" post="disease began region-wide in February 2016, and it is"/>
   <result pre="began region-wide in February 2016, and it is believed that" exact="ZIKV" post="cases were significantly under-reported before that. The changing reporting"/>
   <result pre="changing reporting rate has made it difficult to estimate the" exact="ZIKV" post="infection attack rate, and studies in the literature vary"/>
   <result pre="this paper, we aim to estimate the real number of" exact="ZIKV" post="cases (i.e., the infection attack rate) and their dynamics"/>
   <result pre="makes it possible to infer the true epidemic dynamics of" exact="ZIKV" post="cases based on surveillance data of excess GBS cases."/>
   <result pre="excess GBS cases. The model includes the possibility that asymptomatic" exact="ZIKV" post="cases are infectious. The model is fitted to the"/>
   <result pre="reproductive number R 0 , and to infer the true" exact="ZIKV" post="epidemic dynamics. Findings and conclusions The GBS surveillance data"/>
   <result pre="conclusions The GBS surveillance data can be used to study" exact="ZIKV" post="epidemics and may be appropriate when ZIKV reporting rates"/>
   <result pre="used to study ZIKV epidemics and may be appropriate when" exact="ZIKV" post="reporting rates are not well understood. The overall infection"/>
   <result pre="not well understood. The overall infection attack rate (IAR) of" exact="ZIKV" post="is estimated to be 24.1% (95% confidence interval: 17.1%â€&quot;29.3%)"/>
   <result pre="is likely to be lower than 33% over the two" exact="ZIKV" post="waves. The risk rate from symptomatic ZIKV infection to"/>
   <result pre="over the two ZIKV waves. The risk rate from symptomatic" exact="ZIKV" post="infection to develop GBS was estimated as Ï� ="/>
   <result pre="Our analysis revealed that asymptomatic infections affect the estimation of" exact="ZIKV" post="epidemics and need to also be carefully considered in"/>
   <result pre="reproduction number and population wide susceptibility, we comment that a" exact="ZIKV" post="outbreak would be unlikely in NE Brazil in the"/>
   <result pre="the near future. Author summary The mandatory reporting of the" exact="Zika" post="virus (ZIKV) disease began region-wide in February 2016, and"/>
   <result pre="began region-wide in February 2016, and it is believed that" exact="ZIKV" post="cases could have been highly under-reported before that. Given"/>
   <result pre="act as a reasonably reliable proxy for inferring the true" exact="ZIKV" post="epidemics. We developed a mathematical model incorporating weather effects"/>
   <result pre="epidemiological parameters. It was found that the attack rate of" exact="ZIKV" post="was likely to be lower than 33% over the"/>
   <result pre="over the two epidemic waves. The risk rate from symptomatic" exact="ZIKV" post="case to develop GBS was estimated to be approximately"/>
   <result pre="The analysis suggests that it would be difficult for another" exact="ZIKV" post="outbreak to appear in Northeastern Brazil in the near"/>
   <result pre="within the manuscript and its Supporting Information files. Introduction The" exact="Zika" post="virus (ZIKV) was first identified in 1947 in the"/>
   <result pre="Zika virus (ZIKV) was first identified in 1947 in the" exact="Zika" post="forest of Uganda [1], and within a few years"/>
   <result pre="the bites of mosquito vectors (usually of the Aedes genus)," exact="ZIKV" post="is an arbovirus from the family Flaviviridae [4, 5]."/>
   <result pre="it infected up to 75% of the island population [11]." exact="ZIKV" post="reached Polynesia in 2013, and at least by 2015,"/>
   <result pre="been associated with severe neurological disorders linked to birth defects." exact="ZIKV" post="infection was found to pass from mother to fetus"/>
   <result pre="abnormalities including possible skull collapse [5]. In addition, since 2014" exact="ZIKV" post="was found to be strongly associated with the Guillain-BarrÃ©"/>
   <result pre="[16]. Many studies found a causal link between GBS and" exact="ZIKV" post="disease [17, 18, 19]. In summary, GBS has many"/>
   <result pre="19]. In summary, GBS has many times been associated with" exact="ZIKV" post="outbreaks in many countries [15], making the empirical association"/>
   <result pre="unusually strong. While considered relatively benign for decades since 1947," exact="ZIKV" post="disease suddenly became a major global disease threat. A"/>
   <result pre="true attack rate, the proportion of asymptomatic cases amongst infected" exact="ZIKV" post="cases, the reproductive number. This has led to stepped"/>
   <result pre="associated with the large uncertainties associated with the reporting of" exact="ZIKV" post="cases. Instead, we work with time series of GBS"/>
   <result pre="the doctor. Fig 1 makes clear the strong association between" exact="ZIKV" post="cases and GBS by plotting reported cases of both"/>
   <result pre="GBS data collected during and following the period of a" exact="ZIKV" post="outbreak. We use this to infer the true numbers,"/>
   <result pre="to infer the true numbers, and dynamics in time, of" exact="ZIKV" post="cases. Fig 1 Total ZIKV (top) and GBS (bottom)"/>
   <result pre="and dynamics in time, of ZIKV cases. Fig 1 Total" exact="ZIKV" post="(top) and GBS (bottom) cases as time series summed"/>
   <result pre="in this figure were merely to illustrate the match between" exact="ZIKV" post="and GBS cases data, and the data are not"/>
   <result pre="French Polynesia From October 2013 to April 2014, a severe" exact="ZIKV" post="outbreak hit French Polynesia, and the attack rate (IAR)"/>
   <result pre="delay in the peak timing, and was linked to the" exact="ZIKV" post="outbreak [23]. Based on the IAR of [22], the"/>
   <result pre="[23]. Based on the IAR of [22], the risk of" exact="ZIKV" post="induced GBS can thus be roughly calculated as 0.32"/>
   <result pre="thus be roughly calculated as 0.32 GBS cases per 1,000" exact="ZIKV" post="infections, or just Ï� = 0.00032. [23] estimated the"/>
   <result pre="These findings are notably different from estimates for a previous" exact="ZIKV" post="outbreak in Yap island in 2007, where the asymptomatic"/>
   <result pre="where the asymptomatic ratio was 4.4:1 and the estimated overall" exact="ZIKV" post="IAR was about 75% [11]. Following the ZIKV outbreak"/>
   <result pre="estimated overall ZIKV IAR was about 75% [11]. Following the" exact="ZIKV" post="outbreak in French Polynesia, the region experienced a Chikungunya"/>
   <result pre="the ZIKV outbreak in French Polynesia, the region experienced a" exact="Chikungunya" post="virus (CHIKV) disease outbreak with an estimated 66,000 cases"/>
   <result pre="and 9 GBS cases occurred [24]. The crude risk of" exact="CHIKV" post="induced GBS was found to be 0.136 per 1,000"/>
   <result pre="CHIKV induced GBS was found to be 0.136 per 1,000" exact="CHIKV" post="infections. Thus, based on these studies [23, 24], a"/>
   <result pre="CHIKV infections. Thus, based on these studies [23, 24], a" exact="ZIKV" post="infection is of (0.32 Ã· 0.136 =) 2.35-fold more"/>
   <result pre="2.35-fold more likely to induce GBS when compared to a" exact="CHIKV" post="infection. Cauchemez et al. (2016) [21] also found that"/>
   <result pre="et al. (2016) [21] also found that the risk of" exact="ZIKV" post="induced microcephaly was 95 cases (34-191) per 10,000 women"/>
   <result pre="were also recorded. Over the two years, two waves of" exact="ZIKV" post="disease were accompanied by two waves of reported GBS"/>
   <result pre="of microcephaly cases with a 23-week delay to the first" exact="ZIKV" post="wave was identified and discussed in [26]. The delay"/>
   <result pre="was identified and discussed in [26]. The delay arises because" exact="ZIKV" post="infections in the first trimester of pregnancy are most"/>
   <result pre="induce microcephaly [21, 27, 28, 29]). Fig 2 The reported" exact="ZIKV" post="cases, excess (or surplus) GBS cases and GBS-to-ZIKV ratio"/>
   <result pre="2015 to November 2016. The red dotted line represents weekly" exact="ZIKV" post="disease cases, the dark blue dotted line represents weekly"/>
   <result pre="cases and the light blue bars are GBS-to-ZIKV ratios. The" exact="CHIKV" post="outbreak of 2016 is denoted with different shades of"/>
   <result pre="for the initial few weeks as the scale of the" exact="ZIKV" post="data is not large enough to compute a meaningful"/>
   <result pre="not large enough to compute a meaningful ratio. A substantial" exact="CHIKV" post="wave was also observed during the second ZIKV wave"/>
   <result pre="A substantial CHIKV wave was also observed during the second" exact="ZIKV" post="wave in 2016 as indicated in Fig 2 and"/>
   <result pre="wave in 2016 as indicated in Fig 2 and [26]." exact="CHIKV" post="can induce GBS with a smaller risk ratio (1"/>
   <result pre="GBS with a smaller risk ratio (1 to 2.35) than" exact="ZIKV" post="as discussed above and according to results in [24,"/>
   <result pre="recent cohort study was conducted on 345 pregnant women with" exact="ZIKV" post="rash observed (presenting at the Oswaldo Cruz Foundation) in"/>
   <result pre="between September 2015 and May 2016 [29]. The IAR of" exact="CHIKV" post="was found to be approximately 17%; and in contrast,"/>
   <result pre="to be approximately 17%; and in contrast, the IAR of" exact="ZIKV" post="was 53%, as based on PCR tests. In addition,"/>
   <result pre="based on PCR tests. In addition, a strong cross-protection between" exact="ZIKV" post="and CHIKV was also observed, but no cross-protection was"/>
   <result pre="PCR tests. In addition, a strong cross-protection between ZIKV and" exact="CHIKV" post="was also observed, but no cross-protection was observed between"/>
   <result pre="CHIKV was also observed, but no cross-protection was observed between" exact="ZIKV" post="and dengue virus (DENV). The IAR of CHIKV was"/>
   <result pre="observed between ZIKV and dengue virus (DENV). The IAR of" exact="CHIKV" post="was 21.1%, and 41.7% for ZIKV-negative women while only"/>
   <result pre="women with rash observed in this period, the ratio of" exact="ZIKV" post="and CHIKV is (roughly) 5 to 2. Evident cross-protection"/>
   <result pre="rash observed in this period, the ratio of ZIKV and" exact="CHIKV" post="is (roughly) 5 to 2. Evident cross-protection between CHIKV"/>
   <result pre="and CHIKV is (roughly) 5 to 2. Evident cross-protection between" exact="CHIKV" post="and ZIKV (but not between DENV and ZIKV) can"/>
   <result pre="is (roughly) 5 to 2. Evident cross-protection between CHIKV and" exact="ZIKV" post="(but not between DENV and ZIKV) can be deduced"/>
   <result pre="2. Evident cross-protection between CHIKV and ZIKV (but not between" exact="DENV" post="and ZIKV) can be deduced from the same study"/>
   <result pre="excess GBS cases in NE Brazil were largely due to" exact="ZIKV" post="disease rather than CHIKV, for two reasons: (i) ZIKV"/>
   <result pre="to ZIKV disease rather than CHIKV, for two reasons: (i)" exact="ZIKV" post="is 2.35-fold likely to induce GBS than CHIKV; and"/>
   <result pre="is 2.35-fold likely to induce GBS than CHIKV; and (ii)" exact="ZIKV" post="IAR could be three times higher than that of"/>
   <result pre="ZIKV IAR could be three times higher than that of" exact="CHIKV" post="based on the Rio de Janeiro study [29] to"/>
   <result pre="is difficult to estimate the infection attack rate (IAR) of" exact="ZIKV" post="directly from the reported ZIKV cases time series given"/>
   <result pre="infection attack rate (IAR) of ZIKV directly from the reported" exact="ZIKV" post="cases time series given the non-constant reporting efforts over"/>
   <result pre="and 2016. In the literature, estimates of the IAR of" exact="ZIKV" post="in Brazil (especially Northeast Region of Brazil) vary from"/>
   <result pre="the S1 Text. Most previous works were based on unreliable" exact="ZIKV" post="surveillance data. In this work, we aim to use"/>
   <result pre="relatively reliable GBS data in NE Brazil to infer the" exact="ZIKV" post="epidemic. The under-reporting of ZIKV cases in 2015 also"/>
   <result pre="NE Brazil to infer the ZIKV epidemic. The under-reporting of" exact="ZIKV" post="cases in 2015 also appears to be reflected in"/>
   <result pre="felt it might not be wise to estimate IAR of" exact="ZIKV" post="directly based on the reported number of microcephaly cases."/>
   <result pre="of time-varying birth rates if using microcephaly cases to infer" exact="ZIKV" post="cases. However, it seems a reasonable approximation to assume"/>
   <result pre="approximation to assume that the number of GBS cases per" exact="ZIKV" post="infected individual should remain constant in time, and that"/>
   <result pre="series. Because of the co-circulation of both dengue fever and" exact="ZIKV" post="during the two waves, misdiagnoses of ZIKV could occur"/>
   <result pre="dengue fever and ZIKV during the two waves, misdiagnoses of" exact="ZIKV" post="could occur [29, 27, 26], especially given both diseases"/>
   <result pre="given both diseases have similar symptoms. Nevertheless, no GBS induced" exact="DENV" post="was reported in the 2015 and 2016 years. Thus,"/>
   <result pre="reported in the 2015 and 2016 years. Thus, the large-scale" exact="ZIKV" post="outbreak was the major source of the excess GBS"/>
   <result pre="excess GBS cases time series to infer the pattern of" exact="ZIKV" post="outbreak and the overall IAR of ZIKV in Northeastern"/>
   <result pre="the pattern of ZIKV outbreak and the overall IAR of" exact="ZIKV" post="in Northeastern Brazil. Mathematical modelling provides a possible way"/>
   <result pre="provides a possible way to infer the epidemic waves of" exact="ZIKV" post="(or together with a minor proportion of CHIKV). First,"/>
   <result pre="CHIKV). First, we assume a constant risk ratio between symptomatic" exact="ZIKV" post="cases and reported GBS cases (ZIKV-GBS ratio), denoted by"/>
   <result pre="cases (ZIKV-GBS ratio), denoted by Ï�. Second, we simulate our" exact="ZIKV" post="model, and fit the model to observed GBS cases"/>
   <result pre="fit the model to observed GBS cases with a time-dependent" exact="ZIKV" post="transmission rate. Finally, by using iterated filtering techniques, we"/>
   <result pre="time series are plotted in Fig 2 with datasets of" exact="ZIKV" post="and CHIKV for the period. The GBS data used"/>
   <result pre="are plotted in Fig 2 with datasets of ZIKV and" exact="CHIKV" post="for the period. The GBS data used in this"/>
   <result pre="in 2015, which was likely due to the under-reporting of" exact="ZIKV" post="epidemic before 2016 [20]. Daily mean temperature and total"/>
   <result pre="Text. Methods In previous work [6, 40], we developed a" exact="ZIKV" post="transmission model, including both host and vector, based on"/>
   <result pre="mosquito-borne and sexual (human-to-human) transmission of ZIKV. Hosts infected with" exact="ZIKV" post="generate a proportion of GBS cases as determined by"/>
   <result pre="which is the ratio of reported GBS cases to symptomatic" exact="ZIKV" post="cases. In our earlier work, asymptomatic ZIKV cases were"/>
   <result pre="cases to symptomatic ZIKV cases. In our earlier work, asymptomatic" exact="ZIKV" post="cases were assumed to be non-infectious. However, in this"/>
   <result pre="assumed to be non-infectious. However, in this work the asymptomatic" exact="ZIKV" post="cases are now assumed to be infectious, and we"/>
   <result pre="ZIKV-GBS model Fig 3 shows the model diagram of the" exact="ZIKV" post="disease transmission pathways of both humans and the mosquito"/>
   <result pre="[6, 40], we continue to assume that hosts infected with" exact="ZIKV" post="are infectious during the convalescent stage and can infect"/>
   <result pre="host class, Eh is the exposed host class (i.e., within" exact="ZIKV" post="infection latent period), Ah denotes the asymptomatic host class,"/>
   <result pre="susceptible vector class, Ev is the exposed vector (i.e., within" exact="ZIKV" post="infection latent period) and Iv denotes the infectious vector"/>
   <result pre="hostsâ€™ population, and â€œVâ€� denotes mosquito vectorsâ€™ population. â€œXâ†’Yâ€� denotes" exact="ZIKV" post="infected class X infects the (ZIKV) susceptible class Y."/>
   <result pre="4â€&quot;35 days fixed [49, 50, 51] Ratio: reported GBS symptomatic" exact="ZIKV" post="Ï� 0.001%â€&quot;0.1% Nil to be estimated [15, 22, 23]"/>
   <result pre="Markov model) with a â€œspilloverâ€� rate (Ï�) from local symptomatic" exact="ZIKV" post="cases. Here Ï� is the combined effect of the"/>
   <result pre="the GBS reporting ratio and the risk rate of symptomatic" exact="ZIKV" post="inducing GBS i.e., the ratio Ï� = reported GBS"/>
   <result pre="inducing GBS i.e., the ratio Ï� = reported GBS symptomatic" exact="ZIKV" post="(see Table 1). The simulated (weekly) number of excess"/>
   <result pre="lagged effect on the local mosquito population, the progress from" exact="ZIKV" post="to GBS development and any reporting delay. Previous studies"/>
   <result pre="at least 3 weeks between the exposure of patients to" exact="ZIKV" post="and the development of GBS (i.e., an incubation period"/>
   <result pre="in the mosquito population, due to the possible interference between" exact="ZIKV" post="and CHIKV for instance, and/or local mosquito control measures."/>
   <result pre="mosquito population, due to the possible interference between ZIKV and" exact="CHIKV" post="for instance, and/or local mosquito control measures. The function"/>
   <result pre="programing language (see S1 Text). Results Connecting the GBS and" exact="ZIKV" post="data, and changing reporting rates Fig 1 plots the"/>
   <result pre="changing reporting rates Fig 1 plots the time series of" exact="ZIKV" post="cases and GBS from the period April 1 of"/>
   <result pre="These time series demonstrate the tight connection between the reported" exact="ZIKV" post="disease and GBS, whose case numbers closely mimic one"/>
   <result pre="The connection is the basis of our method for estimating" exact="ZIKV" post="cases from GBS reports, which as we have discussed,"/>
   <result pre="2. The time series indicate two epidemic outbreaks of reported" exact="ZIKV" post="cases, where the second outbreak in 2016 is far"/>
   <result pre="risk rate of 0.032% i.e., 0.32 GBS cases per 1,000" exact="ZIKV" post="infections (asymptomatic and symptomatic) calculated in [23], the total"/>
   <result pre="(asymptomatic and symptomatic) calculated in [23], the total cases of" exact="ZIKV" post="can be approximated according to the excess GBS cases"/>
   <result pre="2015 there were 233 excess GBS cases and 38,641 reported" exact="ZIKV" post="cases, but in 2016 there were 168 excess GBS"/>
   <result pre="2016 there were 168 excess GBS cases and 70,916 reported" exact="ZIKV" post="cases. The ratio of GBS/Zika reported cases is plotted"/>
   <result pre="by a factor of 0.72 (168/233), the number of reported" exact="ZIKV" post="cases rose by a factor of 70, 916Ã·38, 641"/>
   <result pre="is that there must have been a major under-reporting of" exact="ZIKV" post="cases in the first year of 2015 [60, 69]."/>
   <result pre="This also seems reasonable since in 2015 the official WHO" exact="ZIKV" post="reporting program had not yet been launched [20]. Suppose"/>
   <result pre="there should have been some 98,353 (= 233 Ã— 70916Ã·168)" exact="ZIKV" post="reported cases in 2015 rather than only the 38,641"/>
   <result pre="reality. Thus for the 2015 year, it would appear that" exact="ZIKV" post="was under-reported by a factor of 2.5 when compared"/>
   <result pre="under-reported by a factor of 2.5 when compared to the" exact="ZIKV" post="reporting rate in 2016. Fitting the model to GBS"/>
   <result pre="baseline parameters, with several different (possible) values of Î· (asymptomatic" exact="ZIKV" post="relative infectivity) and Î¸ (proportion of symptomatic ZIKV infections)"/>
   <result pre="Î· (asymptomatic ZIKV relative infectivity) and Î¸ (proportion of symptomatic" exact="ZIKV" post="infections) considered. The Î¸ = 0.5 simulations correspond to"/>
   <result pre="correspond to a 1:1 ratio of the symptomatic to asymptomatic" exact="ZIKV" post="infection of [22]. Simulations with Î¸ = 0.2 correspond"/>
   <result pre="correspond to the 4:1 ratio of the symptomatic to asymptomatic" exact="ZIKV" post="infection of [11]. Fig 4 The fitting results for"/>
   <result pre="thus our model successfully reconstructed the two waves of the" exact="ZIKV" post="epidemic in NE Brazil. Since we adopted a Negative"/>
   <result pre="and the IAR are summarised in Table 2. For the" exact="ZIKV" post="symptomatic ratio parameter, Î¸, we follow the previous serological"/>
   <result pre="is sensitive to the change of the symptomatic proportion of" exact="ZIKV" post="infections (Î¸). Setting Î¸ = 0.2 gives Ï� ="/>
   <result pre="0.000129 (0.000117,0.000178) 0.2847 (0.2071, 0.3140) To calculate the number of" exact="ZIKV" post="cases and the IAR, we use the estimate obtained"/>
   <result pre="0.00061â€&quot;ratio of reported GBS to symptomatic ZIKV), and denote the" exact="ZIKV" post="symptomatic ratio as Î¸, as before. Ï� can be"/>
   <result pre="can be estimated from the model. Then, the number of" exact="ZIKV" post="cases equals (the number of reported GBS) Ã· [reported"/>
   <result pre="number of the reported GBS/Ï�/Î¸. The IAR equals the number" exact="ZIKV" post="cases Ã· the total population in the NE Brazil."/>
   <result pre="can be at least 95% sure the IAR of the" exact="ZIKV" post="epidemic is below 33%, and is likely to be"/>
   <result pre="contribution from the sexual transmission path. The sexual transmissibility of" exact="ZIKV" post="can be ignored owing to (i) the contribution of"/>
   <result pre="and (ii) the recommendation to abstain from sexual contact during" exact="ZIKV" post="epidemics [10]. Hence, the term R h could be"/>
   <result pre="of the whole population were not involved in the 2015-16" exact="ZIKV" post="epidemic. The time points (Ï&quot;1) when the baseline of"/>
   <result pre="suggested the existence of the non-weather-driven temporal changes in the" exact="ZIKV" post="transmissibility. Results of the sensitivity analysis As is conventional,"/>
   <result pre="the ratio (or risk) of excess GBS cases to symptomatic" exact="ZIKV" post="infections (Ï�). Fig 5 The Partial Rank Correlation Coefficients"/>
   <result pre="success of de Oliveira et al. (2017) [26] in studying" exact="Zika" post="virus and its impact on human populations including microcephaly"/>
   <result pre="Brazil ([12, 26]. Based on the parallel between cases of" exact="ZIKV" post="disease and cases of GBS (eg., as seen in"/>
   <result pre="(eg., as seen in Fig 1), we have proposed a" exact="ZIKV" post="model that is calibrated on case data of GBS."/>
   <result pre="ZIKV model that is calibrated on case data of GBS." exact="ZIKV" post="case numbers are obtained by scaling up from GBS."/>
   <result pre="trustworthy and reliable compared to numbers obtained through surveillance of" exact="ZIKV" post="where there is much scope for errors in the"/>
   <result pre="reporting rate. Our model considers heterogeneity in symptomatic and asymptomatic" exact="ZIKV" post="infections (i.e., Î¸ and Î·) as well as the"/>
   <result pre="serological study [22], the ratio Ï� of GBS to symptomatic" exact="ZIKV" post="cases was found to be 0.00024 and 0.00032 respectively"/>
   <result pre="â€œwas 2.0 (95% CI 0.5-4.5) GBS reported cases per 10,000" exact="ZIKV" post="infections, i.e., 0.02%, (which is) close to the point"/>
   <result pre="the model estimation finds a ratio between GBS and symptomatic" exact="ZIKV" post="cases as Ï� = 0.000061 or equivalently Ï� ="/>
   <result pre="95% CI 0.0050%-0.0086%. That is, 1 GBS case per 16,400" exact="ZIKV" post="symptomatic cases which is approximately one quarter or 25%"/>
   <result pre="tentative and based on reasonable first approximations, seems plausible since" exact="ZIKV" post="surveillance was generally unreliable and probably severely under-reported, especially"/>
   <result pre="2016 [60, 69]. For this reason, we avoided using the" exact="ZIKV" post="surveillance data to fit the epidemic model, and our"/>
   <result pre="the indicated range. The model analysis estimated the IAR of" exact="ZIKV" post="cases in NE Brazil to lie between 22% to"/>
   <result pre="with caution. Due to poor surveillance, limited knowledge about the" exact="ZIKV" post="reporting ratio and population seropositivity, the estimates may have"/>
   <result pre="as a whole. Previous estimates of IAR relied on poor" exact="ZIKV" post="data in Brazilian regions: some estimates appear to be"/>
   <result pre="GBS data as a proxy to estimate the IAR of" exact="ZIKV" post="epidemics. We found that the IAR is likely to"/>
   <result pre="rarer disease than microcephaly. Nevertheless, we still chose to predict" exact="ZIKV" post="cases based on GBS rather than microcephaly cases, because"/>
   <result pre="the condition. Return now to the dynamics of the reconstructed" exact="ZIKV" post="cases generated by Eq (1) as calibrated on the"/>
   <result pre="to the intensities reported in Fig 3 of [12] for" exact="ZIKV" post="in Brazil. As the net growth rate of mosquitoes"/>
   <result pre="immediately suggests the existence of non-weather-driven temporal changes in the" exact="ZIKV" post="transmissibility. The baseline drop in m(t) would also lead"/>
   <result pre="0 ( t ) , and indicates a decrease in" exact="ZIKV" post="transmissibility across the two epidemic waves. Since the official"/>
   <result pre="transmissibility across the two epidemic waves. Since the official mandatory" exact="ZIKV" post="reporting began in February 2016, this may have increased"/>
   <result pre="in February 2016, this may have increased public awareness of" exact="ZIKV" post="risk, and thus reduced the spread of infection [70,"/>
   <result pre="time point coincides with the peak timing of the concurrent" exact="CHIKV" post="outbreak [26]. Also, very close to this date, R"/>
   <result pre="rate of ZIKV. We argue that the reporting rate of" exact="ZIKV" post="disease increased dramatically around February and March of 2016,"/>
   <result pre="to assume that the data for the second wave of" exact="ZIKV" post="in 2016 is more reliable than that of the"/>
   <result pre="that of the first. Taking the maximum of the second" exact="ZIKV" post="wave divided by the maximum of the GBS wave,"/>
   <result pre="diseases is 436; i.e., 1 GBS case per 436 reported" exact="ZIKV" post="cases. However, our model fitting finds a ratio between"/>
   <result pre="our model fitting finds a ratio between GBS and symptomatic" exact="ZIKV" post="cases as Ï� = 0.000061, or 1 GBS case"/>
   <result pre="as Ï� = 0.000061, or 1 GBS case per 16,400" exact="ZIKV" post="symptomatic cases. Thus, we can conclude that the reporting"/>
   <result pre="Thus, we can conclude that the reporting ratio of symptomatic" exact="ZIKV" post="cases is roughly 16, 400/436 â‰ˆ 38. Namely, for"/>
   <result pre="roughly 16, 400/436 â‰ˆ 38. Namely, for every 38 symptomatic" exact="ZIKV" post="cases, there was 1 case reported, over the second"/>
   <result pre="the population was already exposed to dengue before the 2015" exact="Zika" post="outbreak and this may have provided a significant proportion"/>
   <result pre="titers to dengue virus were associated with reduced risk of" exact="ZIKV" post="infection and symptoms.â€� A similar outcome was noted in"/>
   <result pre="al. [83]. Second, Faria et al. [84] indicated that the" exact="Zika" post="virus (Asian ZIKV genotype) may already have been in"/>
   <result pre="Faria et al. [84] indicated that the Zika virus (Asian" exact="ZIKV" post="genotype) may already have been in Brazil as early"/>
   <result pre="[35]. Messina et al. [85] reported that most of the" exact="ZIKV" post="incidences of NE Brazil were distributed in the coastal"/>
   <result pre="here for additional data file. References References 1DickGW, KitchenSF, AJH." exact="Zika" post="virus (I). Isolations and serological specificity. Transactions of the"/>
   <result pre="Annals of Tropical Medicine &amp;amp; Parasitology. 1975;69(1):49â€&quot;64. 10.1080/00034983.1975.116869831124969 3WikanN, SmithD." exact="Zika" post="virus: history of a newly emerging arbovirus. The Lancet"/>
   <result pre="The Lancet Infectious diseases. 2016;16(7):e119â€&quot;26. 10.1016/S1473-3099(16)30010-X27282424 4PetersenLR, JamiesonDJ, PowersAM, HoneinM." exact="Zika" post="virus. New England Journal of Medicine. 2016;374(16):1552â€&quot;63. 10.1056/NEJMra160211327028561 5MlakarJ,"/>
   <result pre="LouY, HeD, PorcoTC, KuangY, ChowellG, et al.Prevention and control of" exact="Zika" post="as a mosquito-borne and sexually transmitted disease: a mathematical"/>
   <result pre="MubayiA, Romero-VivasC. Estimate of the reproduction number of the 2015" exact="Zika" post="virus outbreak in Barranquilla, Colombia, and estimation of the"/>
   <result pre="10.1016/j.epidem.2016.10.00327846442 8AtkinsonB, HearnP, AfroughB, LumleyS, CarterD, AaronsEJ, et al.Detection of" exact="Zika" post="virus in semen. Emerging infectious diseases. 2016;22(5):94010.3201/eid2205.16010727088817 9MussoD, RocheC,"/>
   <result pre="9MussoD, RocheC, RobinE, NhanT, TeissierA, Cao-LormeauV. Potential sexual transmission of" exact="Zika" post="virus. Emerging infectious diseases. 2015;21(2):35910.3201/eid2102.14136325625872 10World Health Organization official"/>
   <result pre="virus. Emerging infectious diseases. 2015;21(2):35910.3201/eid2102.14136325625872 10World Health Organization official website." exact="Zika" post="virus fact sheet.;. Accessed on June 2017. Available from:"/>
   <result pre="12ZhangQ, SunK, ChinazziM, y PionttiA, DeanN, RojasD, et al.Spread of" exact="Zika" post="virus in the Americas. Proceedings of the National Academy"/>
   <result pre="the National Academy of Sciences. 2017;p. 201620161. 13CamposGS, BandeiraAC, SardiS." exact="Zika" post="virus outbreak, Bahia, Brazil. Emerging infectious diseases. 2015;21(10):188510.3201/eid2110.15084726401719 14OehlerE,"/>
   <result pre="DeloreyMJ, SejvarJJ, JohanssonM. Guillainâ€&quot;BarrÃ© syndrome risk among individuals infected with" exact="Zika" post="virus: a multi-country assessment. BMC medicine. 2018;16(1):6710.1186/s12916-018-1052-429759069 16The World"/>
   <result pre="WenZ, ChengY, HuangWK, QianX, et al.Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
   <result pre="MarchioriE. â€œMagnetic resonance imaging findings in Guillain-BarrÃ© syndrome caused by" exact="Zika" post="virus infectionâ€�. Neuroradiology. 2016;58(8):837â€&quot;8. 10.1007/s00234-016-1687-927067205 20The News press entitled"/>
   <result pre="Neuroradiology. 2016;58(8):837â€&quot;8. 10.1007/s00234-016-1687-927067205 20The News press entitled Exclusive: Brazil says" exact="Zika" post="virus outbreak worse than believed the Reuters.;. Available from:"/>
   <result pre="BompardP, DubT, Guillemette-ArturP, Eyrolle-GuignotD, et al. and others. â€œAssociation between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013â€&quot;15: a retrospective"/>
   <result pre="MonsS, LastereS, RocheC, VanhomwegenJ, et al.Guillain-Barre Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control study. The"/>
   <result pre="SookhareeaC, et al.Increase in cases of Guillain-Barre syndrome during a" exact="Chikungunya" post="outbreak, French Polynesia, 2014 to 2015. Euro Surveill. 2015;20(48):3007910.2807/1560-7917.ES.2015.20.48.3007926690898"/>
   <result pre="theoretical estimate of the risk of microcephaly during pregnancy with" exact="Zika" post="virus infection. Epidemics. 2016;15:66â€&quot;70. 10.1016/j.epidem.2016.03.00127288540 28EllingtonSR, DevineO, BertolliJ, QuiÃ±onesAM,"/>
   <result pre="Perez-PadillaJ, et al.Estimating the number of pregnant women infected with" exact="Zika" post="virus and expected infants with microcephaly following the Zika"/>
   <result pre="with Zika virus and expected infants with microcephaly following the" exact="Zika" post="virus outbreak in Puerto Rico, 2016. JAMA pediatrics. 2016;170(10):940â€&quot;5."/>
   <result pre="De MonredonJ, El AmraniM, RogerJC, ServeauxJ. Guillain-Barre syndrome complicating a" exact="Chikungunya" post="virus infection. Neurology. 2007;69(22):2105â€&quot;7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW, SilveraLA, Paez-CastellanosJ, Rodriguez-MoralesA."/>
   <result pre="Neurology. 2007;69(22):2105â€&quot;7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW, SilveraLA, Paez-CastellanosJ, Rodriguez-MoralesA. Guillain-Barre syndrome after" exact="Chikungunya" post="infection: A case in Colombia. Enfermedades infecciosas y microbiologia"/>
   <result pre="2016;34(2):140â€&quot;1. 10.1016/j.eimc.2015.05.01226164263 33EconomopoulouA, DominguezM, HelynckB, SissokoD, WichmannO, QuenelP, et al.Atypical" exact="Chikungunya" post="virus infections: clinical manifestations, mortality and risk factors for"/>
   <result pre="Sciences. 2013;280(1770):2013117410.1098/rspb.2013.117424026815 40HeD, GaoD, LouY, ZhaoS, RuanSA. comparison study of" exact="Zika" post="virus outbreaks in French Polynesia, Colombia and the State"/>
   <result pre="Interface. 2010;7:271â€&quot;83. 10.1098/rsif.2009.015119535416 42GourinatAC, Oâ€™ConnorO, CalvezE, GoarantC, Dupont-RouzeyrolM. Detection of" exact="Zika" post="virus in urine. Emerging infectious diseases. 2015;21(1):8410.3201/eid2101.14089425530324 43MussoD, RocheC,"/>
   <result pre="43MussoD, RocheC, RobinE, NhanT, TeissierA, Cao-LormeauV. Potential sexual transmission of" exact="Zika" post="virus. Emerg Infect Dis. 2015;21(2):359â€&quot;61. 10.3201/eid2102.14136325625872 44ZhaoS, StoneL, GaoD,"/>
   <result pre="all four serotypes. J Infect Dev Ctries. 2009;3:711â€&quot;22. 10.3855/jidc.61619858573 47BearcroftW." exact="Zika" post="virus infection experimentally induced in a human volunteer. Transactions"/>
   <result pre="simple technique for infection of mosquitoes with viruses transmission of" exact="Zika" post="virus. Transactions of the Royal Society of Tropical Medicine"/>
   <result pre="2016;1(1):79â€&quot;87. 10.1016/j.idm.2016.08.00129928722 55SasmalSK, GhoshI, HuppertA, ChattopadhyayJ. Modeling the Spread of" exact="Zika" post="Virus in a Stage-Structured Population: Effect of Sexual Transmission."/>
   <result pre="10.1214/08-AOAS201 59KucharskiAJ, FunkS, EggoRM, MalletHP, EdmundsWJ, NillesE. Transmission dynamics of" exact="Zika" post="virus in island populations: a modelling analysis of the"/>
   <result pre="in the variability of the basic reproductive number (R0) for" exact="Zika" post="epidemics in the Pacific islands. Elife. 2016;5:e1987410.7554/eLife.1987427897973 61PaploskiIA, PratesAP,"/>
   <result pre="SilvaMM, WallerLA, et al.Time lags between exanthematous illness attributed to" exact="Zika" post="virus, Guillain-BarrÃ© syndrome, and microcephaly, Salvador, Brazil. Emerging infectious"/>
   <result pre="LimaMM, FariaNR, WalkerA, KraemerM, et al.Epidemiological and ecological determinants of" exact="Zika" post="virus transmission in an urban setting. eLife. 2017;6:e29820 Available"/>
   <result pre="2018;451:80â€&quot;85. 10.1016/j.jtbi.2018.04.04129727633 75CousienA, AbelS, MonthieuxA, AndronicoA, CalmontI, CervantesM, et al.Assessing" exact="Zika" post="Virus Transmission Within Households During an Outbreak in Martinique,"/>
   <result pre="NeryN, CastanhaPM, SacramentoGA, et al.Impact of preexisting dengue immunity on" exact="Zika" post="virus emergence in a dengue endemic region. Science. 2019;363(6427):607â€&quot;10."/>
   <result pre="BradyOJ, PigottDM, ShearerFM, WeissDJ, et al.Mapping global environmental suitability for" exact="Zika" post="virus. Elife. 2016;5:e1527210.7554/eLife.1527227090089"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7213779\results\search\tropicalVirus\results.xml">
   <result pre="may lead to meningoencephalitis and neuropathies as seen for herpesviruses," exact="Zika" post="virus, and human immunodeficiency virus (HIV).31 , 32 ,"/>
   <result pre="pathophysiology, and pain management pharmacologyJ Multidiscip Healthc2016944745410.2147/JMDH.S10634027703368 32- Koike H." exact="Zika" post="Virus and Guillain-BarrÃ© Syndrome. Brain Nerve. 2018;70(2):113-20. doi: 10.11477/mf.1416200963KoikeHZika"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7215129\results\search\tropicalVirus\results.xml">
   <result pre="number of complex viruses, including HIV, HCV, CMV, Zika, RSV,Â" exact="Dengue" post="and SARS/MERS. For the same reason, convalescent serum prophylaxis"/>
   <result pre="interferon plays a crucial early antiviral role in protection against" exact="West Nile" post="virus infectionJ Virol2006805338534810.1128/JVI.00274-0616699014 91.LevyDEGarcia-SastreAThe virus battles: IFN induction of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7217786\results\search\tropicalVirus\results.xml">
   <result pre="130CaiL.SunY.SongY.XuL.BeiZ.ZhangD.Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of" exact="Zika" post="virus replicationArch Virol16220172847285328597088 131FangQ.Q.HuangW.J.LiX.Y.ChengY.H.TanM.J.LiuJ.Effectiveness of favipiravir (T-705) against wild-type"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7218368\results\search\tropicalVirus\results.xml">
   <result pre="verruciformis results from disruption of the EVER-CIB1-dependent control of beta" exact="HPV" post="in keratinocytes, a deficiency of non-hematopoietic, cell-intrinsic immunity. Together"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7219397\results\search\tropicalVirus\results.xml">
   <result pre="antigen targets, vaccine platforms, and clinical trial approaches used for" exact="Zika" post="virus (ZIKV) after its emergence in 2015 were based"/>
   <result pre="of myeloid cells expressing Fc-Î³ or complement receptors. ADE of" exact="DENV" post="infection contributes to severe clinical disease in a small"/>
   <result pre="infected for a second time by a heterologous serotype of" exact="DENV" post="or in newborns that have sub-neutralizing levels of maternal"/>
   <result pre="manner. ADE has been demonstrated using immunodeficient murine models of" exact="DENV" post="infection following passive transfer of immune sera, but disease"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7219405\results\search\tropicalVirus\results.xml">
   <result pre="and with the emergence of SARS, pandemic â€˜flu (2009), Ebola," exact="Zika" post="virus and now Covid-19 (this is far from an"/>
   <result pre="Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated" exact="Dengue" post="Vaccine (Dengvaxia): A Model Comparison StudyPLOS Med.132016e100218110.1371/journal.pmed.1002181 FunkS.KingA.A.Choices and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7219742\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="for vector competence using experimental oral exposure of females to" exact="CHIKV" post="and infection, dissemination and transmission assays. Results showed that"/>
   <result pre="showed that both populations of Ae. polynesiensis were competent for" exact="CHIKV" post="(30% at 7 days post-infection). Conclusions/Significance This study showed"/>
   <result pre="been affected by several dengue epidemics, but did not face" exact="Zika" post="or chikungunya outbreaks, unlike other neighboring islands. The near-exclusive"/>
   <result pre="population was recently shown to be able to transmit the" exact="Zika" post="virus under experimental conditions, but its susceptibility to the"/>
   <result pre="Samoa, American Samoa and Tokelau [12, 13]. In 2013, the" exact="Zika" post="virus was detected in French Polynesia and spread very"/>
   <result pre="low vector competence of Ae. polynesiensis from Wallis for the" exact="Zika" post="virus (ZIKV) [28], but the ability of this mosquito"/>
   <result pre="(ZIKV) [28], but the ability of this mosquito to transmit" exact="CHIKV" post="in these islands is unknown. An entomological field survey"/>
   <result pre="investigated the vector competence of local Ae. polynesiensis populations for" exact="CHIKV" post="to determine the risk of transmission of chikungunya in"/>
   <result pre="females (F3) were fed with independent infectious blood meals containing" exact="CHIKV" post="at a titer of 107 pfu/ml. The CHIKV strain,"/>
   <result pre="meals containing CHIKV at a titer of 107 pfu/ml. The" exact="CHIKV" post="strain, isolated in 2011 from a patient in New"/>
   <result pre="transmit CHIKV, we infected two local mosquito populations with a" exact="CHIKV" post="strain isolated during the 2011 chikungunya outbreak in New"/>
   <result pre="exchanges with New Caledonia and therefore the risk of introducing" exact="CHIKV" post="from this territory is high. Results showed that, for"/>
   <result pre="WLALO), more than 80% of female mosquitoes were infected with" exact="CHIKV" post="(84% and 85%, respectively), more than 75% of females"/>
   <result pre="&amp;gt; 0.05) (Fig 3A). We quantified the number of infectious" exact="CHIKV" post="particles in the saliva. The viral loads of the"/>
   <result pre="three islands. Vector competence of Ae. polynesiensis from Wallis for" exact="CHIKV" post="was investigated. This arbovirus has not been detected so"/>
   <result pre="showed that the Ae. polynesiensis vector mosquito from Wallis transmitted" exact="CHIKV" post="(transmission efficiency of 30% at 7 dpi) under experimental"/>
   <result pre="polynesiensis from Tahiti (French Polynesia) displayed a weaker transmission of" exact="CHIKV" post="(3% at 6 dpi) [43]. These contrasting results may"/>
   <result pre="infection; the infection experiments were not conducted with the same" exact="CHIKV" post="strain (though it shares 99% homology); and the detection"/>
   <result pre="immunofluorescent assays. However, in both studies, the vector competence for" exact="CHIKV" post="was confirmed. Furthermore, the CHIKV strain that was used"/>
   <result pre="studies, the vector competence for CHIKV was confirmed. Furthermore, the" exact="CHIKV" post="strain that was used in the present study (NC/2011-568)"/>
   <result pre="the Americas, and Ae. aegypti from New Caledonia, to transmit" exact="CHIKV" post="[11, 44]. Though results of these studies were heterogeneous,"/>
   <result pre="studies were heterogeneous, Ae. polynesiensis appears to be a moderate" exact="CHIKV" post="vector compared to some populations of Ae. aegypti and"/>
   <result pre="order to test the ability of this population to transmit" exact="ZIKV" post="[28]. Results of this study showed that less than"/>
   <result pre="that Ae. polynesiensis from Wallis displays a higher competence for" exact="CHIKV" post="than for ZIKAV under experimental conditions in the laboratory."/>
   <result pre="diseases currently circulating in the Pacific region, namely dengue fever," exact="Zika" post="and chikungunya. Furthermore, the presence of Ae. aegypti on"/>
   <result pre="PetersenLR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis," exact="West Nile" post="and dengue viruses. Nat Med. 2004;10(12 Suppl):S98â€&quot;109. Epub 2004/12/04."/>
   <result pre="1950;30(1):103â€&quot;14, illust. Epub 1950/01/01. 10.4269/ajtmh.1950.s1-30.103 .15401987 6SinghN, KiedrzynskiT, LepersC, BenyonEK." exact="Dengue" post="in the Pacificâ€&quot;an update of the current situation. Pac"/>
   <result pre="HoyD, DuituturagaS, BenyonE, et al.Concurrent outbreaks of dengue, chikungunya and" exact="Zika" post="virus infectionsâ€&quot;an unprecedented epidemic wave of mosquito-borne viruses in"/>
   <result pre="Infect Dis. 2014;20(10):1773â€&quot;4. Epub 2014/10/02. 10.3201/eid2010.14106025271852 14PetersenLR, JamiesonDJ, PowersAM, HoneinMA." exact="Zika" post="Virus. N Engl J Med. 2016;374(16):1552â€&quot;63. Epub 2016/03/31. 10.1056/NEJMra1602113"/>
   <result pre="CalvezE, Chouin-CarneiroT, DialloD, FaillouxAB. An overview of mosquito vectors of" exact="Zika" post="virus. Microbes Infect. 2018;20(11â€&quot;12):646â€&quot;60. Epub 2018/02/27. 10.1016/j.micinf.2018.01.006 .29481868 17Souza-NetoJA,"/>
   <result pre="TidedM, MachiengP, et al.Aedes hensilli as a potential vector of" exact="Chikungunya" post="and Zika viruses. PLoS Negl Trop Dis. 2014;8(10):e3188 Epub"/>
   <result pre="et al.Aedes hensilli as a potential vector of Chikungunya and" exact="Zika" post="viruses. PLoS Negl Trop Dis. 2014;8(10):e3188 Epub 2014/10/10. 10.1371/journal.pntd.000318825299181"/>
   <result pre="of Aedes (Stegomyia) hensilli Farner as an epidemic vector of" exact="Chikungunya" post="virus on Yap Island, Federated States of Micronesia, 2013."/>
   <result pre="de la Statistique et des Etudes Economiques. 2018. URL:https://www.insee.fr/fr/statistiques/2121453. 23YvonJF." exact="Dengue" post="1 Outbreak / Wallis &amp;amp; Futuna 2002â€&quot;2003. Pacific Public"/>
   <result pre="Aedes aegypti and Aedes polynesiensis Populations from French Polynesia for" exact="Chikungunya" post="Virus. PLoS Negl Trop Dis. 2016;10(5):e0004694 Epub 2016/05/06. 10.1371/journal.pntd.000469427144888"/>
   <result pre="American countries as a crucial factor in the spread of" exact="Chikungunya" post="virus. J Virol. 2014;88(11):6294â€&quot;306. Epub 2014/03/29. 10.1128/JVI.00370-1424672026 45KramerLD, EbelGD."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7219790\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Epidemiology: Disease"/>
   <result pre="Posterior predictive checks indicate that BRS replicates temporal trends in" exact="Dengue" post="transmissions well and nowcast accuracy assessed using a post-hoc"/>
   <result pre="to account for plausibly high dimensions of climatic factors affecting" exact="Dengue" post="transmissions, which was then estimated using cross-validation to conduct"/>
   <result pre="infections occur annually creating considerable health and economic burdens [1]." exact="Dengue" post="is widespread across South-East Asian countries and is classified"/>
   <result pre="Regime switching models also characterized the likelihood of change in" exact="Dengue" post="transmissions better with the Bayes factor and relative DIC"/>
   <result pre="Y = X function across endemic and epidemic regimes. (2)" exact="Dengue" post="transmission counts fitted against dengue transmission counts one week"/>
   <result pre="with upcoming epidemic switches. Material and methods Sources of data" exact="Dengue" post="incidence data is collected by the Ministry of Health,"/>
   <result pre="MorrisonAC, RitchieSA, et al.A Critical Assessment of Vector Control for" exact="Dengue" post="Prevention. PLoS Negl Trop Dis. 2015;9: e000365510.1371/journal.pntd.000365525951103 5OoiE-E, GohK-T,"/>
   <result pre="Prevention. PLoS Negl Trop Dis. 2015;9: e000365510.1371/journal.pntd.000365525951103 5OoiE-E, GohK-T, GublerDJ." exact="Dengue" post="Prevention and 35 Years of Vector Control in Singapore."/>
   <result pre="Data. Routledge; 201710.1201/9781315137407 8Morin CoryW., Comrie AndrewC., ErnstKacey. Climate and" exact="Dengue" post="Transmission: Evidence and Implications. Environ Health Perspect. 2013;121: 1264â€&quot;1272."/>
   <result pre="10.1289/ehp.130655624058050 9ShiYuan, LiuXu, KokSuet-Yheng, RajarethinamJayanthi, LiangShaohong, YapGrace, et al.Three-Month Real-Time" exact="Dengue" post="Forecast Models: An Early Warning System for Outbreak Alerts"/>
   <result pre="Interface. 2013;10: 2013041410.1098/rsif.2013.041423825116 12RiouJ, PolettoC, BoÃ«lleP-Y. A comparative analysis of" exact="Chikungunya" post="and Zika transmission. Epidemics. 2017;19: 43â€&quot;52. 10.1016/j.epidem.2017.01.00128139388 13PerkinsTA, MetcalfCJE,"/>
   <result pre="2013041410.1098/rsif.2013.041423825116 12RiouJ, PolettoC, BoÃ«lleP-Y. A comparative analysis of Chikungunya and" exact="Zika" post="transmission. Epidemics. 2017;19: 43â€&quot;52. 10.1016/j.epidem.2017.01.00128139388 13PerkinsTA, MetcalfCJE, GrenfellBT, TatemAJ."/>
   <result pre="13PerkinsTA, MetcalfCJE, GrenfellBT, TatemAJ. Estimating Drivers of Autochthonous Transmission of" exact="Chikungunya" post="Virus in its Invasion of the Americas. PLoS Curr."/>
   <result pre="Monet Econ. 2004;51: 837â€&quot;859. 10.1016/j.jmoneco.2003.09.003 18StruchinerCJ, RocklÃ¶vJ, Wilder-SmithA, MassadE. Increasing" exact="Dengue" post="Incidence in Singapore over the Past 40 Years: Population"/>
   <result pre="Stat Med. 2008;27: 4455â€&quot;4468. 10.1002/sim.332018618414 20ChenY, CookAR, LimAXL. Randomness of" exact="Dengue" post="Outbreaks on the Equator. Emerg Infect Dis. 2015;21: 1651â€&quot;1653."/>
   <result pre="et al.Statistical Modeling Reveals the Effect of Absolute Humidity on" exact="Dengue" post="in Singapore. PLoS Negl Trop Dis. 2014;8: e280510.1371/journal.pntd.000280524786517 23JohanssonMA,"/>
   <result pre="23JohanssonMA, DominiciF, GlassGE. Local and Global Effects of Climate on" exact="Dengue" post="Transmission in Puerto Rico. PLoS Negl Trop Dis. 2009;3:"/>
   <result pre="Dis. 2009;3: e38210.1371/journal.pntd.000038219221592 24HiiYL, ZhuH, NgN, NgLC, RocklÃ¶vJ. Forecast of" exact="Dengue" post="Incidence Using Temperature and Rainfall. PLoS Negl Trop Dis."/>
   <result pre="JrRCR, MorrisonAC, AsteteH, VilcarromeroS, et al.Long-Term and Seasonal Dynamics of" exact="Dengue" post="in Iquitos, Peru. PLoS Negl Trop Dis. 2014;8: e300310.1371/journal.pntd.000300325033412"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7226716\results\search\tropicalVirus\results.xml">
   <result pre="stated in a credit line to the data. Abstract Background" exact="Dengue" post="is endemic in over 100 countries and is an"/>
   <result pre="100 countries and is an important public health problem worldwide." exact="Dengue" post="fever is not endemic in Taiwan; the importation of"/>
   <result pre="high-risk communities remain the major priorities for disease control. Keywords" exact="Dengue" post="virus Imported dengue cases Concealment Indigenous dengue fever Airport"/>
   <result pre="08A1-MRAP04-03507A1-MRAP06-035 and 08A1-MRAP04-03507A1-MRAP06-035 and 08A1-MRAP04-03507A1-MRAP06-035 and 08A1-MRAP04-03507A1-MRAP06-035 and 08A1-MRAP04-035LiuWei-LiangHoHui-PinShuPei-YunChenChun-Hong Background" exact="Dengue" post="is the most prevalent emerging arthropod-borne viral infection (arbovirus)"/>
   <result pre="genome, belonging to the genus Flavivirus of the family Flaviviridae." exact="DENV" post="contains 5â€²- and 3â€²-untranslated regions and a single open"/>
   <result pre="NS5) [11, 12]. There are four genetically and antigenically distinct" exact="DENV" post="serotypes, recognized as DENV-1, âˆ’â€‰2, âˆ’â€‰3, andâ€‰âˆ’â€‰4 [13]. Since"/>
   <result pre="dengue is not considered endemic in Taiwan; thus, importation of" exact="DENV" post="(due to close commercial ties and human migration from"/>
   <result pre="Asian countries) is thought to be the underlying cause of" exact="DENV" post="outbreaks. Preventing the importation of disease has therefore become"/>
   <result pre="gender, clinical manifestations, reporting hospital, diagnosis results and travel history." exact="Dengue" post="case collection and surveillance involved both passive (hospital-based reporting"/>
   <result pre="for additional diagnostics. Specimens were obtained for testing with the" exact="Dengue" post="NS1 Rapid Test (SD BIOLINE Inc., Korea; sensitivity and"/>
   <result pre="in the community 5 3 1 10 12 6 37" exact="Dengue" post="fever imported cases into sthe community which were concealment"/>
   <result pre="0.001 **Correlation is significant on the 0.01 layer (two-tailed) Discussion" exact="Dengue" post="fever spreads via â€œvirus-mosquito-humanâ€� transmission. Current preventive strategies focus"/>
   <result pre="factors (such as the emergence of short-lived cross-protection between heterologous" exact="Dengue" post="serotypes following disease outbreaks) may have also contributed to"/>
   <result pre="of thousands of human and mosquito specimens suggest that the" exact="DENV" post="has not yet localized in Kaohsiung, it is vital"/>
   <result pre="hospital inpatient care. This approach will assist in isolating the" exact="DENV" post="carrier from the vector mosquitoes in the community, effectively"/>
   <result pre="carrier from the vector mosquitoes in the community, effectively blocking" exact="DENV" post="from spreading into the community from foreign sources. Furthermore,"/>
   <result pre="the distance between the top/ bottom 5 countries from which" exact="Dengue" post="was imported and Kaohsiung city. The analysis chart was"/>
   <result pre="available via OpenStreetMap (https://www.openstreetmap.org/). Abbreviations CDC Centers for Disease Control" exact="DENV" post="Dengue virus DF Dengue fever DHF Dengue hemorrhagic fever"/>
   <result pre="via OpenStreetMap (https://www.openstreetmap.org/). Abbreviations CDC Centers for Disease Control DENV" exact="Dengue" post="virus DF Dengue fever DHF Dengue hemorrhagic fever DSS"/>
   <result pre="Abbreviations CDC Centers for Disease Control DENV Dengue virus DF" exact="Dengue" post="fever DHF Dengue hemorrhagic fever DSS Dengue shock syndrome"/>
   <result pre="for Disease Control DENV Dengue virus DF Dengue fever DHF" exact="Dengue" post="hemorrhagic fever DSS Dengue shock syndrome NCIT Noncontact infrared"/>
   <result pre="Dengue virus DF Dengue fever DHF Dengue hemorrhagic fever DSS" exact="Dengue" post="shock syndrome NCIT Noncontact infrared thermometer SARS Severe Acute"/>
   <result pre="techniques to RT-PCR, dengue virus-specific IgM/IgG capture ELISA detection and" exact="DENV" post="serotyping. Authorsâ€™ contributions CYP, JJH, LJL, PYS and CHC"/>
   <result pre="case data is freely available online, with information regarding Kaohsiung" exact="Dengue" post="fever cases being found on the Taiwan CDC website"/>
   <result pre="of arboviral diseases as public health problemsArch Med Res20023333034210.1016/S0188-4409(02)00378-812234522 2.PattersonJSammonMGargMDengue," exact="Zika" post="and Chikungunya: emerging Arboviruses in the New WorldWest J"/>
   <result pre="with implication for prevention and controlPLoS One201813e019063710.1371/journal.pone.019063729293624 26.PerngGCHoTCShihHILeeCHHuangPWChungCHet al.Seroprevalence of" exact="Zika" post="and dengue virus antibodies among migrant workers, Taiwan, 2017Emerg"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7226898\results\search\tropicalVirus\results.xml">
   <result pre="the notion of viral sovereignty as the new legal norm." exact="Zika" post="On 1 February 2016, the WHO declared PHEIC amid"/>
   <result pre="the WHO declared PHEIC amid concerns that the outbreak of" exact="Zika" post="virus occurring across the Caribbean and Latin America was"/>
   <result pre="reporting indicated that Brazil, then â€œthe epicenter of the ongoing" exact="Zika" post="crisisâ€� was not sharing vital epidemiological information or virus"/>
   <result pre="previous outbreaksâ€� or obtain virus samples surreptitiously.107 The experience with" exact="Zika" post="in 2016 serves to demonstrate that the international regime"/>
   <result pre="CDC. https://www.cdc.gov/globalhealth/security/ghsagenda.htm Cheng M, Satter R, Goodman J (2016) Few" exact="Zika" post="samples are being shared by brazil, worrying international researchers."/>
   <result pre="an international threatBrown J World Aff2004102185197 HeymannDLLiuJLillywhiteLPartnerships, not parachutists, for" exact="Zika" post="researchNew England J Med2016374161504150526958936 Hinterberger A, Porter N (2015)"/>
   <result pre="health secured or a missed opportunity?Polit Stud2011594831 Khaled SS (2016)" exact="Zika" post="samples are scanty for preventive and curative research. The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7227788\results\search\tropicalVirus\results.xml">
   <result pre="problem in tropical and subtropical regions around the world. Most" exact="DENV" post="cases in the Americas between January and July 2019"/>
   <result pre="the southeast of Brazil has reported nearly half of all" exact="DENV" post="infections in the country. OBJECTIVES To understand the origin"/>
   <result pre="OBJECTIVES To understand the origin and dynamics of the 2019" exact="DENV" post="outbreak. METHODS Here using portable nanopore sequencing we generated20"/>
   <result pre="outbreak. METHODS Here using portable nanopore sequencing we generated20 new" exact="DENV" post="genome sequences from viremic patients with suspected dengue infection"/>
   <result pre="Preto. We conducted a comprehensive phylogenetic analysis with 1,630 global" exact="DENV" post="strains to better understand the evolutionary history of the"/>
   <result pre="DENV strains to better understand the evolutionary history of the" exact="DENV" post="lineages that currently circulate in the region. FINDINGS The"/>
   <result pre="that the 2019 outbreak is the result of a novel" exact="DENV" post="lineage that was recently introduced to Brazil from the"/>
   <result pre="vectors such as the mosquitoes Aedes aegypti and Aedes albopictus.2" exact="DENV" post="is classified into four distinct virus lineages named serotypes"/>
   <result pre="virus lineages named serotypes 1 to 4 (DENV1-4). Within each" exact="DENV" post="serotype there is some degree of genetic variation, and"/>
   <result pre="is some degree of genetic variation, and at least 19" exact="DENV" post="genotypes have now been described.3 Increasing human mobility has"/>
   <result pre="same region,4 a pattern known as hyperendemicity. In such regions," exact="DENV" post="epidemiological dynamics are complex and typically characterised by virus"/>
   <result pre="seem to be more frequently associated with severe disease outcomes.8,10,11" exact="DENV" post="was first detected in Brazil in 1982.12 Since then,"/>
   <result pre="Santo. Between 1995 and 2015, Brazil reported nearly 8 million" exact="DENV" post="cases, which comprises 55% of all cases reported in"/>
   <result pre="the country.17 Here, we characterise the genetic diversity of circulating" exact="DENV" post="in two municipalities of SÃ£o Paulo State. We generated"/>
   <result pre="Paulo State, samples are collected from patients suspected of acute" exact="DENV" post="infection and tested for DENV by real-time quantitative reverse"/>
   <result pre="from patients suspected of acute DENV infection and tested for" exact="DENV" post="by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR)"/>
   <result pre="in SÃ£o Paulo State, we selected 20 qRT-PCR positive samples" exact="DENV" post="serotype 2 from patients in two municipalities, Araraquara and"/>
   <result pre="which has been used previously in Brazil during outbreaks of" exact="Zika" post="virus and yellow fever virus.9,10,11 Sequencing was performed using"/>
   <result pre="n = 373/712) and DENV4 (39%, n = 274/712) predominated," exact="DENV" post="2 (9%, n = 64/712) and DENV3 (0.1%, n"/>
   <result pre="been made available. Molecular clock analyses have shown that novel" exact="DENV" post="lineages have been introduced in Brazil every 7 to"/>
   <result pre="serotype 2 (DENV2) in Brazil. Bayesian dated phylogeographic tree of" exact="DENV" post="serotype 2 (n = 426) in the Americas. New"/>
   <result pre="approaches will be particularly critical in geographic regions with year-round" exact="DENV" post="transmission in Aedes spp. mosquitoes, such as locations with"/>
   <result pre="Microbiol20194585486330833735 3FonsecaVLibinPJKTheysKFariaNRNunesMRTRestovicMIet al.A computational method for the identification of Dengue," exact="Zika" post="and Chikungunya virus species and genotypes.PLoS Negl Trop Dis2019135e000723131067235"/>
   <result pre="al.A computational method for the identification of Dengue, Zika and" exact="Chikungunya" post="virus species and genotypes.PLoS Negl Trop Dis2019135e000723131067235 4TianHSunZFariaNRYangJCazellesBHuangSet al.Increasing"/>
   <result pre="SaÃºdeMonitoramento dos casos de arboviroses urbanas transmitidas pelo Aedes (Dengue," exact="Chikungunya" post="e Zika) atÃ© a Semana epidemiolÃ³gica 12 de 2019"/>
   <result pre="virus transmission potential.Science2018361640589489930139911 19FariaNRQuickJClaroIMThezeJde JesusJGGiovanettiMet al.Establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the AmericasNature2017546765840641028538727 20PriceMNDehalPSArkinAPFastTree 2 -"/>
   <result pre="25QuickJGrubaughNDPullanSTClaroIMSmithADGangavarapuKet al.Multiplex PCR method for MinION and Illumina sequencing of" exact="Zika" post="and other virus genomes directly from clinical samples.Nat Protoc20171261261127628538739"/>
   <result pre="clinical samples.Nat Protoc20171261261127628538739 26DrumondBPMondiniASchmidtDJde Morais BronzoniRVBoschINogueiraMLCirculation of different lineages of" exact="Dengue" post="virus 2, genotype American/Asian in Brazil: dynamics and molecular"/>
   <result pre="dynamics and molecular and phylogenetic characterizationPLoS One201383e5942223533624 27GrubaughNDFariaNRAndersenKGPybusOGGenomic insights into" exact="Zika" post="virus emergence and spreadCell201817261160116229522736 28RomanoCMde MatosAMAraujoESVillas-BoasLSda SilvaWCOliveiraOMet al.Characterization of"/>
   <result pre="Zika virus emergence and spreadCell201817261160116229522736 28RomanoCMde MatosAMAraujoESVillas-BoasLSda SilvaWCOliveiraOMet al.Characterization of" exact="Dengue" post="virus type 2: new insights on the 2010 Brazilian"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7229957\results\search\tropicalVirus\results.xml">
   <result pre="valuable insights that can be used for screening purposes. The" exact="HPV" post="Serology Lab at FNLCR has been temporarily repurposed to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7231083\results\search\tropicalVirus\results.xml">
   <result pre="and rapid spread of arthropod-borne viruses significant to public health." exact="Yellow fever" post="virus (YFV), dengue virus (DENV), West Nile virus (WNV),"/>
   <result pre="to public health. Yellow fever virus (YFV), dengue virus (DENV)," exact="West Nile" post="virus (WNV), and Zika virus (ZIKV) are mosquito-borne flaviviruses"/>
   <result pre="virus (YFV), dengue virus (DENV), West Nile virus (WNV), and" exact="Zika" post="virus (ZIKV) are mosquito-borne flaviviruses that have reemerged in"/>
   <result pre="viral replication [152, 153]. Recently, it has been reported that" exact="DENV" post="infection activates TLR-9 signaling, which is known to recognize"/>
   <result pre="restricting flavivirus infections [151]. It has been reported that during" exact="DENV" post="infection, mtDNA is spilled into the cytoplasm and this"/>
   <result pre="mice are highly susceptible to infection by DENV, ZIKV, and" exact="WNV" post="[163â€&quot;166]. The reported effects of IFN-I in flavivirus infections"/>
   <result pre="cells and subjects are discussed in the following sections. 2.2.1." exact="Dengue" post="Virus (DENV) DENV is an acute febrile disease caused"/>
   <result pre="are discussed in the following sections. 2.2.1. Dengue Virus (DENV)" exact="DENV" post="is an acute febrile disease caused by four distinct"/>
   <result pre="an acute febrile disease caused by four distinct antigenically related" exact="DENV" post="serotypes (DENV-1, -2, -3, and -4) that are transmitted"/>
   <result pre="the bite of Aedes spp. mosquitoes, mainly Aedes aegypti [167]." exact="DENV" post="infects an estimated 390 million people every year of"/>
   <result pre="million people every year of which 96 million have apparent" exact="DENV" post="infections, with different levels of disease severity [168]. The"/>
   <result pre="leading to potentially life-threatening hypovolemic shock [169]. At present, several" exact="DENV" post="vaccines are under development, including one that has been"/>
   <result pre="the limited efficacy in naÃ¯ve individuals and against all four" exact="DENV" post="serotypes [170]. DENV has been reported to trigger a"/>
   <result pre="in naÃ¯ve individuals and against all four DENV serotypes [170]." exact="DENV" post="has been reported to trigger a robust IFN-I response,"/>
   <result pre="response, which has been shown to be important in controlling" exact="DENV" post="infection [171]. IFN-I has been reported to inhibit DENV"/>
   <result pre="controlling DENV infection [171]. IFN-I has been reported to inhibit" exact="DENV" post="infection in a variety of human cells, including hepatoma,"/>
   <result pre="and myeloid cells [172, 173]. RIG-I and MDA5 sensing of" exact="DENV" post="has been critical in the immune response [39], as"/>
   <result pre="of RIG-I and MDA5 in Huh7 cells resulted in increased" exact="DENV" post="replication [174]. In addition to TLR-3, 7, and 8"/>
   <result pre="replication [174]. In addition to TLR-3, 7, and 8 [151]," exact="DENV" post="has been reported to activate and upregulate the expression"/>
   <result pre="[175]. NLRs have also been shown to be activated in" exact="DENV" post="and WNV infections leading to the formation of the"/>
   <result pre="have also been shown to be activated in DENV and" exact="WNV" post="infections leading to the formation of the inflammasome complex"/>
   <result pre="subsequent production of inflammatory cytokines of the IL-1Î² family [176]." exact="DENV" post="sensing by PRRs results in the secretion of IFN-I"/>
   <result pre="to the production of ISGs with diverse antiviral properties [151]." exact="DENV" post="nonstructural proteins have been involved in the downregulation of"/>
   <result pre="decreasing STAT1 phosphorylation in human A549 cells [178]. Furthermore, the" exact="DENV" post="NS2B-NS3 protease complex has been involved in the cleavage"/>
   <result pre="molecule STING or MITA, inhibiting IFN-I production [179, 180]. Interestingly," exact="DENV" post="cleaves STING in humans but not in nonhuman primates"/>
   <result pre="as its sustaining reservoir in nature [181]. In addition, the" exact="DENV" post="NS2B-NS3 protease interacts with the cellular IÎºB kinase, an"/>
   <result pre="disrupting RIG-I signaling and inhibiting the IFN production [182]. The" exact="DENV" post="polymerase NS5 has also been reported as a potent"/>
   <result pre="STAT2 for ubiquitin-mediated proteasomal degradation [183, 184]. The ability of" exact="DENV" post="NS5 to bind and degrade human but not mouse"/>
   <result pre="mouse cells [185]. Recently, increased virulence of different type 1" exact="DENV" post="isolates has been associated with a higher capacity of"/>
   <result pre="NS proteins to suppress IFN signaling [186]. Likewise, sfRNA of" exact="DENV" post="strains that are associated with greater epidemic potential prevents"/>
   <result pre="by IFN-I in dengue patients and human cells infected with" exact="DENV" post="have been studied in several reports [172, 173, 187â€&quot;189]."/>
   <result pre="in patients undergoing primary infection compared to those with secondary" exact="DENV" post="infections [77, 190, 192, 195], while other studies observed"/>
   <result pre="probably due to the differential kinetics of IFN-I induction during" exact="DENV" post="infection of human cells [199, 200]. 2.2.2. Zika Virus"/>
   <result pre="induction during DENV infection of human cells [199, 200]. 2.2.2." exact="Zika" post="Virus (ZIKV) ZIKV is a newly emerging flavivirus transmitted"/>
   <result pre="infection of human cells [199, 200]. 2.2.2. Zika Virus (ZIKV)" exact="ZIKV" post="is a newly emerging flavivirus transmitted to humans by"/>
   <result pre="spp. mosquitoes, including Aedes aegypti [201]. Since the first human" exact="ZIKV" post="infection was reported in Uganda in 1964 [202], human"/>
   <result pre="ZIKV infection was reported in Uganda in 1964 [202], human" exact="ZIKV" post="infections had remained sporadic and limited to small-scale epidemics"/>
   <result pre="decades [203, 204], until 2007, when a large outbreak of" exact="Zika" post="fever was reported on Yap Island (Micronesia) [205]. Over"/>
   <result pre="other Pacific Islands [206]. In 2015, the largest outbreak of" exact="ZIKV" post="ever reported began in Brazil, with a rapid expansion"/>
   <result pre="of the virus in South and Central America [207â€&quot;209]. Typically," exact="ZIKV" post="infections can be asymptomatic or manifested as a self-limiting"/>
   <result pre="Guillain-BarrÃ© syndrome (GBS) in adults and microcephaly in newborns [210â€&quot;212]." exact="ZIKV" post="has been shown to cross the placental barrier, disrupting"/>
   <result pre="to cross the placental barrier, disrupting brain development [213]. Recently," exact="ZIKV" post="spread by sexual contact has also been documented [214]."/>
   <result pre="to combat ZIKV. The induction of antiviral immune responses after" exact="ZIKV" post="infection of human cells has been reported in several"/>
   <result pre="reported in several studies [215â€&quot;219]. The innate immune response after" exact="ZIKV" post="infection of skin cells and endometrial stromal cells was"/>
   <result pre="RIG-I, and MDA5 has been reported to be induced upon" exact="ZIKV" post="infection of human skin cells [215]. Similar to DENV,"/>
   <result pre="to DENV, NLR (inflammasome) activation has also been reported in" exact="ZIKV" post="infection of monocytes [220]. Elevated secretion of IFN-Î² was"/>
   <result pre="lung epithelial cells, which may delay the apoptosis exerted by" exact="ZIKV" post="infection [217]. Schwann cells (SC), which play a central"/>
   <result pre="target for damage in GBS, were susceptible to infection with" exact="ZIKV" post="and YFV, but not DENV, and ZIKV infection of"/>
   <result pre="to infection with ZIKV and YFV, but not DENV, and" exact="ZIKV" post="infection of SC induced expression of IL-6, IFN-Î², IFN-Î»,"/>
   <result pre="IL-23A mRNAs, and negative regulators of IFN signaling [218]. Furthermore," exact="ZIKV" post="infection of human DCs produced a strong induction of"/>
   <result pre="the RLR signaling pathway at the RNA transcription level, but" exact="ZIKV" post="was able to block IFN-I signaling by targeting STAT1"/>
   <result pre="targeting STAT1 and STAT2 phosphorylation [219]. The mechanisms by which" exact="ZIKV" post="antagonizes IFN-I induction and signaling in human cells, which"/>
   <result pre="of ZIKV, have been reported in recent studies [159, 221â€&quot;223]." exact="ZIKV" post="NS1 has been reported to interact with RIG-I and"/>
   <result pre="[224]. In addition, Donald et al. reported that sfRNA in" exact="ZIKV" post="acts as the antagonist of RIG-I-dependent IFN production [161]."/>
   <result pre="acts as the antagonist of RIG-I-dependent IFN production [161]. Furthermore," exact="ZIKV" post="NS4A impairs RLR-MAVS interaction and subsequent induction of antiviral"/>
   <result pre="MAVS and thus blocking its accessibility by RLRs [225, 226]." exact="ZIKV" post="NS3 has been shown to antagonize antiviral gene induction"/>
   <result pre="by binding to and sequestering the scaffold proteins 14-3-3Îµ/Î· [227]." exact="ZIKV" post="NS1, NS2A, NS2B, and NS4B have been shown to"/>
   <result pre="IRF-3 [159, 228]. In addition, the NS2B-NS3 protease complex of" exact="ZIKV" post="has been reported to impair the JAK/STAT signaling pathway"/>
   <result pre="by impairing IFN-induced degradation of NS2B-NS3 [159]. Similar to DENV," exact="ZIKV" post="NS5 has been reported as a potent antagonist of"/>
   <result pre="ubiquitin-mediated proteasomal degradation [183, 185, 221, 222]. However, unlike DENV," exact="ZIKV" post="NS5 did not require the E3 ubiquitin ligase UBR4"/>
   <result pre="ligase UBR4 interaction, exhibiting a virus-specific mechanism [222]. In addition," exact="ZIKV" post="NS1 and NS5 interact with NLRP3 and promote assembly"/>
   <result pre="the NLRP3 inflammasome complex resulting in IL-1Î² production and stimulated" exact="ZIKV" post="replication [229â€&quot;231]. Recently, ZIKV microcephaly in newborns has been"/>
   <result pre="resulting in IL-1Î² production and stimulated ZIKV replication [229â€&quot;231]. Recently," exact="ZIKV" post="microcephaly in newborns has been associated with rs3775291 single"/>
   <result pre="NF-ÎºB and thus decreasing IFN-I responses in mothers infected by" exact="ZIKV" post="during pregnancy [232]. Furthermore, comparative analysis of African and"/>
   <result pre="pregnancy [232]. Furthermore, comparative analysis of African and Asian lineage-derived" exact="ZIKV" post="strains revealed pronounced differences in the activation of innate"/>
   <result pre="to differential pathogenesis [233]. Compared to the replication of other" exact="ZIKV" post="strains, the replication of Asian ZIKV strain Brazil Fortaleza"/>
   <result pre="the replication of other ZIKV strains, the replication of Asian" exact="ZIKV" post="strain Brazil Fortaleza 2015, which was associated with neurodevelopmental"/>
   <result pre="induced weaker and delayed innate immune responses in vitro. 2.2.3." exact="West Nile" post="Virus (WNV) WNV is a mosquito-borne flavivirus of international"/>
   <result pre="innate immune responses in vitro. 2.2.3. West Nile Virus (WNV)" exact="WNV" post="is a mosquito-borne flavivirus of international health concern. WNV"/>
   <result pre="(WNV) WNV is a mosquito-borne flavivirus of international health concern." exact="WNV" post="is maintained in a natural cycle involving primarily Culex"/>
   <result pre="but it also infects humans, horses, and other animals [234]." exact="WNV" post="is endemic in parts of Asia, Africa, and Europe,"/>
   <result pre="prophylactic or therapeutic measures are currently available [234]. Infection with" exact="WNV" post="in humans remains asymptomatic and/or subclinical in most cases"/>
   <result pre="and mortality [234, 237]. The protective role of IFN-I after" exact="WNV" post="infection has been extensively demonstrated in mice by the"/>
   <result pre="IFN-Î±/Î² receptor-deficient mice [166]. The studies of IFN-I protection after" exact="WNV" post="infection are more limited in human cells. Recently, the"/>
   <result pre="induction of IFN-I antiviral responses, have been shown to control" exact="West Nile" post="virus infection in human and mouse cells [238]. The"/>
   <result pre="DCs early activation of RLR or IFN-I signaling could block" exact="WNV" post="infection [239]. Furthermore, in human glioblastoma cells, WNV replication"/>
   <result pre="could block WNV infection [239]. Furthermore, in human glioblastoma cells," exact="WNV" post="replication was regulated by early IFN-Î² induction, while in"/>
   <result pre="concealing of viral dsRNA in intracellular membranes, resulted in efficient" exact="WNV" post="replication [240]. In addition, differences in replication and induction"/>
   <result pre="replication and induction of IFN-I responses between attenuated and virulent" exact="WNV" post="strains in human monocyte-derived DCs accounted for the differing"/>
   <result pre="monocyte-derived DCs accounted for the differing virulence in humans [241]." exact="WNV" post="NS4B and NS5 have been reported as important IFN-I"/>
   <result pre="signaling pathway by decreasing STAT1 phosphorylation [178]. The NS5 of" exact="WNV" post="strain NY99 blocked IFN-I responses by inhibition of STAT1"/>
   <result pre="by inhibition of STAT1 phosphorylation [242]. The helicase domain of" exact="WNV" post="NS3 has been reported to inhibit IFN-I signaling and"/>
   <result pre="differences in virulence between the NY99 and NSW2011 strains of" exact="WNV" post="have been attributed to differential inhibition of the helicase"/>
   <result pre="differential inhibition of the helicase domain of NS3 [243]. Furthermore," exact="WNV" post="NS1 has been demonstrated to antagonize IFN-Î² production by"/>
   <result pre="activation [244]. The human studies evaluating the IFN-I response to" exact="WNV" post="infection and its relationship with disease severity are scarce"/>
   <result pre="was associated with an inability to maintain continuing immunity during" exact="WNV" post="infection, suggesting that an increased initial inflammation may negatively"/>
   <result pre="[150]. Despite the presence of an effective vaccine YF17D [247]," exact="YFV" post="infection has remained a public health concern in restricted"/>
   <result pre="per year, leading to about 30,000 deaths [150]. In humans," exact="YFV" post="infection produces variable clinical manifestations, ranging from asymptomatic infection"/>
   <result pre="250] and combined IFN-I and -III are crucial for controlling" exact="YFV" post="infection in mice [251]. Recently, it has been reported"/>
   <result pre="[251]. Recently, it has been reported that cells infected with" exact="YFV" post="stimulated pDCs to produce IFN-I in a TLR7- and"/>
   <result pre="RNA participated in pDC stimulation [252]. NS4B and NS5 of" exact="YFV" post="have been reported as IFN-I antagonists. YFV NS4B interacts"/>
   <result pre="and NS5 of YFV have been reported as IFN-I antagonists." exact="YFV" post="NS4B interacts with STING, blocking IFN-I stimulation [253]. Moreover,"/>
   <result pre="YFV NS4B interacts with STING, blocking IFN-I stimulation [253]. Moreover," exact="YFV" post="NS5 inhibits IFN-I signaling via binding and inhibition of"/>
   <result pre="STAT1 and requires K6 ubiquitination [254]. This IFN-induced ubiquitination of" exact="YFV" post="NS5 is absent in murine cells resulting in a"/>
   <result pre="in murine cells resulting in a lack of binding of" exact="YFV" post="NS5 and human STAT2 in murine cells, highlighting the"/>
   <result pre="and human STAT2 in murine cells, highlighting the importance of" exact="YFV" post="ubiquitination in determining the host cell range for YFV"/>
   <result pre="of YFV ubiquitination in determining the host cell range for" exact="YFV" post="[255, 256]. Gene expression microarray analysis in PBMCs from"/>
   <result pre="and SARS-CoV patients improved with IFN-Î± therapy [289, 290]. Regarding" exact="DENV" post="infections, the studies evaluating the association of IFN-I response"/>
   <result pre="regard to ZIKV, IFN-I treatment has not been described in" exact="ZIKV" post="patients. A recent murine model of ZIKV infection using"/>
   <result pre="been described in ZIKV patients. A recent murine model of" exact="ZIKV" post="infection using dexamethasone-immunosuppressed mice showed that IFN-I treatment improved"/>
   <result pre="might have potential beneficial effects. However, the dynamic course of" exact="WNV" post="neuroinvasive disease prevented the determination of whether the beneficial"/>
   <result pre="combination with other antiviral drugs might be needed. Similar to" exact="WNV" post="and JEV, the use of IFN-Î± was evaluated in"/>
   <result pre="and their pathogenesis. Currently, there are vaccines for influenza virus," exact="YFV" post="and JEV; however, neither effective vaccines nor specific therapies"/>
   <result pre="BST2, RyDEN, TRIM69, and IFI6 has been shown to block" exact="DENV" post="infection [314â€&quot;320] at multiple steps of the viral cycle."/>
   <result pre="and IFITM3 disrupted the early steps (entry and/or uncoating) of" exact="DENV" post="and WNV infection [314, 316]. In contrast, three IFN-induced"/>
   <result pre="disrupted the early steps (entry and/or uncoating) of DENV and" exact="WNV" post="infection [314, 316]. In contrast, three IFN-induced cellular enzymes,"/>
   <result pre="ISG20, and dsRNA-activated protein kinase, inhibited the steps of the" exact="DENV" post="and WNV cycle in viral proteins and/or RNA biosynthesis"/>
   <result pre="dsRNA-activated protein kinase, inhibited the steps of the DENV and" exact="WNV" post="cycle in viral proteins and/or RNA biosynthesis [314]. DENV"/>
   <result pre="and WNV cycle in viral proteins and/or RNA biosynthesis [314]." exact="DENV" post="infection-induced viperin which has antiviral properties residing in the"/>
   <result pre="C-terminal region of the protein that acts to restrict early" exact="DENV" post="RNA production/accumulation, potentially via the interaction of viperin with"/>
   <result pre="DENV RNA production/accumulation, potentially via the interaction of viperin with" exact="DENV" post="NS3 and replication complexes [315]. The expression of the"/>
   <result pre="complexes [315]. The expression of the Repressor of yield of" exact="DENV" post="(RyDEN) conferred resistance to all serotypes of DENV in"/>
   <result pre="yield of DENV (RyDEN) conferred resistance to all serotypes of" exact="DENV" post="in human cells. RyDEN is likely to interfere with"/>
   <result pre="cells. RyDEN is likely to interfere with the translation of" exact="DENV" post="via interaction with viral RNA and cellular mRNA-binding proteins,"/>
   <result pre="its downstream effector RNase L have been reported to block" exact="DENV" post="replication and likely contributed to host defense against DENV"/>
   <result pre="block DENV replication and likely contributed to host defense against" exact="DENV" post="infection playing a role in determining the outcomes of"/>
   <result pre="DENV infection playing a role in determining the outcomes of" exact="DENV" post="disease severity [318]. ZIKV has been reported to induce"/>
   <result pre="role in determining the outcomes of DENV disease severity [318]." exact="ZIKV" post="has been reported to induce the expression of ISG15"/>
   <result pre="human corneal epithelial cells, and the silencing of ISG15 increased" exact="ZIKV" post="infectivity [321]. ISG15 has also inhibited the replication of"/>
   <result pre="(YFV, WNV, and DENV) replication machinery [320]. TRIM69 interacts with" exact="DENV" post="NS3 directly and mediates its ubiquitination and degradation, thus,"/>
   <result pre="NS3 directly and mediates its ubiquitination and degradation, thus, interrupting" exact="DENV" post="replication [319]. Recently, Schlafen 11, an ISG that controls"/>
   <result pre="tRNA abundance, has been reported to restrict WNV, DENV, and" exact="ZIKV" post="replication by impairing viral infectivity [325]. 5. Conclusions After"/>
   <result pre="M.FlavivirusesFields Virology2013PhiladelphiaLippincott-Raven747794 151GackM. U.DiamondM. S.Innate immune escape by dengue and" exact="West Nile" post="virusesCurrent Opinion in Virology20162011912810.1016/j.coviro.2016.09.01327792906 152CumberworthS. L.ClarkJ. J.KohlA.DonaldC. L.Inhibition of"/>
   <result pre="L.et al.Full genome sequence and sfRNA interferon antagonist activity of" exact="Zika" post="virus from Recife, BrazilPLoS Neglected Tropical Diseases20161010, article e000504810.1371/journal.pntd.000504827706161"/>
   <result pre="Host &amp;amp; Microbe20107212813910.1016/j.chom.2010.01.00420153282 165LazearH. M.GoveroJ.SmithA. M.et al.A mouse model of" exact="Zika" post="virus pathogenesisCell Host &amp;amp; Microbe201619572073010.1016/j.chom.2016.03.01027066744 166SamuelM. A.DiamondM. S.Alpha/beta interferon"/>
   <result pre="Host &amp;amp; Microbe201619572073010.1016/j.chom.2016.03.01027066744 166SamuelM. A.DiamondM. S.Alpha/beta interferon protects against lethal" exact="West Nile" post="virus infection by restricting cellular tropism and enhancing neuronal"/>
   <result pre="C.TanC. H.Oral susceptibility of Singapore Aedes (Stegomyia) aegypti (Linnaeus) to" exact="Zika" post="virusPLoS Neglected Tropical Diseases201268, article e179210.1371/journal.pntd.000179222953014 202SimpsonD. I.Zika virus"/>
   <result pre="Medicine and Hygiene19645833533814175744 203HaddowA. D.SchuhA. J.YasudaC. Y.et al.Genetic characterization of" exact="Zika" post="virus strains: geographic expansion of the Asian lineagePLoS Neglected"/>
   <result pre="P.SantosG. I. V.SantosC. N. D.LuzK.First report of autochthonous transmission of" exact="Zika" post="virus in BrazilMemÃ³rias do Instituto Oswaldo Cruz2015110456957210.1590/0074-0276015019226061233 208EnfissiA.CodringtonJ.RoosbladJ.KazanjiM.RoussetD.Zika virus"/>
   <result pre="as concerns mount over birth defectsBMJ2015351p. h698310.1136/bmj.h6983 211RodriguesL. C.Microcephaly and" exact="Zika" post="virus infectionLancet2016387100332070207210.1016/S0140-6736(16)00742-X26993880 212SmithD. W.MackenzieJ.Zika virus and Guillain-BarrÃ© syndrome: another"/>
   <result pre="listLancet2016387100271486148810.1016/S0140-6736(16)00564-X26948432 213MartinesR. B.BhatnagarJ.KeatingM. K.et al.Notes from the field: evidence of" exact="Zika" post="virus infection in brain and placental tissues from two"/>
   <result pre="and Mortality Weekly Report201665615916010.15585/mmwr.mm6506e126890059 214D'OrtenzioE.MatheronS.YazdanpanahY.et al.Evidence of sexual transmission of" exact="Zika" post="virusThe New England Journal of Medicine2016374222195219810.1056/NEJMc160444927074370 215HamelR.DejarnacO.WichitS.et al.Biology of"/>
   <result pre="Zika virusThe New England Journal of Medicine2016374222195219810.1056/NEJMc160444927074370 215HamelR.DejarnacO.WichitS.et al.Biology of" exact="Zika" post="virus infection in human skin cellsJournal of Virology201589178880889610.1128/JVI.00354-1526085147 216PaganiI.GhezziS.UlisseA.et"/>
   <result pre="endometrial stromal cells are highly permissive to productive infection by" exact="Zika" post="virusScientific Reports201771p. 4428610.1038/srep44286 217FrumenceE.RocheM.Krejbich-TrototP.et al.The South Pacific epidemic strain"/>
   <result pre="virusScientific Reports201771p. 4428610.1038/srep44286 217FrumenceE.RocheM.Krejbich-TrototP.et al.The South Pacific epidemic strain of" exact="Zika" post="virus replicates efficiently in human epithelial A549 cells leading"/>
   <result pre="inductionVirology201649321722610.1016/j.virol.2016.03.00627060565 218DhimanG.AbrahamR.GriffinD. E.Human Schwann cells are susceptible to infection with" exact="Zika" post="and yellow fever viruses, but not dengue virusScientific Reports201991p."/>
   <result pre="signalingCell Host &amp;amp; Microbe201619688289010.1016/j.chom.2016.05.00927212660 223LÃ³pezJ. F. V.VelillaP. A.Urcuqui-InchimaS.Chikungunya virus and" exact="Zika" post="virus, two different viruses examined with a common aim:"/>
   <result pre="immunityCell Host &amp;amp; Microbe2019264493503.e610.1016/j.chom.2019.09.01231600501 228XiaH.LuoH.ShanC.et al.An evolutionary NS1 mutation enhances" exact="Zika" post="virus evasion of host interferon inductionNature Communications201891p. 41410.1038/s41467-017-02816-229379028 229TricaricoP."/>
   <result pre="axisThe EMBO Journal2018371810.15252/embj.20189934730065070 232SantosC. N. O.RibeiroD. R.Cardoso AlvesJ.et al.Association between" exact="Zika" post="virus microcephaly in newborns with the rs3775291 variant in"/>
   <result pre="233Esser-NobisK.AarrebergL. D.RobyJ. A.FairgrieveM. R.GreenR.GaleM.Jr.Comparative analysis of African and Asian lineage-derived" exact="Zika" post="virus strains reveals differences in activation of and sensitivity"/>
   <result pre="J.WebbC. E.A review of the epidemiological and clinical aspects of" exact="West Nile" post="virusInt J Gen Med2014719320310.2147/IJGM.S5990224748813 235MostashariF.BunningM. L.KitsutaniP. T.et al.Epidemic West"/>
   <result pre="West Nile virusInt J Gen Med2014719320310.2147/IJGM.S5990224748813 235MostashariF.BunningM. L.KitsutaniP. T.et al.Epidemic" exact="West Nile" post="encephalitis, New York, 1999: results of a household-based seroepidemiological"/>
   <result pre="a household-based seroepidemiological surveyLancet2001358927826126410.1016/S0140-6736(01)05480-011498211 236Centers for Disease Control and Prevention," exact="West Nile" post="Virus, Statistics and Mapshttps://www.cdc.gov/westnile/statsmaps/index.html 237HayesE. B.GublerD. J.West Nile virus:"/>
   <result pre="Medicine200657118119410.1146/annurev.med.57.121304.131418 238WangL.YangL.FikrigE.WangP.An essential role of PI3K in the control of" exact="West Nile" post="virus infectionScientific Reports201771p. 372410.1038/s41598-017-03912-528623344 239ZimmermanM. G.BowenJ. R.McDonaldC. E.PulendranB.SutharM. S.West"/>
   <result pre="dendritic cellsJournal of Virology2019932310.1128/JVI.00664-1931534040 240TakamatsuY.UchidaL.MoritaK.Delayed IFN response differentiates replication of" exact="West Nile" post="virus and Japanese encephalitis virus in human neuroblastoma and"/>
   <result pre="Virology20159682194219910.1099/vir.0.00016825920530 241RawleD. J.SetohY. X.EdmondsJ. H.KhromykhA. A.Comparison of attenuated and virulent" exact="West Nile" post="virus strains in human monocyte-derived dendritic cells as a"/>
   <result pre="4610.1186/s12985-015-0279-3 242Laurent-RolleM.BoerE. F.LubickK. J.et al.The NS5 protein of the virulent" exact="West Nile" post="virus NY99 strain is a potent antagonist of type"/>
   <result pre="type I interferon-mediated JAK-STAT signalingJournal of Virology20108473503351510.1128/JVI.01161-0920106931 243SetohY.PeriasamyP.PengN.AmarillaA.SlonchakA.KhromykhA.Helicase domain of" exact="West Nile" post="virus NS3 protein plays a role in inhibition of"/>
   <result pre="chemokine expression is associated with control of acute viremia in" exact="West Nile" post="virus-infected blood donorsThe Journal of Infectious Diseases2008198797998310.1086/59146618729779 246HoffmanK. W.SachsD.BardinaS."/>
   <result pre="associated with development of a greater number of symptoms following" exact="West Nile" post="virus infectionThe Journal of Infectious Diseases2016214463464310.1093/infdis/jiw17927142077 247MonathT. P.Yellow fever:"/>
   <result pre="interferonseBioMedicine20161411212210.1016/j.ebiom.2016.11.01727884655 293KalilA. C.DevettenM. P.SinghS.et al.Use of interferon-alpha in patients with" exact="West Nile" post="encephalitis: report of 2 casesClinical Infectious Diseases200540576476610.1086/42794515714427 294HwangJ.RyuH. S.KimH.LeeS."/>
   <result pre="casesClinical Infectious Diseases200540576476610.1086/42794515714427 294HwangJ.RyuH. S.KimH.LeeS. A.The first reported case of" exact="West Nile" post="encephalitis in KoreaJournal of Korean Medical Science201530334334510.3346/jkms.2015.30.3.34325729260 295Chan-TackK. M.ForrestG.Failure"/>
   <result pre="Science201530334334510.3346/jkms.2015.30.3.34325729260 295Chan-TackK. M.ForrestG.Failure of interferon alpha-2b in a patient with" exact="West Nile" post="virus meningoencephalitis and acute flaccid paralysisScandinavian Journal of Infectious"/>
   <result pre="flaccid paralysisScandinavian Journal of Infectious Diseases20053711-1294494610.1080/0036554050026269016308241 296LewisM.AmsdenJ. R.Successful treatment of" exact="West Nile" post="virus infection after approximately 3 weeks into the disease"/>
   <result pre="IFITM proteins mediate cellular resistance to influenza A H1N1 virus," exact="West Nile" post="virus, and dengue virusCell200913971243125410.1016/j.cell.2009.12.01720064371 317SuzukiY.ChinW. X.HanQ.et al.Characterization of RyDEN"/>
   <result pre="blocks flavivirus replicationNature Microbiology20183111214122310.1038/s41564-018-0244-130224801 321SinghP. K.SinghS.FarrD.KumarA.Interferon-stimulated gene 15 (ISG15) restricts" exact="Zika" post="virus replication in primary human corneal epithelial cellsThe Ocular"/>
   <result pre="Ocular Surface201917355155910.1016/j.jtos.2019.03.00630905842 322DaiJ.PanW.WangP.ISG15 facilitates cellular antiviral response to dengue and" exact="West Nile" post="virus infection in vitroVirology Journal201181p. 46810.1186/1743-422X-8-46821992229 323MoralesD. J.LenschowD. J.The"/>
   <result pre="in newborns [232] Human (in vitro) Protective Replication of Asian" exact="ZIKV" post="strain Brazil 2015 (associated with neurodevelopmental disorders) was less"/>
   <result pre="neurodevelopmental disorders) was less sensitive to IFN-I, compared to other" exact="ZIKV" post="strains [233] â€ƒWNV Human (in vitro) Protective PI3K that"/>
   <result pre="â€ƒWNV Human (in vitro) Protective PI3K that induces IFN-I controls" exact="WNV" post="infection [238] Human (in vitro) Protective Early activation of"/>
   <result pre="Protective Early activation of RLR or IFN-I signaling could block" exact="WNV" post="infection [239] Human (in vivo) Inconclusive IFN-Î± treatment was"/>
   <result pre="Flaviviruses IFITM2/3 DENVWNV Entry and/or uncoating disruption [314, 316] Viperin" exact="DENV" post="Restriction of early DENV RNA production/accumulation, via interaction with"/>
   <result pre="and/or uncoating disruption [314, 316] Viperin DENV Restriction of early" exact="DENV" post="RNA production/accumulation, via interaction with DENV NS3 and replication"/>
   <result pre="DENV Restriction of early DENV RNA production/accumulation, via interaction with" exact="DENV" post="NS3 and replication complexes [315] RyDEN DENV Interference with"/>
   <result pre="via interaction with DENV NS3 and replication complexes [315] RyDEN" exact="DENV" post="Interference with DENV translation via interaction with viral RNA"/>
   <result pre="DENV NS3 and replication complexes [315] RyDEN DENV Interference with" exact="DENV" post="translation via interaction with viral RNA and cellular mRNA-binding"/>
   <result pre="interaction with viral RNA and cellular mRNA-binding proteins [317] OAS" exact="DENV" post="Blockade in DENV replication [318] ISG15 DENVZIKVWNVJEV Inhibition of"/>
   <result pre="RNA and cellular mRNA-binding proteins [317] OAS DENV Blockade in" exact="DENV" post="replication [318] ISG15 DENVZIKVWNVJEV Inhibition of viral replication [321â€&quot;324]"/>
   <result pre="ER membrane invaginations formation, that house replication machinery [320] TRIM69" exact="DENV" post="DENV NS3 ubiquitination and degradation, thus interrupting DENV replication"/>
   <result pre="membrane invaginations formation, that house replication machinery [320] TRIM69 DENV" exact="DENV" post="NS3 ubiquitination and degradation, thus interrupting DENV replication [319]"/>
   <result pre="[320] TRIM69 DENV DENV NS3 ubiquitination and degradation, thus interrupting" exact="DENV" post="replication [319] Schlafen 11 WNVDENVZIKV Viral replication restriction by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7231470\results\search\tropicalVirus\results.xml">
   <result pre="pathogens in the 21st century (i.e., SARS-CoV, pandemic H1N1, MERS-CoV," exact="Zika" post="virus and now HCoV-19), it remains difficult to predict"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7233243\results\search\tropicalVirus\results.xml">
   <result pre="have been found in 8 out of the 120 identified" exact="HPV" post="types, all belonging to the â€œhigh riskâ€� HPV subgroup.37"/>
   <result pre="120 identified HPV types, all belonging to the â€œhigh riskâ€�" exact="HPV" post="subgroup.37 Nevertheless, the majority of the identified sequences are"/>
   <result pre="formation of different alternative structures, i.e., hairpins.39 Such dynamism makes" exact="HPV" post="G4s difficult to study and, above all, to target;"/>
   <result pre="in-depth studies will be necessary to disclose the involvement of" exact="HPV" post="G4s in the viral life cycle. 2.2.2 Hepatitis B"/>
   <result pre="re-emerging arboviruses of global significance, such as Japanese encephalitis (JEV)," exact="West Nile" post="(WNV), Zika (ZIKV), dengue (DENV), yellow fever (YFV), and"/>
   <result pre="global significance, such as Japanese encephalitis (JEV), West Nile (WNV)," exact="Zika" post="(ZIKV), dengue (DENV), yellow fever (YFV), and tick-borne encephalitis"/>
   <result pre="flaviviral pandemics, specific treatments are craved for.44 3.1.1 ZIKA virus" exact="ZIKV" post="is transmitted to humans by mosquito bites: in adults,"/>
   <result pre="sequences have been discovered in the positive strand of the" exact="ZIKV" post="genome, while the negative one is devoid of PQSs."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7233246\results\search\tropicalVirus\results.xml">
   <result pre="be put into perspective if we consider the experience of" exact="Chikungunya" post="for which there is no infection of PBMC in"/>
   <result pre="been optimized. In comparison, another virus of interest in obstetrics," exact="ZIKV" post="is detectable repeatedly or even continuously in the blood"/>
   <result pre="Finally, transmission of some viruses, such as herpes simplex virus," exact="HPV" post="and HIV, may occur via the ascending route, from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7235449\results\search\tropicalVirus\results.xml">
   <result pre="4â€&quot;6). Antibody-based serological assays highlighted the nearly complete cross-reactivity between" exact="CHIKV" post="and ONNV (6â€&quot;8), hindering proper detection and diagnosis. Concordantly,"/>
   <result pre="coastal Kenya and Uganda populations, particularly to ONNV and closely-related" exact="CHIKV" post="(4, 9, 10). The absence of epidemiological data on"/>
   <result pre="ONNV-infected joints up to 40 dpi, which is similar to" exact="CHIKV" post="infection (16). Figure 1 ONNV infection in wild-type C57BL/6"/>
   <result pre="CD4+ T cells were previously reported for other alphaviruses, including" exact="CHIKV" post="(16, 21, 26, 28), and Sindbis virus (SINV) (27),"/>
   <result pre="R Soc Trop Med Hyg. (1961) 55:135â€&quot;41. 10.1016/0035-9203(61)90017-713785469 4.ClementsTLRossiCAIrishAKKibuukaHEllerLARobbMLet al.." exact="Chikungunya" post="and O'nyong-nyong viruses in uganda: implications for diagnostics. Open"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7236111\results\search\tropicalVirus\results.xml">
   <result pre="the Gynaeco-Obstetric and Paediatric Hospital of the City of YaoundÃ©." exact="HPV" post="genotyping was performed by real-time PCR, HIV serological screening"/>
   <result pre="viremia was 50 RNA copies/mL [IQR: pâ€‰=â€‰0.0319. Following HIV status," exact="HPV" post="rate was 43.48% (80/184) among HIV+ vs. 28.72% (27/94)"/>
   <result pre="and other genotypes (72.50% vs. 77.78%, pâ€‰=â€‰0.80). Among HIV+ participants," exact="HPV" post="rate following CD4 was 62.88% (61/97) for CD4â€‰ pâ€‰=â€‰0.0012)"/>
   <result pre="rate following CD4 was 62.88% (61/97) for CD4â€‰ pâ€‰=â€‰0.0012) while" exact="HPV" post="rate following HIV viremia was 42.71% (41/96) with â€‰1000"/>
   <result pre="(41/96) with â€‰1000 RNA copies/ml (ORâ€‰=â€‰0.384; pâ€‰=â€‰0.009). Conclusion In YaoundÃ©," exact="HPV" post="rate appear to be very high, with higher rates"/>
   <result pre="18. In the event of HIV infection, the risk of" exact="HPV" post="positivity is two times higher, favoured essentially by immunodeficiency."/>
   <result pre="closely monitored to prevent the emergence of cervical cancer. Keywords" exact="HPV" post="HIV Women YaoundÃ© Background Human papilloma viruses (HPV) are"/>
   <result pre="widespread sexually transmitted infection worldwide, with more than 200 species." exact="HPV" post="genotypes are responsible for 95% of the occurrence of"/>
   <result pre="of the occurrence of cervical cancer in women [1]. Notably," exact="HPV" post="causes benign and malignant tumours in humans and viral"/>
   <result pre="are oncogenic are classified as high-risk (HR-HPV) or low-risk oncogenic" exact="HPV" post="(LR-HPV) [2]. Although all HR-HPV genotypes have oncogenic potential,"/>
   <result pre="some are more frequently involved in cancers than others. Thus," exact="HPV" post="16 and 18 represent approximately 70% of all cervical"/>
   <result pre="represent approximately 70% of all cervical cancers worldwide, followed by" exact="HPV" post="31, 33, 45, 52, 58 and 68 which are"/>
   <result pre="cancer is known to be a viro-induced neoplasm and that" exact="HPV" post="is the causal agent in 99% of cases [4]."/>
   <result pre="increase the burden of this cancer [5, 6]. In SSA," exact="HPV" post="and HIV co-infection is commonly found and contributes to"/>
   <result pre="than their HIV-negative peers. Even though little is known on" exact="HPV" post="genotypes circulating among HIV-infected women in SSA countries, recommendations"/>
   <result pre="genotypes circulating among HIV-infected women in SSA countries, recommendations for" exact="HPV" post="vaccination in the population of people living with HIV"/>
   <result pre="persistence and reactivation subsequently [7, 9]. Factors that contribute to" exact="HPV" post="infections include: early sexual activity, multiple sexual partners, smoking,"/>
   <result pre="immuno-compromission (due to HIV essentially) [9]. HIV infection also promotes" exact="HPV" post="infection at molecular and cellular levels during different phases"/>
   <result pre="infection at molecular and cellular levels during different phases of" exact="HPV" post="replication cycle such as, penetration into the target cell,"/>
   <result pre="HPV replication cycle such as, penetration into the target cell," exact="HPV" post="multiplication and HPV immune evasion from the hostâ€™s defences."/>
   <result pre="such as, penetration into the target cell, HPV multiplication and" exact="HPV" post="immune evasion from the hostâ€™s defences. Direct consequences are"/>
   <result pre="As reported by Kevin A. Ault in 2006, High-risk, oncogenic" exact="HPV" post="types (including HPV 16 and HPV 18) are associated"/>
   <result pre="Kevin A. Ault in 2006, High-risk, oncogenic HPV types (including" exact="HPV" post="16 and HPV 18) are associated with 99.7% of"/>
   <result pre="in 2006, High-risk, oncogenic HPV types (including HPV 16 and" exact="HPV" post="18) are associated with 99.7% of all cervical cancers"/>
   <result pre="observations are very concerning and suggest a high burden of" exact="HPV" post="in these settings where HIV is also highly prevalent"/>
   <result pre="with similar programmatic challenges [14, 16], understanding the burden of" exact="HPV" post="among women, its circulating genotypes and the effect of"/>
   <result pre="the effect of HIV-infection on HPV-positivity, might help in shaping" exact="HPV" post="preventive measures according to local realities in Cameroon. Our"/>
   <result pre="HIV screening tests, CD4 lymphocyte counts, HIV viral load, and" exact="HPV" post="genotyping were performed at the Chantal BIYA International Reference"/>
   <result pre="was performed by using the FACS Calibur of Becton Dickinson." exact="HPV" post="genotyping For HPV genotyping, the Abbott Real Time HR-HPV"/>
   <result pre="using the FACS Calibur of Becton Dickinson. HPV genotyping For" exact="HPV" post="genotyping, the Abbott Real Time HR-HPV test was used."/>
   <result pre="polymerase chain reaction assay, with simultaneous detection and genotyping of" exact="HPV" post="16, HPV 18, and a pooled detection of 12"/>
   <result pre="reaction assay, with simultaneous detection and genotyping of HPV 16," exact="HPV" post="18, and a pooled detection of 12 other HR-HPV"/>
   <result pre="a pooled detection of 12 other HR-HPV genotypes (HPV 31," exact="HPV" post="33, HPV 35, HPV 39, HPV 45, HPV 51,"/>
   <result pre="detection of 12 other HR-HPV genotypes (HPV 31, HPV 33," exact="HPV" post="35, HPV 39, HPV 45, HPV 51, HPV 52,"/>
   <result pre="12 other HR-HPV genotypes (HPV 31, HPV 33, HPV 35," exact="HPV" post="39, HPV 45, HPV 51, HPV 52, HPV 56,"/>
   <result pre="HR-HPV genotypes (HPV 31, HPV 33, HPV 35, HPV 39," exact="HPV" post="45, HPV 51, HPV 52, HPV 56, HPV 58,"/>
   <result pre="(HPV 31, HPV 33, HPV 35, HPV 39, HPV 45," exact="HPV" post="51, HPV 52, HPV 56, HPV 58, HPV 59,"/>
   <result pre="HPV 33, HPV 35, HPV 39, HPV 45, HPV 51," exact="HPV" post="52, HPV 56, HPV 58, HPV 59, HPV 66"/>
   <result pre="HPV 35, HPV 39, HPV 45, HPV 51, HPV 52," exact="HPV" post="56, HPV 58, HPV 59, HPV 66 and HPV"/>
   <result pre="HPV 39, HPV 45, HPV 51, HPV 52, HPV 56," exact="HPV" post="58, HPV 59, HPV 66 and HPV 68). Statistical"/>
   <result pre="HPV 45, HPV 51, HPV 52, HPV 56, HPV 58," exact="HPV" post="59, HPV 66 and HPV 68). Statistical analysis Data"/>
   <result pre="HPV 51, HPV 52, HPV 56, HPV 58, HPV 59," exact="HPV" post="66 and HPV 68). Statistical analysis Data were collected"/>
   <result pre="52, HPV 56, HPV 58, HPV 59, HPV 66 and" exact="HPV" post="68). Statistical analysis Data were collected using Excel 2016,"/>
   <result pre="women consenting for participation, most of whom were still asymptomatic." exact="HPV" post="positivity rate and circulating genotypes Overall, HPV positivity rate"/>
   <result pre="were still asymptomatic. HPV positivity rate and circulating genotypes Overall," exact="HPV" post="positivity rate was 38.49% (107/278), indicating a high burden"/>
   <result pre="positivity rate was 38.49% (107/278), indicating a high burden of" exact="HPV" post="in the study population (TableÂ 1). According to HIV"/>
   <result pre="in the study population (TableÂ 1). According to HIV serostatus," exact="HPV" post="prevalence was significantly higher in the group of HIV-seropositive"/>
   <result pre="HIV-infection increasing by about 8 folds more risks of acquiring" exact="HPV" post="as compared to those free of HIV (OR: 8.609,"/>
   <result pre="free of HIV (OR: 8.609, 95% CI: 2.841â€&quot;27,338). Table 1" exact="HPV" post="positivity according to HIV serostatus HPVHIV HPV +n (%)"/>
   <result pre="2.841â€&quot;27,338). Table 1 HPV positivity according to HIV serostatus HPVHIV" exact="HPV" post="+n (%) HPV â€&quot;n (%) Total P-value HIV+ 80"/>
   <result pre="HPV positivity according to HIV serostatus HPVHIV HPV +n (%)" exact="HPV" post="â€&quot;n (%) Total P-value HIV+ 80 (43.47) 104 (56.53)"/>
   <result pre="67 (70.53) 95 0.019 Total 107 (38.49) 171 (61.51) 278" exact="HPV" post="human papillomavirus, HIV human immunodeficiency virus Diversity of HPV"/>
   <result pre="278 HPV human papillomavirus, HIV human immunodeficiency virus Diversity of" exact="HPV" post="genotypes in infected women Several HPV genotypes were identified"/>
   <result pre="immunodeficiency virus Diversity of HPV genotypes in infected women Several" exact="HPV" post="genotypes were identified in the study population. Interestingly, 74%"/>
   <result pre="and 4% of the study population were infected solely with" exact="HPV" post="16 and HPV 18 respectively (Fig.Â 1). Fig. 1"/>
   <result pre="the study population were infected solely with HPV 16 and" exact="HPV" post="18 respectively (Fig.Â 1). Fig. 1 Distribution of HPV"/>
   <result pre="and HPV 18 respectively (Fig.Â 1). Fig. 1 Distribution of" exact="HPV" post="genotypes Legend, HPV: human papillomavirus; others refer to oncogenic"/>
   <result pre="HPV genotypes Legend, HPV: human papillomavirus; others refer to oncogenic" exact="HPV" post="other than the 16 and 18 genotypes identified by"/>
   <result pre="HPV-infection The age range 20â€&quot;29â€‰years was the most infected by" exact="HPV" post="(51.66%). This latter prevalence was significantly higher when compared"/>
   <result pre="with that obtained in those aged 40â€&quot;49â€‰years (25.00%); pâ€‰=â€‰0.03. Overall," exact="HPV" post="positivity decreased as participants grow older (TableÂ 2). Table"/>
   <result pre="positivity decreased as participants grow older (TableÂ 2). Table 2" exact="HPV" post="positivity by age HPVAge (years) HPV+n (%) HPV-n (%)"/>
   <result pre="25 (69.44) 36 0.64 Total 107 (38.49) 171 (61.51) 278" exact="HPV" post="human papillomavirus, Age different age groups According to marital"/>
   <result pre="Age different age groups According to marital status, the highest" exact="HPV" post="positivity rate was recorded among divorced women (60%), and"/>
   <result pre="to those that were single (pâ€‰=â€‰0.04) (TableÂ 3). Table 3" exact="HPV" post="Association and Marital Status HPVMarital status HPV +n (%)"/>
   <result pre="3). Table 3 HPV Association and Marital Status HPVMarital status" exact="HPV" post="+n (%) HPV â€&quot;n (%) Total P-value Single 63"/>
   <result pre="HPV Association and Marital Status HPVMarital status HPV +n (%)" exact="HPV" post="â€&quot;n (%) Total P-value Single 63 (43.75) 81 (56.25)"/>
   <result pre="(64.29) 28 0.55 Total 107 (38.49) 171 (61.51) 278 0.32" exact="HPV" post="human papillomavirus, Marital status different marital status Participants with"/>
   <result pre="poor immune status (CD4â€‰â‰¤â€‰500) had a significantly higher rate of" exact="HPV" post="positivity as compared to those with a normal immunity"/>
   <result pre="Interestingly, the lower the CD4-count, the higher the rate of" exact="HPV" post="positivity (TableÂ 4). Table 4 HPV-infection according to immune"/>
   <result pre="4). Table 4 HPV-infection according to immune status HPVCD4 (cells/mm3)" exact="HPV" post="+n (%) HPV â€&quot;n (%) Total P-value 500â€&quot;1600 20"/>
   <result pre="HPV-infection according to immune status HPVCD4 (cells/mm3) HPV +n (%)" exact="HPV" post="â€&quot;n (%) Total P-value 500â€&quot;1600 20 (35.71) 36 (64.29)"/>
   <result pre="(16.67) 24 0.048 Total 81 (52.94) 72 (47.05) 153 Overall," exact="HPV" post="positivy seemingly increased with increasing values of viral loads."/>
   <result pre="these increments were not statically significant (TableÂ 5). Table 5" exact="HPV" post="positivity rates by HIV viremia HPVHIV viremia(Log copies/mL) HPV+n"/>
   <result pre="21 (35.59) 59 0.12 Total 88 (50.88) 85 (49.13) 173" exact="HPV" post="Human papillomavirus, viremia different variation of HIV viral load"/>
   <result pre="purpose of our study was to compare the rate of" exact="HPV" post="positivity among HIV-positive women with that of HIV-negative women,"/>
   <result pre="rate of genotypes 16 and 18. 3% for mono-infection with" exact="HPV" post="genotype 16 and 4% for mono-infection with HPV genotype"/>
   <result pre="mono-infection with HPV genotype 16 and 4% for mono-infection with" exact="HPV" post="genotype 18. This suggests that other genotypes are drivers"/>
   <result pre="review conducted by Doh et al., the prevalence of pure" exact="HPV" post="16 and 18 was 6.25 and 3.28% respectively, a"/>
   <result pre="finding very similar to our report showing evidence of 3%" exact="HPV" post="16 and 4% HPV 18 within the same country"/>
   <result pre="our report showing evidence of 3% HPV 16 and 4%" exact="HPV" post="18 within the same country [24]. This thererfore stresses"/>
   <result pre="HR-HPV infections. Prospective studies have reported a higher incidence of" exact="HPV" post="among HIV-positive women compared to HIV-negative women [1, 14,"/>
   <result pre="are often associated with viral persistence, especially if co-present with" exact="HPV" post="16. HIV is confirmed as a contributing factor to"/>
   <result pre="to HPV-infection (pâ€‰ 26], which henceforth increases risk of acquiring" exact="HPV" post="[27, 28]. This calls for the need to regularly"/>
   <result pre="This calls for the need to regularly test people with" exact="HPV" post="infection for HIV [27]. Younger age are at higher"/>
   <result pre="viral load and HPV-infection simply confirmed that HIV-infection interfers with" exact="HPV" post="through immunodeficiency induced by HIV, and not via a"/>
   <result pre="associated with the risk of infection with this high-risk oncogenic" exact="HPV" post="(12 times higher risk), as previously demonstrated [34, 35]."/>
   <result pre="HIV-status as the main independent factor associated with risk of" exact="HPV" post="infection among women, likely due to immunodeficiency. In other"/>
   <result pre="the HIV condition) were found to be significantly associated with" exact="HPV" post="infection [36]. Our study has some limitations. For instance,"/>
   <result pre="city of Yaounde and the reference molecular technique used for" exact="HPV" post="detection made it possible to identify only genotypes 16"/>
   <result pre="for a better molecular characterization toward a rational selection of" exact="HPV" post="vaccine candidate for the country. Conclusion In this sub-population"/>
   <result pre="for the country. Conclusion In this sub-population of Cameroonian women," exact="HPV" post="burden appears to be very high, with higher rates"/>
   <result pre="risk of HPV-infection becomes higher, favoured essentially by immunodeficiency. Further" exact="HPV" post="gentopic studies, coupled to vaccine trials, would are needed"/>
   <result pre="prevention and management DNA Deoxyribonucleic acid HIV Human Immunodeficiency Virus;" exact="HPV" post="Human papilloma virus HR-HPV High risk oncogenic Human Immunodeficiency"/>
   <result pre="and management DNA Deoxyribonucleic acid HIV Human Immunodeficiency Virus; HPV" exact="Human papilloma virus" post="HR-HPV High risk oncogenic Human Immunodeficiency Virus LR-HPV Low"/>
   <result pre="interpreted the data. SMS, JF, RK and MCTT performed the" exact="HPV" post="testing. VC and AN managed all aspects of the"/>
   <result pre="2011:2011 Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189592/. [citÃ© 20 sept 2019]. 8.BestSRNiparkoKJPaiSIBiology of" exact="HPV" post="Infection and Immune Therapy for HPV-related Head and Neck"/>
   <result pre="et al. Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences" exact="HPV" post="Persistence at the Oral Mucosa. PLoS ONE [Internet]. 2017;12(1)."/>
   <result pre="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040737/. [citÃ© 20 sept 2019]. 30.KahnJABurkRDSquiresKEKapogiannisBGPrevalence and Risk Factors for" exact="HPV" post="in HIV-Positive Young Women Receiving Their First HPV VaccinationJAIDS"/>
   <result pre="Factors for HPV in HIV-Positive Young Women Receiving Their First" exact="HPV" post="VaccinationJAIDS J Acquir Immune Defic Syndr201261339039910.1097/QAI.0b013e3182676fe322820809 31.BadialRMDiasMCStuquiBMelliPPDSDetection and genotyping"/>
   <result pre="relationship with HPV/HIV co-infectionMedicine (Baltimore)20189714e954510.1097/MD.000000000000954529620669 32.CastellsaguÃ©XPaavonenJJaisamrarnUWheelerCMSkinnerSRLehtinenMet al.Risk of first cervical" exact="HPV" post="infection and pre-cancerous lesions after onset of sexual activity:"/>
   <result pre="absence of anal intercourseAnn Intern Med2003138645345910.7326/0003-4819-138-6-200303180-0000812639077 36.TartagliaEFalascaKVecchietJSabuscoGPPiccianoGDi MarcoRet al.Prevalence of" exact="HPV" post="infection among HIV-positive and HIV-negative women in Central/Eastern Italy:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7236691\results\search\tropicalVirus\results.xml">
   <result pre="coronavirus 2 (SARS-CoV-2; the virus responsible for COVID-19 disease; 2019â€&quot;ongoing)," exact="Zika" post="(2015â€&quot;2016), H1N1 (2009), and SARS (2002â€&quot;2004), and forewarns of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7236962\results\search\tropicalVirus\results.xml">
   <result pre="is similar, clinically, to other arboviral diseases, such as dengue," exact="Zika" post="or chikungunya. Most of the alphaviruses are transmitted between"/>
   <result pre="The sera were analyzed by ELISA using specific antibodies against" exact="West Nile" post="virus (VWN), VEEV, EEEV. 2.9% of the sample (11/384)"/>
   <result pre="Oryzomys alfaroi). Rodent specimens were negative for VEEV, WEEV, and" exact="WNV" post="[31]. A study carried out in the Colombian Caribbean"/>
   <result pre="in countries endemic to flaviviruses, the first diagnostic impression is" exact="Dengue" post="and recently Zika. Despite having had an epidemic peak"/>
   <result pre="Emerg Dis.201764399099326608567 13.MattarGSThe Madariaga virus follows the footsteps of the" exact="Chikungunya" post="and Zika viruses RevMVZ CÃ³rdoba.201823Suppl69376941 14.KubesVRÃ­osFAThe causative agent of"/>
   <result pre="13.MattarGSThe Madariaga virus follows the footsteps of the Chikungunya and" exact="Zika" post="viruses RevMVZ CÃ³rdoba.201823Suppl69376941 14.KubesVRÃ­osFAThe causative agent of infectious equine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7237041\results\search\tropicalVirus\results.xml">
   <result pre="credited.pntd.0008304.pdf Abstract Background To counter the increasing global risk of" exact="Yellow fever" post="(YF), the World Health Organisation initiated the Eliminate Yellow"/>
   <result pre="Yellow fever (YF), the World Health Organisation initiated the Eliminate" exact="Yellow fever" post="Epidemics (EYE) strategy. Estimating YF burden, as well as"/>
   <result pre="remains a significant public health threat [1,2]. The epidemics of" exact="Zika" post="and chikungunya in Latin America have also highlighted the"/>
   <result pre="the World Health Organisation (WHO) adopted a strategy to Eliminate" exact="Yellow fever" post="Epidemics (EYE) by 2026. This strategy aims to prevent"/>
   <result pre="for granting access to epidemiological data. References References 1collab: WHO." exact="Yellow fever" post="in Africa and the Americas, 2016. Wkly Epidemiol Rec"/>
   <result pre="Epidemiol Rec WER. 2016;91: 181â€&quot;192.27066609 5collab: World Health Organization. Eliminate" exact="Yellow fever" post="Epidemics (EYE): a global strategy, 2017â€&quot;2026. Wkly Epidemiol Rec."/>
   <result pre="a modelling analysis. Lancet Glob Health. 2018;010.1016/S2214-109X(18)30024-X29398634 11World Health Organization." exact="Yellow fever" post="key facts. 1 May 2018. http://www.who.int/en/news-room/fact-sheets/detail/yellow-fever 12FariaNR, KraemerMUG, HillSC,"/>
   <result pre="fever virus transmission potential. Science. 2018; eaat7115. 10.1126/science.aat711530139911 13MonathTP, VasconcelosPFC." exact="Yellow fever." post="J Clin Virol. 2015;64: 160â€&quot;173. 10.1016/j.jcv.2014.08.03025453327 14AndersonR, MayRM. Infectious"/>
   <result pre="burden of dengue. Nature. 2013;496: 504â€&quot;507. 10.1038/nature1206023563266 21World Health Organization." exact="Yellow fever" post="vaccine. Wkly Epidemiol Rec. 2003; 349â€&quot;359. 22KwagonzaL, MasiiraB, Kyobe-BosaH,"/>
   <result pre="retrospective analysis. Lancet Infect Dis. 2017;010.1016/S1473-3099(17)30419-X28822780 28collab: World Health Organization." exact="Yellow fever" post="in Africa and South America, 2015. Wkly Epidemiol Rec."/>
   <result pre="solution. The Lancet. 2016;387: 1599â€&quot;1600. 10.1016/S0140-6736(16)30195-7 34Global Strategy to Eliminate" exact="Yellow fever" post="Epidemics (EYE)â€&quot;Document for SAGE. World Health Organisation; 2016 Sep."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7237725\results\search\tropicalVirus\results.xml">
   <result pre="demonstrated for several viruses including porcine reproductive and respiratory virus," exact="Dengue" post="virus, and West Nile virus, among others (106â€&quot;110). Accelerated"/>
   <result pre="viruses including porcine reproductive and respiratory virus, Dengue virus, and" exact="West Nile" post="virus, among others (106â€&quot;110). Accelerated disease has been observed"/>
   <result pre="recognition and neutralization determinants on domains I and II of" exact="West Nile" post="virus envelope protein. J Virol. (2006) 80:12149â€&quot;59. 10.1128/JVI.01732-0617035317 109.HalsteadSBMahalingamSMarovichMAUbolSMosserDM."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7237951\results\search\tropicalVirus\results.xml">
   <result pre="recognized viruses, including hepatitis C, HIV/AIDS, SARS-CoV-1, MERS, Lassa fever," exact="Zika" post="virus, and Ebolavirus, as well as Yellow Fever, influenza,"/>
   <result pre="newly available technology, was able to demonstrate genetic signatures of" exact="HPV" post="in some cervical cancer samples.6 This observation initiated a"/>
   <result pre="oropharyngeal cancers, are now recognized to be associated with persistent" exact="HPV" post="infection. Discovery by zur Hausen and his colleagues of"/>
   <result pre="to cervical cancer laid the foundation for the development of" exact="HPV" post="vaccines to prevent this disease, especially once it was"/>
   <result pre="to prevent this disease, especially once it was established that" exact="HPV" post="infection was common, and progression to cancer slow and"/>
   <result pre="to the development of a new vaccine were precluded because" exact="HPV" post="could not be grown in the lab, which would"/>
   <result pre="a killed virus vaccine. However, technological developments enabled progress on" exact="HPV" post="vaccines. The then newly achieved ability to express genes"/>
   <result pre="to express genes in cell culture enabled laboratory production of" exact="HPV" post="proteins. Prokaryotic expression systems were initially used to produce"/>
   <result pre="Cambridge, England, agreed with me to try to assemble the" exact="HPV" post="shell when he came to work in my lab"/>
   <result pre="of a vaccine, induced an antibody that bound to the" exact="HPV" post="capsid. These vaccines were shown to prevent papilloma virus"/>
   <result pre="introduced.14 There are take-home messages from the story of the" exact="HPV" post="vaccine for future research on epidemic prevention. These include"/>
   <result pre="transformation of primary human keratinocytesJ.Â Virol.631989441744212476573 9ZhouJ.SunX.Y.StenzelD.J.FrazerI.H.Expression of vaccinia recombinant" exact="HPV" post="16 L1 and L2 ORF proteins in epithelial cells"/>
   <result pre="ORF proteins in epithelial cells is sufficient for assembly of" exact="HPV" post="virion-like particlesVirology185119912512571656586 10KirnbauerR.BooyF.ChengN.LowyD.R.SchillerJ.T.Papillomavirus L1 major capsid protein self-assembles into"/>
   <result pre="16 in fission yeast Schizosaccharomyces pombeVirology206119951261357831768 14GertigD.M.BrothertonJ.M.BuddA.C.DrennanK.ChappellG.SavilleA.M.Impact of a population-based" exact="HPV" post="vaccination program on cervical abnormalities: a data linkage studyBMC"/>
   <result pre="Declaration of Interest The author holds patents relevant to the" exact="HPV" post="vaccines mentioned in this article and receives royalties from"/>
   <result pre="in this article and receives royalties from sale of these" exact="HPV" post="vaccines."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7237993\results\search\tropicalVirus\results.xml">
   <result pre="A virus polymerase activityJ. Biol. Chem.20142897599761410.1074/jbc.M113.50779824474693 19.TaguwaS.MaringerK.LiX.Bernal-RubioD.RauchJ.N.GestwickiJ.E.AndinoR.Fernandez-SesmaA.FrydmanJ.Defining Hsp70 Subnetworks in" exact="Dengue" post="Virus Replication Reveals Key Vulnerability in Flavivirus InfectionCell20151631108112310.1016/j.cell.2015.10.04626582131 20.ZhangZ.YangX.XuP.WuX.ZhouL.WangH.Heat"/>
   <result pre="enterovirus A71 infectionAntivir. Res.2018150394610.1016/j.antiviral.2017.11.02029180285 25.PujhariS.BrustolinM.MaciasV.M.NisslyR.H.NomuraM.KuchipudiS.V.RasgonJ.L.Heat shock protein 70 (Hsp70) mediates" exact="Zika" post="virus entry, replication, and egress from host cellsEmerg. Microbes"/>
   <result pre="and egress from host cellsEmerg. Microbes Infect.2019881610.1080/22221751.2018.155798830866755 26.KhachatoorianR.CohnW.BuzzancoA.RiahiR.ArumugaswamiV.DasguptaA.WhiteleggeJ.P.FrenchS.W.HSP70 Copurifies with" exact="Zika" post="Virus ParticlesVirology201852222823310.1016/j.virol.2018.07.00930053656 27.Reyes-Del ValleJ.Chavez-SalinasS.MedinaF.Del AngelR.M.Heat shock protein 90 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7238163\results\search\tropicalVirus\results.xml">
   <result pre="mosquitoes from two genera, Sabethes sp. and especially Haemagogus sp." exact="Yellow fever" post="virus thus had a second phase of cross species"/>
   <result pre="the same viruses as Aedes aegypti: yellow fever, dengue [16]," exact="Zika" post="[17], and chikungunya [18], all introduced into South America."/>
   <result pre="able to transmit dengue fever virus and the recently introduced" exact="Zika" post="virus. It is thought that the Brazil 2016-18 yellow"/>
   <result pre="to human habitats, such as yellow fever, dengue, chikungunya, and" exact="Zika" post="viruses [13]. Mogi et al. [40], suggest that the"/>
   <result pre="urban environment and able to transmit viruses such as chikungunya," exact="Zika" post="and dengue, spread to all continents. It is likely"/>
   <result pre="establishment may be abrupt and rapid, as was the recent" exact="Zika" post="pandemic with Ae. aegypti as vector, or more gradual,"/>
   <result pre="mechanisms, as was the case with the emergence of the" exact="West Nile" post="virus in several temperate cities, particularly in the USA"/>
   <result pre="of tropical or equatorial origin: dengue, chikungunya, Zika, yellow fever," exact="West Nile," post="as well as, at least potentially, many other tropical"/>
   <result pre="In Africa, the Spondweni virus is genetically close to the" exact="Zika" post="virus, which places it on the list of viruses"/>
   <result pre="in BrazilVirol. J.2010715210.1186/1743-422X-7-15220624314 17.FernandesR.S.BersotM.I.CastroM.G.TelleriaE.L.Ferreira-de-BritoA.RaphaelL.M.BonaldoM.C.LourenÃ§o-de-OliveiraR.Low vector competence in sylvatic mosquitoes limits" exact="Zika" post="virus to initiate an enzootic cycle in South AmericaSci."/>
   <result pre="What makes a malaria vector?Trends Parasitol.20102613013610.1016/j.pt.2009.12.00120056485 31.AzarS.R.WeaverS.C.Vector competence: What has" exact="Zika" post="virus taught usViruses20191186710.3390/v11090867 32.HouÃ©V.GabianeG.DaugaC.SuezM.MadecY.MoussonL.MarconciniM.YenP.S.de LamballerieX.BonizzoniM.et al.Evolution and biological significance"/>
   <result pre="to the lightMicrobes Infect.2009111177118510.1016/j.micinf.2009.05.00519450706 36.ReiterP.FontenilleD.PaupyC.Aedes albopictusas an epidemic vector of" exact="Chikungunya" post="virus: Another emerging problem?Lancet Inf. Dis.2006646346410.1016/S1473-3099(06)70531-X 37.DelatteH.DesvarsA.BouetardA.BordS.GimonneauG.Vourcâ€™hG.FontenilleD.Blood-feeding behavior of"/>
   <result pre="Evol.2011111769178110.1016/j.meegid.2011.07.01621827872 49.GouldE.PetterssonJ.HiggsS.CharrelR.de LamballerieX.Emerging arboviruses: Why today?One Health2017411310.1016/j.onehlt.2017.06.00128785601 50.HadfieldJ.BritoA.F.SwetnamD.M.VogelsC.B.F.TokarzR.E.AndersenK.G.SmithR.C.BedfordT.GrubaughN.D.Twenty years of" exact="West Nile" post="virus spread and evolution in the Americas visualized by"/>
   <result pre="Robert Ellis Shope (1929â€&quot;2004)Emerg. Infect. Dis.20041076276510.3201/eid1004.IM1004 52.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.C.LavenirR.PardigonN.ReynesJ.M.PettinelliF.et al.Genome Microevolution of" exact="Chikungunya" post="Viruses Causing the Indian Ocean OutbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 53.PowellJ.R.An evolutionary"/>
   <result pre="part 5: Entomological aspectsAntivir. Res.202017410467010.1016/j.antiviral.2019.10467031812638 56.HaddowA.D.NasarF.GuzmanH.PonlawatA.JarmanR.G.TeshR.B.WeaverS.C.Genetic Characterization of Spondweni and" exact="Zika" post="Viruses and Susceptibility of Geographically Distinct Strains of Aedes"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7239023\results\search\tropicalVirus\results.xml">
   <result pre="Medicine235201659560510.1007/s12529-016-9549-826931780 BlakeyS.M.AbramowitzJ.S.Psychological predictors of health anxiety in response to the" exact="Zika" post="virusJournal of Clinical Psychology in Medical Settings243-4201727027810.1007/s10880-017-9514-y29063232 BrownR.J.SkellyN.Chewâ€�GrahamC.A.Online health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7239338\results\search\tropicalVirus\results.xml">
   <result pre="results in animal models against Ebola virus (EBOV)4, 5 or" exact="Zika" post="virus,6 there are no antiviral drugs available against the"/>
   <result pre="RNA viruses, in particular Ebola, Lassa fever, Marburg, Nipah, and" exact="Zika" post="viruses.7, 8, 9 The main advantages of applying an"/>
   <result pre="virus; MARV, Marburg virus; RVFV, Rift valley fever virus; YFV," exact="Yellow fever" post="virus. Reproduced from ref. 8. Next, we used these"/>
   <result pre="which could limit inflammation and extend survival. Potential applications to" exact="Zika" post="and Marburg viruses Given the broad antiviral activity of"/>
   <result pre="of favipiravir, we also evaluated in vitro its efficacy against" exact="Zika" post="and Marburg viruses and reported antiviral EC50 of 6.5"/>
   <result pre="the group of James Whitney published the first model of" exact="Zika" post="viral dynamics in NHPs.81 By using the target cell"/>
   <result pre="the target cell limited model (Eq. 2), the parameters of" exact="Zika" post="viral dynamics could be estimated, in particular R0 found"/>
   <result pre="90%, and, therefore, close to the critical efficacy to abrogate" exact="Zika" post="replication (Figure 7). Given that peak viremia occurred 2â€&quot;3Â"/>
   <result pre="these compartments is unknown. Figure 7 Viral dynamic predictions in" exact="Zika" post="infections. Left: Prophylactic treatment assuming two different levels of"/>
   <result pre="effective concentration (EC50); right: effect of delayed treatment initiations on" exact="Zika" post="dynamics. This dosing regimen was also recently evaluated in"/>
   <result pre="directâ€�acting antiviral drug, abrogates viremia in rhesus macaques challenged with" exact="Zika" post="virus. Open Forum Infect. Dis.4 (suppl. 1), S55 (2017)."/>
   <result pre="Med.22, 1448â€&quot;1455 (2016).27694931 82Lanciotti, R.S.et alGenetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
   <result pre="L.et alInfection dynamics in a traveller with persistent shedding of" exact="Zika" post="virus RNA in semen for six months after returning"/>
   <result pre="Eurosurveillance21, (2016). 84Osuna, C.E. &amp;amp; Whitney, J.B.Nonhuman primate models of" exact="Zika" post="virus infection, immunity, and therapeutic development. J. Infect. Dis.216,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7241685\results\search\tropicalVirus\results.xml">
   <result pre="to characterize transmissibility and forecast patterns and final burden of" exact="Zika" post="epidemics,â€� PLoS Curr. (published online 2016). 28.G.Chowell, â€œFitting dynamic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7241834\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Epidemiology: Spatial"/>
   <result pre="Epidemiology Incidence and epidemiological features of dengue in Sabah, Malaysia" exact="Dengue" post="in Sabah, Malaysia http://orcid.org/0000-0002-8993-033XMurphyAmandaConceptualizationData curationFormal analysisInvestigationMethodologyProject administrationWriting â€&quot; original"/>
   <result pre="(haemorrhagic) dengue cases (44%) were focused in Sandakan and Tawau." exact="Dengue" post="incidence was highest for those aged between 10 and"/>
   <result pre="contact Ms Angelica Fiona Tan, Research Officer, at tanangelica91@gmail.com. Introduction" exact="Dengue" post="is the most rapidly spreading vector-borne disease in the"/>
   <result pre="human movement facilitate the ongoing circulation of all four human" exact="DENV" post="serotypes across the country, although circulation patterns are distinct"/>
   <result pre="patterns are distinct between states [22, 23]. In addition, sylvatic" exact="DENV" post="serotypes detected from human cases on the island of"/>
   <result pre="in close proximity to disturbed forest environments, facilitating interactions among" exact="DENV" post="vectors and hosts, and increasing potential risk of spill-over"/>
   <result pre="severe cases in these areas followed a serotype switch from" exact="DENV" post="4 to DENV 1 reported to have occurred in"/>
   <result pre="these areas followed a serotype switch from DENV 4 to" exact="DENV" post="1 reported to have occurred in Sandakan between 2013"/>
   <result pre="2016 [26]. Major dengue outbreaks commonly follow the switching of" exact="DENV" post="serotypes and the subsequent loss of herd immunity in"/>
   <result pre="S2 Fig Variation in dengue incidence across Sabah districts, 2010â€&quot;2016." exact="Dengue" post="mean monthly incidence rates are plotted a) for the"/>
   <result pre="dengue. Nature. 2013;496(7446):504â€&quot;7. 10.1038/nature1206023563266 2World Health Organization. Global Strategy for" exact="Dengue" post="Prevention and Control, 2012â€&quot;2020. Geneva, 2012. 3KyleJL, HarrisE. Global"/>
   <result pre="hemorrhagic fever in Malaysiaâ€&quot;a retrospective epidemiological study. 1973â€&quot;1987. Part II:" exact="Dengue" post="fever (DF). Asia Pac J Public Health. 1992;6(3):126â€&quot;33. Epub"/>
   <result pre="Epub 2006/10/17. .17041556 18Muhammad AzamiNA, SallehSA, NeohHM, Syed ZakariaSZ, JamalR." exact="Dengue" post="epidemic in Malaysia: Not a predominantly urban disease anymore."/>
   <result pre="determining dengue outbreak in Malaysia. PLoS One. 2018;13(2):e019332610.1371/journal.pone.0193326 .29474401 21MudinRN." exact="Dengue" post="Incidence and the Prevention and Control Program in Malaysia."/>
   <result pre="Microbiol. 2011;9(7):532â€&quot;41. 10.1038/nrmicro259521666708 25LiuW, PickeringP, DucheneS, HolmesEC, AaskovJG. Highly Divergent" exact="Dengue" post="Virus Type 2 in Traveler Returning from Borneo to"/>
   <result pre="links zoonotic malaria to deforestation. Proc Biol Sci. 2019;286(1894):2018235110.1098/rspb.2018.235130963872 33OrganizationWH." exact="Dengue" post="guidelines for diagnosis, treatment, prevention and control In: (TDR)"/>
   <result pre="In: (TDR) SPfRaTiTD, editor. France: WHO, Geneva, Switzerland; 2009. 34WHO." exact="Dengue" post="Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: 2009."/>
   <result pre="dengue. Geneva, Switzerland: WHO; 2012. 36collab: World Health Organization (WHO)." exact="Dengue" post="control, vector surveillance: WHO; 2019 [Accessed April 4, 2019]."/>
   <result pre="Health Organ. 2010;88(3):173â€&quot;84. Epub 2010/04/30. 10.2471/BLT.09.06789220428384 49BanuS, HuW, HurstC, TongS." exact="Dengue" post="transmission in the Asia-Pacific region: impact of climate change"/>
   <result pre="cover types in Sarawak, Malaysian Borneo. Parasit Vectors. 2017;10(1):40610.1186/s13071-017-2341-z28859676 60GublerDJ." exact="Dengue" post="and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480â€&quot;96. Epub"/>
   <result pre="et al.Comparative Susceptibility of Aedes albopictus and Aedes aegypti to" exact="Dengue" post="Virus Infection After Feeding on Blood of Viremic Humans:"/>
   <result pre="AdnanTH, OoiCH, IbrahimM, HusinD, AbdullahNA, et al.Adult Aedes Mosquito and" exact="Dengue" post="Virus Surveillance in Residential and Public Areas of Selangor,"/>
   <result pre="in dengue surveillance: a report from the Asia-Pacific and Americas" exact="Dengue" post="Prevention Boards. PLoS Negl Trop Dis. 2010;4(11):e890 Epub 2010/11/26."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7245076\results\search\tropicalVirus\results.xml">
   <result pre="distributed under Creative Commons Attribution License 4.0 (CC BY).pnas.201919287.pdf Significance" exact="Dengue" post="affects approximately one-half of the worldâ€™s population. While it"/>
   <result pre="to intercept impending outbreaks before many lives are affected. Abstract" exact="Dengue" post="virus (DENV) is a global health threat, causing repeated"/>
   <result pre="levels to any one of the four antigenic types of" exact="DENV" post="predispose populations to outbreaks, viral genetic determinants that confer"/>
   <result pre="TanMilly M. ChoyTanamas SiriphanitchakornColin ChengSubhash G VasudevanEng Eong Ooi page-count:" exact="Dengue" post="is the most common vector-borne viral disease globally. Dengue"/>
   <result pre="page-count: Dengue is the most common vector-borne viral disease globally." exact="Dengue" post="virus (DENV), which exists as four antigenically distinct serotypes,"/>
   <result pre="some of which are life-threatening (1). The geographic footprints of" exact="DENV" post="and its mosquito vector, Aedes aegypti, are both set"/>
   <result pre="Without a vaccine that effectively prevents infection by all four" exact="DENV" post="serotypes or a licensed drug that can rapidly knock"/>
   <result pre="burden in dengue patients and thereby reduce the likelihood of" exact="DENV" post="transmission, cyclical dengue epidemics will continue to plague global"/>
   <result pre="transmission, cyclical dengue epidemics will continue to plague global health." exact="Dengue" post="epidemics are mostly thought to result from the emergence"/>
   <result pre="to result from the emergence of a new serotype of" exact="DENV" post="in populations with low serotype-specific herd immunity (3). However,"/>
   <result pre="(3). However, several outbreaks have occurred in areas where new" exact="DENV" post="strains emerged and displaced endemic strains without a change"/>
   <result pre="fitness. Defining the molecular underpinnings of such epidemiologic fitness of" exact="DENV" post="not only improves our understanding of dengue virology, but"/>
   <result pre="understanding of dengue virology, but also could be developed into" exact="DENV" post="genomic surveillance that scales disease prevention measures based on"/>
   <result pre="in Puerto Rico. In this outbreak, sequence data of the" exact="DENV" post="genome revealed the emergence of a clade of DENV2"/>
   <result pre="relative to gRNA further enabled sfRNA to be packaged into" exact="DENV" post="envelope (E) protein containing infectious particles. Thus, on infection,"/>
   <result pre="TRIM25 in a sequence-dependent manner (12). These findings suggest that" exact="DENV" post="NS5 and 3â€² UTR interact under epistasis to reveal"/>
   <result pre="3â€² UTR interact under epistasis to reveal the function of" exact="DENV" post="sfRNA. Fig. 2. NS5 mutations result in retardation of"/>
   <result pre="in PR1NS5 or PR13UTR, further suggesting that epistatic interaction between" exact="DENV" post="NS5 and 3â€² UTR elicited the PR2B phenotype. We"/>
   <result pre="with the addition of the antiviral compound NITD008, to inhibit" exact="DENV" post="NS5 polymerase activity (22). To avoid completely eliminating DENV"/>
   <result pre="inhibit DENV NS5 polymerase activity (22). To avoid completely eliminating" exact="DENV" post="infection, we used NITD008 concentrations below those previously shown"/>
   <result pre="used NITD008 concentrations below those previously shown to fully inhibit" exact="DENV" post="polymerase activity (22). Indeed, cotreatment of NITD008 yielded lower"/>
   <result pre="that a higher sfRNA-to-gRNA ratio provides a â€œone-two punchâ€� for" exact="DENV" post="against host cell antiviral responseâ€&quot;less gRNA would result in"/>
   <result pre="4B). While this finding supports previously published data indicating that" exact="DENV" post="gRNA can be contained inside exosomes (27, 28), the"/>
   <result pre="whether sfRNA is packaged in virions or infectious particles containing" exact="DENV" post="envelope (E) protein and are thus infectious, we used"/>
   <result pre="optimized levels of magnetic bead-conjugated monoclonal antibody 4G2 that binds" exact="DENV" post="E protein (SI Appendix, Fig. S5B) was incubated with"/>
   <result pre="together, these findings suggest that sfRNA may be packaged in" exact="DENV" post="E protein-containing particles, including both exosomes and virions. Regardless"/>
   <result pre="was packaged in exosomes, virions, or both, the presence of" exact="DENV" post="E protein raises the possibility that sfRNA could be"/>
   <result pre="at the tantalizing possibility that sfRNA can be packaged in" exact="DENV" post="E protein-containing infectious particles and delivered into cells for"/>
   <result pre="inhibition of the type I IFN response but in a" exact="DENV" post="strain-dependent manner. Discussion Epidemiologic observations have long suggested that"/>
   <result pre="to identify the genetic determinants of the epidemiologic fitness of" exact="DENV" post="(12). Here we add to this body of knowledge"/>
   <result pre="the NS5 gene. The largest multifunctional NS protein in the" exact="DENV" post="genome, NS5 consists of an N-terminal methyltransferase domain and"/>
   <result pre="R891K) and one was located in the linker region (S269N)." exact="DENV" post="NS5 RdRp binds the 5â€² UTR stem-loop A for"/>
   <result pre="replication, an increased abundance of which would stimulate RIG-I. Histologically," exact="DENV" post="replication and encapsidation occur concurrently in vesicle packets (VPs)"/>
   <result pre="sites in the ER for encapsidation by the positively charged" exact="DENV" post="capsid protein (40). A recently reported study found that"/>
   <result pre="DENVs in cell cultures may select against slower-replicating but sfRNA-packaging" exact="DENV" post="strains. This possibility underscores the need to use low-passaged"/>
   <result pre="type I IFN expression likely would have resulted in a" exact="DENV" post="strain that was unable to achieve sufficiently high viremia"/>
   <result pre="the 3â€² UTR to reveal a â€œpreemptive strikeâ€� function of" exact="DENV" post="sfRNA for increased epidemiologic fitness. Materials and Methods Cell"/>
   <result pre="to synthesize six DNA fragments that amount to the complete" exact="DENV" post="genome using Q5 Hotstart 2Ã— Master Mix (New England"/>
   <result pre="accompanies clade reintroduction. J. Gen. Virol.87, 885â€&quot;893 (2006).16528038 6LeeK.-S.et al.," exact="Dengue" post="virus surveillance for early warning, Singapore. Emerg. Infect. Dis.16,"/>
   <result pre="on Dengue, (World Health Organization, 2007), pp. 124â€&quot;133. 12ManokaranG.et al.," exact="Dengue" post="subgenomic RNA binds TRIM25 to inhibit interferon expression for"/>
   <result pre="virus. Proc. Natl. Acad. Sci. U.S.A.106, 20435â€&quot;20439 (2009).19918064 23XieX.et al.," exact="Dengue" post="NS2A protein orchestrates virus assembly. Cell Host Microbe26, 606â€&quot;622.e8"/>
   <result pre="orchestrates virus assembly. Cell Host Microbe26, 606â€&quot;622.e8 (2019).31631053 24ZhangX.et al.," exact="Zika" post="virus NS2A-mediated virion assembly. mBio10, e02375-19 (2019).31662457 25LiD.et al.,"/>
   <result pre="in mice. Sci. Transl. Med.11, eaat7726 (2019).31243154 32BeattyP. R.et al.," exact="Dengue" post="virus NS1 triggers endothelial permeability and vascular leak that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7246487\results\search\tropicalVirus\results.xml">
   <result pre="to be more troublesome. Similarly, the first human cases of" exact="Zika" post="virus infections can be traced back to 1950s, with"/>
   <result pre="world (e.g., 2013 Ebola virus epidemic in West Africa, 2015" exact="Zika" post="virus epidemic in Brazil, and COVID-19 epidemic in China)."/>
   <result pre="retrospective lens to reconsider past lessons from SARS, Ebola, and" exact="Zika" post="epidemics. It is only through such retrospection that we"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7247193\results\search\tropicalVirus\results.xml">
   <result pre="Infectious Diseases1471-2334BioMed CentralLondon pmcid: 72471935093 doi: 10.1186/s12879-020-05093-5 : Research Article" exact="Zika" post="virus in southeastern Senegal: survival of the vectors and"/>
   <result pre="stated in a credit line to the data. Abstract Background" exact="Zika" post="virus (ZIKV, genus Flavivirus, family Flaviviridae) is transmitted mainly"/>
   <result pre="epidemics associated to neurological complications in the pacific and America." exact="ZIKV" post="is the most frequently amplified arbovirus in southeastern Senegal."/>
   <result pre="season. The aim of this study was to investigate how" exact="ZIKV" post="and its vectors are maintained locally during the dry"/>
   <result pre="The F0 and F1 adults were identified and tested for" exact="ZIKV" post="by Reverse Transcriptase-Real time Polymerase Chain Reaction. Results A"/>
   <result pre="forest and village tree holes, Ae. vittatus in rock holes." exact="ZIKV" post="was detected from 4 out of the 82 mosquito"/>
   <result pre="identified breeding sites types and land cover classes where several" exact="ZIKV" post="vectors are maintained, and their maintenance rates during the"/>
   <result pre="the start of the rainy season in this area. Keywords" exact="Zika" post="virus Aedes Eggs Vertical transmission Local maintenance Southeastern Senegal"/>
   <result pre="virus Aedes Eggs Vertical transmission Local maintenance Southeastern Senegal Background" exact="Zika" post="virus (ZIKV, genus Flavivirus, family Flaviviridae) was isolated for"/>
   <result pre="family Flaviviridae) was isolated for the first time in the" exact="Zika" post="forest near Entebbe, Uganda, in 1947 from a febrile"/>
   <result pre="[2]. Subsequently, serological and virological studies showed the circulation of" exact="ZIKV" post="in several other African [3] and Asian countries [4]."/>
   <result pre="is during the last decade that the Asian genotype of" exact="ZIKV" post="has experienced significant geographic expansion causing major epidemics in"/>
   <result pre="[6] and in America [7]. Indeed, phylogenic studies on sequenced" exact="ZIKV" post="strains isolated from Brazil, Puerto Rico and Guatemala indicated"/>
   <result pre="and closely related to the French Polynesia strain [8, 9]." exact="ZIKV" post="is known to cause several debilitating neurological complications, including"/>
   <result pre="America and the Pacific Islands [10â€&quot;13]. In the urban cycle," exact="ZIKV" post="is mainly transmitted by Ae. aegypti and Ae. albopictus,"/>
   <result pre="fluid transmissions were reported [7, 14, 15]. In West Africa," exact="ZIKV" post="has a sylvatic cycle (described in southeastern Senegal) involving"/>
   <result pre="Ae. furcifer and Ae. vittatus in villages [17]. Evidences of" exact="ZIKV" post="presence in human populations in Senegal were shown by"/>
   <result pre="Bandia, and MeckhÃ©) between 1962 and 2015 [17â€&quot;20]. In vectors," exact="ZIKV" post="was isolated in western Senegal from Ae. luteocephalus collected"/>
   <result pre="vectors in southeastern Senegal (1972â€&quot;2015), more than 400 strains of" exact="ZIKV" post="were isolated from around 20 species of mosquitoes belonging"/>
   <result pre="Aedes, Anopheles, Culex and Mansonia [17]. Recent studies have detected" exact="ZIKV" post="from mosquitoes collected in different types of land covers"/>
   <result pre="villages across a large geographical area indicating wide spread of" exact="ZIKV" post="in southeastern Senegal [17]. However, the main vectors belong"/>
   <result pre="(Ae. luteocephalus)) accounting for more than 90% of the isolates." exact="ZIKV" post="is the most frequently amplified arbovirus in Senegal [12,"/>
   <result pre="and 2015 in the southeastern part of the country. However," exact="ZIKV" post="prevalence and vector density drop dramatically beyond detection by"/>
   <result pre="May. These data suggest that in southeastern Senegal, vectors and" exact="ZIKV" post="are maintained locally in nature during adverse conditions corresponding"/>
   <result pre="first objective was to identify the vector species in which" exact="Zika" post="virus is maintained during dry season, and their specific"/>
   <result pre="qualitative statistical approach on vector species occurrence. We expected that" exact="Zika" post="virus would be maintained through certain mosquito species, and"/>
   <result pre="area favorable to the circulation of several arboviruses such as" exact="ZIKV" post="and dengue virus. It is the rainiest region of"/>
   <result pre="and land cover of origin, and kept at âˆ’â€‰80â€‰Â°C for" exact="ZIKV" post="detection attempts by Reverse Transcriptase-Real time Polymerase Chain Reaction"/>
   <result pre="each primer, 0.5â€‰Î¼l of probe, and 0.2â€‰Î¼l of enzymes. Primers" exact="ZIKV" post="835 (TTGGTCATGATACTGCTGATTGC) and ZIKV 911c (CCTTCCACAAAGTCCCTATTGC) and probe ZIKV"/>
   <result pre="probe, and 0.2â€‰Î¼l of enzymes. Primers ZIKV 835 (TTGGTCATGATACTGCTGATTGC) and" exact="ZIKV" post="911c (CCTTCCACAAAGTCCCTATTGC) and probe ZIKV 860-FAM (CGGCATACAGCATCAGGTGCATAGGAG), described by"/>
   <result pre="Primers ZIKV 835 (TTGGTCATGATACTGCTGATTGC) and ZIKV 911c (CCTTCCACAAAGTCCCTATTGC) and probe" exact="ZIKV" post="860-FAM (CGGCATACAGCATCAGGTGCATAGGAG), described by Lanciotti et al. [32] were"/>
   <result pre="from forests (11.1%, 30/270). Table 2 Maintenance rates of potential" exact="Zika" post="virus vectors in the different breeding sites and land"/>
   <result pre="land cover (pâ€‰Table 3 Abundance of species potential vectors of" exact="Zika" post="virus potential vectors in the different breeding sites and"/>
   <result pre="land cover classes have eggs Minimum field infection rate of" exact="ZIKV" post="in potential vectors A total of 1768 mosquitoes (748"/>
   <result pre="(748 males and 1020 females, 82 pools) were tested for" exact="ZIKV" post="infection by RT-PCR. Four (4) of the 28 pools"/>
   <result pre="(pâ€‰=â€‰0.7). Table 4 Minimum infection rate of species infected with" exact="Zika" post="virus collected in the KÃ©dougou in March 2017 in"/>
   <result pre="and thus more favorable to eggs survival of this species." exact="ZIKV" post="detection by RT-PCR in 4 mosquito pools from 3"/>
   <result pre="Ae. furcifer in the area [17]. A recent study detected" exact="ZIKV" post="in 5 adults Ae. albopictus emerged from eggs collected"/>
   <result pre="2015 in Bahia, Brazil [45]. In addition, vertical transmission of" exact="ZIKV" post="has also been proven for Ae. aegypti and Ae."/>
   <result pre="Ae. albopictus in laboratory studies [46, 47]. The maintenance of" exact="ZIKV" post="in 3 species in southeastern Senegal explains its frequent"/>
   <result pre="sensitive hosts are rare. The implication of Ae. vittatus in" exact="ZIKV" post="maintenance strengthens its status of potential epidemic vector. Indeed,"/>
   <result pre="vector. Indeed, Ae. vittatus has already been found associated with" exact="ZIKV" post="in nature and competent for the virus in laboratory"/>
   <result pre="for the first time the association of Ae. bromeliae with" exact="ZIKV" post="in the area. Particular attention should be paid to"/>
   <result pre="for ZIKV. Aedes unilineatus has already been found associated to" exact="ZIKV" post="in nature and able to disseminate but not to"/>
   <result pre="to transmit the virus [17, 48]. Its implication in maintaining" exact="ZIKV" post="suggests that it may also play a more important"/>
   <result pre="it may also play a more important epidemiological role in" exact="ZIKV" post="epidemiology in Africa. Conclusion This study allows us to"/>
   <result pre="sites, land cover classes and maintenance rates of several important" exact="ZIKV" post="vectors in southeastern Senegal. It has also highlighted ZIKV"/>
   <result pre="important ZIKV vectors in southeastern Senegal. It has also highlighted" exact="ZIKV" post="maintenance in the area as well as species involved"/>
   <result pre="These results provide a better understanding of the epidemiology of" exact="ZIKV" post="disease in southeastern Senegal. Abbreviations ZIKV Zika virus MFIR"/>
   <result pre="of the epidemiology of ZIKV disease in southeastern Senegal. Abbreviations" exact="ZIKV" post="Zika virus MFIR Minimum field Infection Rate BS+â€‰=â€‰Number of"/>
   <result pre="the epidemiology of ZIKV disease in southeastern Senegal. Abbreviations ZIKV" exact="Zika" post="virus MFIR Minimum field Infection Rate BS+â€‰=â€‰Number of positive"/>
   <result pre="Negl Trop Dis.20148e268124516683 6.RothAMercierALepersCHoyDDuituturagaSBenyonEet al.Concurrent outbreaks of dengue, chikungunya and" exact="Zika" post="virus infections â€&quot; an unprecedented epidemic wave of mosquito-borne"/>
   <result pre="to KnowPediatr Infect J.201736333336 8.ZanlucaCMeloVCMosimannALSantosGISantosCNLuzKFirst report of autochthonous transmission of" exact="Zika" post="virus in BrazilMem Inst Oswaldo Cruz.201511056957226061233 9.LanciottiRSLambertAJHolodniyMSaavedraSSignorLCPhylogeny of Zika"/>
   <result pre="of Zika virus in BrazilMem Inst Oswaldo Cruz.201511056957226061233 9.LanciottiRSLambertAJHolodniyMSaavedraSSignorLCPhylogeny of" exact="Zika" post="Virus in Western Hemisphere, 2015Emerg Infect Dis.20162293393527088323 10.CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.Association"/>
   <result pre="Virus in Western Hemisphere, 2015Emerg Infect Dis.20162293393527088323 10.CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013-15: a retrospective"/>
   <result pre="Latin America and the Caribbean before and during the 2015-2016" exact="Zika" post="virus epidemic: A systematic review and meta-analysisPLoS Negl Trop"/>
   <result pre="Virus Associated with MicrocephalyN Engl J Med.201637495195826862926 14.GrischottFPuhanMHatzCSchlagenhaufPNon-vector-borne transmission of" exact="Zika" post="virus: A systematic reviewTravel Med Infect Dis.20161431333027425793 15.BaudDMussoDVougaMAlvesMPVulliemozNZika virus:"/>
   <result pre="reproductionAm J Reprod Immunol.201777e12614 16.BoyerSCalvezEChouin-CarneiroTDialloDFaillouxABAn overview of mosquito vectors of" exact="Zika" post="virusMicrobes Infect.20182064666029481868 17.DialloDSallAADiagneCTFayeOFayeOBaYet al.Zika Virus Emergence in Mosquitoes in"/>
   <result pre="hÃ©morrhagiques (CRORA). 2005. 23.DialloMBaYSallAADiopOMNdioneJAMondoMet al.Amplification of the Sylvatic Cycle of" exact="Dengue" post="Virus Type 2, Senegal, 1999â€&quot;2000: Entomologic Findings and Epidemiologic"/>
   <result pre="American Mosquito Control Association; 1994. 31.FayeOFayeODialloDDialloMWeidmannMSallAQuantitative real-time PCR detection of" exact="Zika" post="virus and evaluation with field-caught MosquitoesVirol J.20131031124148652 32.LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.Genetic"/>
   <result pre="with field-caught MosquitoesVirol J.20131031124148652 32.LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.Genetic and Serologic Properties of" exact="Zika" post="Virus Associated with an Epidemic, Yap State, Micronesia, 2007Emerg"/>
   <result pre="south IndiaTrop Med Int Health.2004949950715078269 45.SmarttCTStennTMSChenT-YTeixeiraMGQueirozEPSouza Dos SantosLet al.Evidence of" exact="Zika" post="Virus RNA Fragments in Aedes albopictus (Diptera: Culicidae) Field-Collected"/>
   <result pre="Eggs From CamaÃ§ari, Bahia, BrazilJ Med Entomol.2017541085108728419254 46.ThangamaniSHuangJHartCEGuzmanHTeshRBVertical Transmission of" exact="Zika" post="Virus in Aedes aegypti MosquitoesAm J Trop Med Hyg.2016951169117327573623"/>
   <result pre="Aedes aegypti MosquitoesAm J Trop Med Hyg.2016951169117327573623 47.CiotaATBialosukniaSMEhrbarDJKramerLDVertical Transmission of" exact="Zika" post="Virus by Aedes aegypti and Ae. albopictus MosquitoesEmerg Infect"/>
   <result pre="of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit" exact="Zika" post="virusBMC Infect Dis.20151549226527535 49.HuangY-MAedes (Stegomyia) bromeliae (Diptera: Culicidae), the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7249458\results\search\tropicalVirus\results.xml">
   <result pre="Ebola virus,3 2015 Middle Eastern Respiratory Syndrome Coronavirus,4 and 2015" exact="Zika" post="virus outbreaks5) suggests that new mechanisms to combat viral"/>
   <result pre="epidemiological outbreak study. Lancet388,994, 201627402381 5.ChangC., OrtizK., AnsariA., and GershwinM.E.The" exact="Zika" post="outbreak of the 21st century. J Autoimmun68,1, 201626925496 6.MazzocchiA.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7249615\results\search\tropicalVirus\results.xml">
   <result pre="caused panic in recent memory. These include SARS, MERS, the" exact="Zika" post="virus, swine flu, and Ebola. This is the third"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7250535\results\search\tropicalVirus\results.xml">
   <result pre="Recently, the Ebola vaccine was developed in 5Â years, and" exact="Zika" post="vaccine was developed in less than 2Â years. However,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7251044\results\search\tropicalVirus\results.xml">
   <result pre="additional challenge for the health systems and economies where recent" exact="Zika" post="and Chikungunya outbreaks have had significant impact [24]. The"/>
   <result pre="for the health systems and economies where recent Zika and" exact="Chikungunya" post="outbreaks have had significant impact [24]. The economic consequences"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7252029\results\search\tropicalVirus\results.xml">
   <result pre="herpes virus (HHV)-6, BK polyomavirus (BK), [56] parainfluenza virus, [65]" exact="Zika" post="virus, [57] mycobacteria, [58] norovirus, [59] herpes simplex virus"/>
   <result pre="the prophylaxis and treatment of viral infectionsMol Ther20820121622163222801446 57HanajiriR.SaniG.M.HanleyP.J.SilveiraC.G.KallasE.G.KellerM.D.Generation of" exact="Zika" post="virus-specific T cells from seropositive and virus-naive donors for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7252171\results\search\tropicalVirus\results.xml">
   <result pre="virus disease outbreak in west Africa,2 but also cholera and" exact="Zika" post="virus disease outbreaks, led to regional environments where domestic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7252625\results\search\tropicalVirus\results.xml">
   <result pre="3444 cases reported [18]) evidence on viral persistence e.g. of" exact="Zika" post="virus is also increasing [19]. Clinical research in which"/>
   <result pre="reports https://www.who.int/emergencies/diseases/ebola/drc-2019/situation-reports 19Paz-BaileyG, RosenbergES, DoyleK, Munoz-JordanJ, SantiagoGA, KleinLet al.Persistence of" exact="Zika" post="virus in body fluidsâ€&quot;final report. N Engl J Med2018;"/>
   <result pre="Eldersâ€™ memories and perceptions of sleeping sickness control interventions in" exact="West Nile," post="Uganda. PLoS Negl Trop Dis2016; 10(6): e000474510.1371/journal.pntd.000474527253367"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7252634\results\search\tropicalVirus\results.xml">
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Genetics: Mutagenesis"/>
   <result pre="residues onto the surface of the structure of the related" exact="CHIKV" post="E1/E2 heterodimer (PDB 3N42) [26], we found that most"/>
   <result pre="(C) Loss-of-binding residues mapped onto the crystal structure of the" exact="CHIKV" post="E1/E2 heterodimer (PDB 3N42), with three heterodimers subunits combined"/>
   <result pre="domain (green) and C domain (magenta) when overlaid on the" exact="CHIKV" post="E1/E2 trimer, whereas those in the second group (orange)"/>
   <result pre="group as determined through alanine scanning mutagenesis mapped onto the" exact="CHIKV" post="E1/E2 trimer of heterodimers (PDB 3N42). Space-filling models for"/>
   <result pre="Mxra8 binding to cell-surface-displayed chikungunya proteins are mapped onto the" exact="CHIKV" post="E1/E2 trimer of heterodimers (PDB 3J2W) in red, and"/>
   <result pre="cell surface protein Mxra8 was identified as a receptor for" exact="CHIKV" post="and several other arthritogenic alphaviruses, including RRV, Mayaro, and"/>
   <result pre="and B domain. We overlaid these residues (yellow) on the" exact="CHIKV" post="E1/E2 heterodimer along with the known Mxra8 contact residues"/>
   <result pre="range to the best-in-class human neutralizing antibodies for the related" exact="CHIKV" post="[22]. For nearly half of these RRV mAbs, a"/>
   <result pre="could affect mAb binding to domain B allosterically. Previously, neutralizing" exact="CHIKV" post="antibodies have been shown to target analogous sites within"/>
   <result pre="protein that resulted in loss of Mxra8 binding to cell-surface-displayed" exact="CHIKV" post="proteins are residues 62â€&quot;64, 71â€&quot;72, and 74â€&quot;76 [25,28,29], which"/>
   <result pre="tissues examined. A combination mAb therapy has proven efficacious for" exact="CHIKV" post="[24], so it is possible that pairing antibodies such"/>
   <result pre="a protective effect when administered prophylactically, as was seen with" exact="CHIKV" post="mAb studies [22,24,40]. While the market for an RRV"/>
   <result pre="therapy has already shown promise in mice and macaques for" exact="CHIKV" post="[42,43]. A future challenge that must be addressed before"/>
   <result pre="Biotek plate reader. A similarly prepared human mAb specific for" exact="Zika" post="virus (ZIKV-117 [47]) was included as a negative control"/>
   <result pre="SamI-C. Characterisation of mouse monoclonal antibodies targeting linear epitopes on" exact="Chikungunya" post="virus E2 glycoprotein. J Virol Methods. 2014;195: 126â€&quot;133. 10.1016/j.jviromet.2013.10.01524134938"/>
   <result pre="al.Development of a highly protective combination monoclonal antibody therapy against" exact="Chikungunya" post="virus. PLoS Pathog. 2013;9: e100331210.1371/journal.ppat.100331223637602 25ZhangR, KimAS, FoxJM, NairS,"/>
   <result pre="26VossJE, VaneyM-C, DuquerroyS, VonrheinC, Girard-BlancC, CrubletE, et al.Glycoprotein organization of" exact="Chikungunya" post="virus particles revealed by X-ray crystallography. Nature. 2010;468: 709â€&quot;712."/>
   <result pre="FernandezE, KoseN, BinCao, FoxJM, BombardiRG, et al.Neutralizing human antibodies prevent" exact="Zika" post="virus replication and fetal disease in mice. Nature. 2016;540:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7252670\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="draftWriting â€&quot; review &amp;amp; editing1[1], Institut Pasteur de Nouvelle-CalÃ©donie, URE" exact="Dengue" post="et Arboviroses, Institut Pasteur International Network, Noumea, New Caledonia[2],"/>
   <result pre="prevalent arbovirosis in NC. Since World War II, the four" exact="DENV" post="serotypes have circulated regularly in NC. The epidemiological profile,"/>
   <result pre="the persistence of DENV-1 circulation and the co-circulation of several" exact="DENV" post="serotypes. The current study evaluated the ability of Ae."/>
   <result pre="the ability of Ae. aegypti from NC to transmit four" exact="DENV" post="serotypes (and two DENV-1 genotypes) isolated during recent outbreaks"/>
   <result pre="aegypti F1 generation was twice independently orally challenged with each" exact="DENV" post="strain (107 FFU/ml). Infection, dissemination and transmission rates and"/>
   <result pre="Infection rates between 18 and 58% were measured for all" exact="DENV" post="serotypes/genotypes tested. Although dissemination rates ranged from 78 to"/>
   <result pre="values not exceeding 21% at 14 days post-infection for all" exact="DENV" post="strains. This study shows that NC Ae. aegypti are"/>
   <result pre="study shows that NC Ae. aegypti are moderately competent for" exact="DENV" post="in laboratory conditions. In link with epidemiological data, these"/>
   <result pre="known vector for dengue virus (DENV) in New Caledonia (NC)." exact="DENV" post="are divided into four serotypes (DENV-1 to -4), based"/>
   <result pre="antigenic properties, these being subdivided into different genotypes. All four" exact="DENV" post="serotypes have regularly circulated in New Caledonia in the"/>
   <result pre="last ten years, suggesting a possible preferential transmission of this" exact="DENV" post="serotype by Ae. aegypti. In this study, we examine"/>
   <result pre="Ae. aegypti from New Caledonia to transmit the four circulating" exact="DENV" post="serotypes, and more precisely two genotypes of DENV-1. Our"/>
   <result pre="is moderately competent for DENV, with slight differences observed between" exact="DENV" post="serotype/genotype in terms of transmission. These findings suggest that"/>
   <result pre="vector-virus interactions studies should be undertaken to better understand the" exact="DENV" post="epidemiological profile in NC. Funding This works was funded"/>
   <result pre="preparation of the manuscript. fig-count: table-count: page-count: Data Availability All" exact="DENV" post="sequences files are available from the GenBankdatabase (accession numbers"/>
   <result pre="are within the manuscript and its Supporting Information files. Introduction" exact="Dengue" post="fever is a worldwide public health concern, with approximately"/>
   <result pre="treatment is available and dengue vaccines still need improvement [3]." exact="Dengue" post="virus (DENV) is a positive-sense single-stranded RNA virus belonging"/>
   <result pre="it possible to identify distinct genotypes within each serotype [5]." exact="DENV" post="are transmitted to humans by the bite of infected"/>
   <result pre="Pacific Island Countries and Territories (PICTs), NC has regularly experienced" exact="DENV" post="epidemics since World War II [7, 8]. Before 2000,"/>
   <result pre="every five years and outbreaks were due to a single" exact="DENV" post="serotype/genotype, which was replaced by another one during the"/>
   <result pre="was replaced by another one during the next epidemic. This" exact="DENV" post="epidemiological profile, however, has changed over the last fifteen"/>
   <result pre="an unusual persistence of DENV-1, with the co-circulation of other" exact="DENV" post="serotypes and/or other arboviruses such as Zika virus or"/>
   <result pre="co-circulation of other DENV serotypes and/or other arboviruses such as" exact="Zika" post="virus or chikungunya virus [9]. Interestingly, in 2012, DENV-1"/>
   <result pre="in 2008â€&quot;2009 [9]. Although many Aedes species are vectors of" exact="DENV" post="in the Pacific region [11], the only known DENV"/>
   <result pre="of DENV in the Pacific region [11], the only known" exact="DENV" post="vector in NC to date is Ae. aegypti. A"/>
   <result pre="ability of Ae. aegypti from NC to transmit chikungunya or" exact="Zika" post="viruses [14, 15]. Few data, however, are available regarding"/>
   <result pre="Zika viruses [14, 15]. Few data, however, are available regarding" exact="DENV" post="and this vectorâ€™s capacity to transmit DENV in NC"/>
   <result pre="are available regarding DENV and this vectorâ€™s capacity to transmit" exact="DENV" post="in NC has not yet been investigated except for"/>
   <result pre="from NC to transmit the four serotypes of DENV. One" exact="DENV" post="strain representative of each serotype/genotype isolated in NC during"/>
   <result pre="Virus stock production As part of the molecular characterization of" exact="DENV" post="strains circulating in the south Pacific region, the envelope"/>
   <result pre="in the south Pacific region, the envelope gene sequences of" exact="DENV" post="strains from 1997 to 2016 were obtained as described"/>
   <result pre="elsewhere [10, 17, 18]. One epidemic viral strain of each" exact="DENV" post="serotype/genotype, selected from 1997 to 2016 during NC outbreaks,"/>
   <result pre="was then incubated for 5 days at 28Â°C. 10.1371/journal.pntd.0008303.t001Table 1" exact="Dengue" post="virus strains used in this study. DENV Year of"/>
   <result pre="28Â°C. 10.1371/journal.pntd.0008303.t001Table 1 Dengue virus strains used in this study." exact="DENV" post="Year of collection Serotype Genotype GenBank accession number DENV-1"/>
   <result pre="were challenged with infectious blood-meals containing each of the different" exact="DENV" post="serotype/genotype. Briefly, mosquitoes were allowed to feed for 20"/>
   <result pre="performed with the same population of mosquitoes and the same" exact="DENV" post="strains. All percentages used for the comparison of the"/>
   <result pre="were â€œdays post-infectionâ€� (with 7 dpi as reference) and the" exact="DENV" post="strains. All tests were performed using R software, considering"/>
   <result pre="out under the same experimental conditions. In both cases, all" exact="DENV" post="strains were able to infect mosquitoes, disseminate and be"/>
   <result pre="14 days post-infection (dpi) according to the four dengue serotypes." exact="DENV" post="strains Experiment Days post-infection (dpi) Number of individuals %"/>
   <result pre="7 dpi ranged from 18% to 40% for the four" exact="DENV" post="serotypes, with no significant difference (Fig 1A; S1 Table)."/>
   <result pre="infection rate for the DENV-4 strain compared to the others" exact="DENV" post="(Fisherâ€™s exact test: p-values = 0.03, &amp;lt; 0.001, ="/>
   <result pre="for Aedes aegypti from New Caledonia orally infected with different" exact="DENV" post="serotype/genotype. (A) Infection rate, (B) dissemination rate, (C) transmission"/>
   <result pre="1.27â€&quot;39.79 respectively). Transmission efficiency No significant difference was found between" exact="DENV" post="transmission efficiencies (Fisherâ€™s exact test: p-values &amp;gt; 0.05; Fig"/>
   <result pre="0.05; Fig 1D). The efficiency of transmission for all the" exact="DENV" post="strains at 7 dpi did not exceed 4%, with"/>
   <result pre="At 14 dpi, transmission efficiencies were observed for all four" exact="DENV" post="serotypes, ranging from 7% to 21%, with the higher"/>
   <result pre="infectious viral particles in their bodies compared to the other" exact="DENV" post="(two-sample Wilcoxon test: p-value &amp;lt; 0.001, &amp;lt; 0.001, ="/>
   <result pre="obtained from positive bodies, heads and saliva according to the" exact="DENV" post="serotype/genotype strain. (A) Body infection titer, (B) head infection"/>
   <result pre="to the small number of saliva analyzed. Discussion Since 2008," exact="DENV" post="circulation has increased in NC and caused recurrent outbreaks"/>
   <result pre="Ae. aegypti population from NC to transmit the four circulating" exact="DENV" post="serotypes and two genotypes of DENV-1. Vector competence is"/>
   <result pre="in saliva from 7 dpi for three out of five" exact="DENV" post="strains. All four DENV serotypes can infect NC Ae."/>
   <result pre="dpi for three out of five DENV strains. All four" exact="DENV" post="serotypes can infect NC Ae. aegypti from 7 dpi."/>
   <result pre="7 dpi. Infection rates of mosquitoes do not differ by" exact="DENV" post="strain, except for DENV-4 which has a lower infection"/>
   <result pre="the transmission efficiencies were low with no differences observed between" exact="DENV" post="strains in pairwise comparison. These results, however, need to"/>
   <result pre="and dissemination indices at 14 dpi showed differences between the" exact="DENV" post="serotypes, with a tendency towards lower infectious viral titers"/>
   <result pre="statistically, viral titers in saliva seemed similar between all the" exact="DENV" post="strains tested. We can suppose that this may be"/>
   <result pre="salivary glands are a site for replication and accumulation of" exact="DENV" post="[22]. Vector competence studies have been performed in other"/>
   <result pre="aegypti populations were mainly used in these studies, but the" exact="DENV" post="strains used were mostly old strains, with an overrepresentation"/>
   <result pre="[28], suggesting that NC Ae. aegypti are less susceptible to" exact="DENV" post="infection. Many intrinsic and extrinsic factors [13] are involved"/>
   <result pre="factors, however, need to be considered. Indeed, only a single" exact="DENV" post="strain per serotype/genotype was tested, which constitutes a bias"/>
   <result pre="a bias of our experimental design considering the diversity of" exact="DENV" post="serotype/genotype strains which circulate during an outbreak. Furthermore, the"/>
   <result pre="aegypti which can increase the competence of this species for" exact="DENV" post="[38, 39]. Furthermore, DENV co-infection experiments in Ae. aegypti"/>
   <result pre="the competence of this species for DENV [38, 39]. Furthermore," exact="DENV" post="co-infection experiments in Ae. aegypti can highlight significant competitive"/>
   <result pre="in the recent years [41]. Some studies have indicated that" exact="DENV" post="genotype replacements were associated with differences in viral fitness,"/>
   <result pre="the capacity of our local vector to transmit the four" exact="DENV" post="serotypes. This indicates that factors related to humans would"/>
   <result pre="of NC vector population Ae. aegypti to transmit all four" exact="DENV" post="serotypes. Further studies on virus-vector interactions should be undertaken"/>
   <result pre="in the light of our results to better understand the" exact="DENV" post="epidemiological profile in NC and the evolutionary dynamics of"/>
   <result pre="DENV epidemiological profile in NC and the evolutionary dynamics of" exact="DENV" post="at a larger scale. Indeed, DENV evolutionary dynamics are"/>
   <result pre="the evolutionary dynamics of DENV at a larger scale. Indeed," exact="DENV" post="evolutionary dynamics are often characterized by DENV serotypic and/or"/>
   <result pre="larger scale. Indeed, DENV evolutionary dynamics are often characterized by" exact="DENV" post="serotypic and/or genotypic replacements that can be epidemiologically significant."/>
   <result pre="the possible role of the vector in the selection of" exact="DENV" post="variants and to better understand the evolutionary mechanisms driving"/>
   <result pre="DENV variants and to better understand the evolutionary mechanisms driving" exact="DENV" post="genotype replacement. Deepening our knowledge in this field is"/>
   <result pre="knowledge in this field is all the more important as" exact="DENV" post="genotypes may differ in their antigenic properties and thus"/>
   <result pre="7 and 14 days post-infection (dpi) according to the four" exact="DENV" post="serotypes. (DOCX) LINK Click here for additional data file."/>
   <result pre="saliva at 14 days post-infection (dpi) according to the four" exact="DENV" post="serotypes. (DOCX) LINK Click here for additional data file."/>
   <result pre="and Control: New EditionGeneva: World Health Organization.; 2009. 3RobinsonML, DurbinAP." exact="Dengue" post="vaccines: implications for dengue control.Curr Opin Infect Dis. 2017;30(5):449â€&quot;54."/>
   <result pre="implications for dengue control.Curr Opin Infect Dis. 2017;30(5):449â€&quot;54. 10.1097/QCO.000000000000039428719400 4GublerDJ." exact="Dengue" post="and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480â€&quot;96. 9665979"/>
   <result pre="Ann Trop Med Parasitol. 2006;100(4):327â€&quot;36. 10.1179/136485906X10558916762113 8SinghN, KiedrzynskiT, LepersC, BenyonEK." exact="Dengue" post="in the Pacificâ€&quot;an update of the current situation.Pac Health"/>
   <result pre="RoussetD, FayeO, RichardV, et al.Differential transmission of Asian and African" exact="Zika" post="virus lineages by Aedes aegypti from New Caledonia. Emerg"/>
   <result pre="blood samples on filter paper to improve the surveillance of" exact="Dengue" post="in Pacific Island Countries.J Clin Virol. 2012;55(1):23â€&quot;9. 10.1016/j.jcv.2012.05.01022695001 18Cao-LormeauVM,"/>
   <result pre="Barriers to Arbovirus Infection in Mosquitoes.Viruses. 2015;7(7):3741â€&quot;67. 10.3390/v707279526184281 22RaquinV, LambrechtsL." exact="Dengue" post="virus replicates and accumulates in Aedes aegypti salivary glands."/>
   <result pre="vector competence of Culex pipiens quinquefasciatus Say (Diptera: Culicidae) for" exact="West Nile" post="virus.Vector Borne Zoonotic Dis. 2007;7(4):629â€&quot;36. 10.1089/vbz.2007.010118021028 35TeslaB, DemakovskyLR, MordecaiEA,"/>
   <result pre="10.1089/vbz.2007.010118021028 35TeslaB, DemakovskyLR, MordecaiEA, RyanSJ, BondsMH, NgonghalaCN, et al.Temperature drives" exact="Zika" post="virus transmission: evidence from empirical and mathematical models. Proc"/>
   <result pre="FoyBD, EbelGD, et al.Sequential Infection of Aedes aegypti Mosquitoes with" exact="Chikungunya" post="Virus and Zika Virus Enhances Early Zika Virus Transmission.Insects."/>
   <result pre="al.Sequential Infection of Aedes aegypti Mosquitoes with Chikungunya Virus and" exact="Zika" post="Virus Enhances Early Zika Virus Transmission.Insects. 2018;9(4). 40VazeilleM, GaboritP,"/>
   <result pre="aegypti Mosquitoes with Chikungunya Virus and Zika Virus Enhances Early" exact="Zika" post="Virus Transmission.Insects. 2018;9(4). 40VazeilleM, GaboritP, MoussonL, GirodR, FaillouxAB. Competitive"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7253103\results\search\tropicalVirus\results.xml">
   <result pre="Medicine and Hygiene pmcid: 7253103tpmd190881 doi: 10.4269/ajtmh.19-0881 : Articles Harnessing" exact="Dengue" post="Rapid Diagnostic Tests for the Combined Surveillance of Dengue,"/>
   <result pre="Diagnostic Tests for the Combined Surveillance of Dengue, Zika, and" exact="Chikungunya" post="Viruses in Laos VongsouvathManivanh1BharuchaTehmina12SeephoneleeMalee1de LamballerieXavier3NewtonPaul N.14â€ Dubot-PÃ©rÃ¨sAudrey134*â€ [1], [2],"/>
   <result pre="highlight the need for improved surveillance, especially in resource-poor settings." exact="Dengue" post="virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV)"/>
   <result pre="in resource-poor settings. Dengue virus (DENV), chikungunya virus (CHIKV), and" exact="Zika" post="virus (ZIKV) share the same vectors as well as"/>
   <result pre="in remote areas for subsequent detection of DENV, CHIKV, and" exact="ZIKV" post="by reverse transcription real-time polymerase chain reaction (RT-qPCR). CHIKV"/>
   <result pre="and ZIKV by reverse transcription real-time polymerase chain reaction (RT-qPCR)." exact="CHIKV" post="and ZIKV dilutions were spotted on dengue RDTs (SD"/>
   <result pre="by reverse transcription real-time polymerase chain reaction (RT-qPCR). CHIKV and" exact="ZIKV" post="dilutions were spotted on dengue RDTs (SD BIOLINE Dengue"/>
   <result pre="and ZIKV dilutions were spotted on dengue RDTs (SD BIOLINE" exact="Dengue" post="DUO, Standard Diagnostics, Gyeonggi-do, Republic of Korea), dried, and"/>
   <result pre="slightly lower in comparison to direct extracts, two logfold for" exact="CHIKV" post="and one logfold for ZIKV. For analysis of temperature"/>
   <result pre="and one logfold for ZIKV. For analysis of temperature stability," exact="DENV" post="dilutions were spotted on RDTs and stored for up"/>
   <result pre="three viruses. page-count: Note: Supplemental table appears at www.ajtmh.org. INTRODUCTION" exact="Dengue" post="virus (DENV) infection is hyperendemic in tropical and subtropical"/>
   <result pre="global expansion of two other mosquito-borne viruses, chikungunya (CHIKV) and" exact="Zika" post="(ZIKV) viruses.3â€&quot;5 In Southeast Asia (SEA), urban outbreaks of"/>
   <result pre="Zika (ZIKV) viruses.3â€&quot;5 In Southeast Asia (SEA), urban outbreaks of" exact="CHIKV" post="have been well documented in the past decade, but"/>
   <result pre="decade, but epidemiology in rural areas is not well characterized.6" exact="Zika" post="virus is considered to be endemic at low prevalence"/>
   <result pre="at low prevalence in SEA. With only limited data available," exact="ZIKV" post="circulation is probably underestimated.7 However, a few countries reported"/>
   <result pre="are the mainstay for specific detection of DENV, CHIKV, and" exact="ZIKV" post="acute infection. However, in many resource-limited settings of high"/>
   <result pre="surveillance of diseases such as DENV, but not yet for" exact="CHIKV" post="or ZIKV.10,11 We aimed to produce a pragmatic and"/>
   <result pre="PDR (Laos) but also applicable to other resource-limited settings. Successful" exact="DENV" post="RNA detection by RT-qPCR from positive dry dengue RDTs"/>
   <result pre="group.12 Here, we aimed to evaluate RT-qPCR detection of both" exact="CHIKV" post="and ZIKV from dengue RDTs and to assess the"/>
   <result pre="we aimed to evaluate RT-qPCR detection of both CHIKV and" exact="ZIKV" post="from dengue RDTs and to assess the temperature stability"/>
   <result pre="and to assess the temperature stability of the detection of" exact="DENV" post="in RDTs by RT-qPCR. We used serial viral dilutions"/>
   <result pre="virus dilutions. Rapid diagnostic tests loaded with serial dilutions of" exact="DENV" post="solutions were stored at different temperatures, 4Â°C, âˆ’80Â°C, and"/>
   <result pre="by RT-qPCR. MATERIALS AND METHODS Description of RDT. The SD" exact="Dengue" post="DUO RDT (Standard Diagnostics, Kyonggi-do, Korea) is an in"/>
   <result pre="is an in vitro immunochromatographic assay for the detection of" exact="DENV" post="NS1 Ag and anti-dengue IgM/IgG antibodies in human serum,"/>
   <result pre="blood. This test comprises a pair of test devices, a" exact="DENV" post="NS1 Ag test on the left side, and a"/>
   <result pre="DENV NS1 Ag test on the left side, and a" exact="DENV" post="IgM/IgG Ab test on the right side. Each device"/>
   <result pre="obtained in 15 minutes. Virus dilutions and spotting on RDT." exact="DENV" post="serotype 1 isolated in cell culture from a dengue"/>
   <result pre="was the last dilution with detactable RNA purified from RDT." exact="Zika" post="virus (H/PF/2013, EVA 001v-EVA1545)â€&quot; and CHIKV (H20235/STMARTIN/2013, EVA 001v-EVA1540)â€&quot;inactivated"/>
   <result pre="RNA purified from RDT. Zika virus (H/PF/2013, EVA 001v-EVA1545)â€&quot; and" exact="CHIKV" post="(H20235/STMARTIN/2013, EVA 001v-EVA1540)â€&quot;inactivated strains provided by the European Virus"/>
   <result pre="alongside the RDT extract. Real-time RT-PCR (RT-qPCR). DENV, CHIKV, and" exact="ZIKV" post="extracts were tested by the respective hydrolysis probe RT-qPCR"/>
   <result pre="polymerase chain reaction detection of dengue virus, chikungunya virus, and" exact="Zika" post="virus RNA Chikungunya: Pastorino et al.14 Forward primer AAG"/>
   <result pre="between the different storage conditions for DENV. RESULTS Temperature stability." exact="DENV" post="RT-qPCR results from the RDTs loaded with the three"/>
   <result pre="displayed in Table 2 and supplemental data (Supplemental Table 1)." exact="DENV" post="was successfully detected from the RDT stored at 35Â°C"/>
   <result pre="month for the three viral dilutions. For the â€œlow-titerâ€� dilution," exact="DENV" post="RNA could not be amplified for one of the"/>
   <result pre="found to be PCR negative after 1 month. Table 2" exact="Dengue" post="RT-qPCR Cq for RNA purified from RDT stored at"/>
   <result pre="27.40 (1.11) 34.21 (0.42) NDÂ§ Cq = quantification cycle value;" exact="DENV" post="= dengue virus; RDT = rapid diagnostic test; RT-qPCR"/>
   <result pre="DENV1 isolate dilutions stored at âˆ’80Â°C, to serve as reference." exact="DENV" post="1 dilutions correspond to 1/10 serial dilution, with H"/>
   <result pre="polymerase chain reaction was negative for 3/3 of triplicate RDTs." exact="Chikungunya" post="virus detection. CHIKV RT-qPCR data, for experiments performed on"/>
   <result pre="was negative for 3/3 of triplicate RDTs. Chikungunya virus detection." exact="CHIKV" post="RT-qPCR data, for experiments performed on RNA directly extracted"/>
   <result pre="RNA directly extracted and extracted after loading on RDT for" exact="CHIKV" post="dilutions 10âˆ’4â€&quot;10âˆ’9, are presented in Table 3. The LOD"/>
   <result pre="at the LOD). This is indicative of good reproducibility of" exact="CHIKV" post="RT-qPCR from RDTs. Table 3 Chikungunya RT-qPCR results for"/>
   <result pre="of good reproducibility of CHIKV RT-qPCR from RDTs. Table 3" exact="Chikungunya" post="RT-qPCR results for direct vs. RDT RNA extract Virus"/>
   <result pre="positive by RT-qPCR tested in triplicate is shaded in gray." exact="Zika" post="virus detection. ZIKV RT-qPCR data, for experiments performed on"/>
   <result pre="tested in triplicate is shaded in gray. Zika virus detection." exact="ZIKV" post="RT-qPCR data, for experiments performed on RNA directly extracted"/>
   <result pre="RNA directly extracted and extracted after loading on RDT for" exact="ZIKV" post="dilutions 10âˆ’2â€&quot;10âˆ’8, are presented in Table 4. The LOD"/>
   <result pre="at the LOD). This is indicative of good reproducibility of" exact="ZIKV" post="RT-qPCR from RDTs. Table 4 Zika RT-qPCR results for"/>
   <result pre="of good reproducibility of ZIKV RT-qPCR from RDTs. Table 4" exact="Zika" post="RT-qPCR results for direct vs. RDT RNA extract Virus"/>
   <result pre="few weeks at elevated temperature does not compromise detection of" exact="DENV" post="RNA by RT-qPCR. DENV RNA was purified and could"/>
   <result pre="temperature does not compromise detection of DENV RNA by RT-qPCR." exact="DENV" post="RNA was purified and could be detected for the"/>
   <result pre="of RNA recovered varies between RDTs.12 This may explain why" exact="DENV" post="RT-qPCR was negative for some â€œlowâ€� RDTs tested after"/>
   <result pre="at 35Â°C. This proof-of-principle study demonstrates the potential use of" exact="DENV" post="RDTs for the storage, transport, and RT-qPCR co-detection of"/>
   <result pre="DENV RDTs for the storage, transport, and RT-qPCR co-detection of" exact="CHIKV" post="and ZIKV as well as for DENV.12 CHIKV RNA"/>
   <result pre="for the storage, transport, and RT-qPCR co-detection of CHIKV and" exact="ZIKV" post="as well as for DENV.12 CHIKV RNA was detected"/>
   <result pre="co-detection of CHIKV and ZIKV as well as for DENV.12" exact="CHIKV" post="RNA was detected at 2 logfold lower dilution from"/>
   <result pre="2 logfold lower dilution from RDT than direct extraction, and" exact="ZIKV" post="RNA at 1 logfold lower dilution from RDT than"/>
   <result pre="would still enable detection of infected patients as shown for" exact="DENV" post="with high agreement when comparing RT-qPCR results after direct"/>
   <result pre="RDTs using patient samples collected in the provinces, especially for" exact="ZIKV" post="which is known to produce low viremia.18 It would"/>
   <result pre="areas. Our findings suggest that the distribution of SD BIOLINE" exact="Dengue" post="DUO RDTs in rural areas could be extremely useful"/>
   <result pre="lowest viral titers would probably not be detected, especially for" exact="Zika" post="infection, the detection of the patients with medium and"/>
   <result pre="the identification of epidemics. To date, in Laos, reports of" exact="ZIKV" post="and CHIKV infections have been limited, despite a favorable"/>
   <result pre="of epidemics. To date, in Laos, reports of ZIKV and" exact="CHIKV" post="infections have been limited, despite a favorable climate for"/>
   <result pre="transmission of the viruses. There have been only 18 confirmed" exact="ZIKV" post="cases detected from a retrospective analysis of sera, 2012â€&quot;2013,"/>
   <result pre="detected from a retrospective analysis of sera, 2012â€&quot;2013, and one" exact="ZIKV" post="case was reported in 2016.8 Co-circulation of CHIKV during"/>
   <result pre="and one ZIKV case was reported in 2016.8 Co-circulation of" exact="CHIKV" post="during a DENV epidemic in 2013 in southern Laos"/>
   <result pre="case was reported in 2016.8 Co-circulation of CHIKV during a" exact="DENV" post="epidemic in 2013 in southern Laos has been reported.19"/>
   <result pre="in southern Laos has been reported.19 It is likely that" exact="CHIKV" post="and ZIKV circulation have been underestimated and misdiagnosed as"/>
   <result pre="Laos has been reported.19 It is likely that CHIKV and" exact="ZIKV" post="circulation have been underestimated and misdiagnosed as other febrile"/>
   <result pre="cost-effective tool to improve laboratory detection of DENV, CHIKV, and" exact="ZIKV" post="across wide geographical areas. Large-scale implementation of surveillance for"/>
   <result pre="Asia. Asian Pac J Trop Med10: 211â€&quot;219.28442104 4.QuyenNTHet al.2017Chikungunya and" exact="Zika" post="virus cases detected against a backdrop of endemic dengue"/>
   <result pre="Asian Pac J Trop Med10: 1â€&quot;5.28107856 8.LimSKLimJKYoonIK, 2017An update on" exact="Zika" post="virus in Asia. Infect Chemother49: 91â€&quot;100.28681575 9.PattersonJSammonMGargM, 2016Dengue, Zika"/>
   <result pre="on Zika virus in Asia. Infect Chemother49: 91â€&quot;100.28681575 9.PattersonJSammonMGargM, 2016Dengue," exact="Zika" post="and chikungunya: emerging arboviruses in the New World. West"/>
   <result pre="Negl Trop Dis10: e0004704.27159058 13.LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJStanfieldSMDuffyMR, 2008Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia. Emerg"/>
   <result pre="18.WaggonerJJet al.2016Viremia and clinical presentation in Nicaraguan patients infected with" exact="Zika" post="virus, chikungunya virus, and dengue virus. Clin Infect Dis63:"/>
   <result pre="arthropod-borne viral diseases: a global prospective on dengue, chikungunya and" exact="Zika" post="fevers. Acta Trop166: 155â€&quot;163.27876643"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7254006\results\search\tropicalVirus\results.xml">
   <result pre="activities against coronaviruses (MERS-CoV and SARS-CoV), influenza viruses, enterovirus A71," exact="Zika" post="virus, and adenovirus [21]. We therefore additionally tested the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7255039\results\search\tropicalVirus\results.xml">
   <result pre="32483462 doi: 10.7150/thno.43177thnov10p6430 : Research Paper In vivo imaging of" exact="Zika" post="virus reveals dynamics of viral invasion in immune-sheltered tissues"/>
   <result pre="(https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Abstract Rationale:" exact="Zika" post="virus (ZIKV) is a pathogenic virus known to cause"/>
   <result pre="complications, in humans. This study investigated the noninvasive detection of" exact="ZIKV" post="infection in vivo, which is necessary for elucidating the"/>
   <result pre="of anti-ZIKV therapeutic strategies. Methods: In this study, a recombinant" exact="ZIKV" post="harbouring Nluc gene (ZIKV-Nluc) was designed, recovered, and purified."/>
   <result pre="viral loads in vitro and in vivo. The dynamics of" exact="ZIKV" post="infection in A129 (interferon (IFN)-Î±/Î² receptor deficient), AG6 (IFN-Î±/Î²"/>
   <result pre="replicated well in cells with similar properties to the wild-type" exact="ZIKV" post="(ZIKVwt). Striking bioluminescence signals were consistently observed in animal"/>
   <result pre="visceral target. Infection of pregnant dams with ZIKV-Nluc showed that" exact="ZIKV" post="was capable of crossing the maternal-fetal barrier to infect"/>
   <result pre="to report the real-time noninvasive tracking of the progression of" exact="ZIKV" post="invading immune-sheltered tissues and propagating vertically during pregnancy. The"/>
   <result pre="the study of the replication, dissemination, pathogenesis, and treatment of" exact="ZIKV" post="in vitro and in vivo. Zika virus Bioluminescence imaging"/>
   <result pre="pathogenesis, and treatment of ZIKV in vitro and in vivo." exact="Zika" post="virus Bioluminescence imaging Viscera dissemination Tissue localization Vertical transmission"/>
   <result pre="Viscera dissemination Tissue localization Vertical transmission Pooled immune sera Introduction" exact="Zika" post="virus (ZIKV) is a mosquito-borne virus that belongs to"/>
   <result pre="a mosquito-borne virus that belongs to the Flaviviridae family 1." exact="ZIKV" post="was first isolated in 1947 from a febrile rhesus"/>
   <result pre="isolated in 1947 from a febrile rhesus macaque in the" exact="Zika" post="forest of Uganda 2. Only 14 cases of sporadic"/>
   <result pre="and in French Polynesia and other Pacific islands in 2013-2014," exact="ZIKV" post="colonised the Americas in February 2015, causing 707,133 cases"/>
   <result pre="3, 6, 7. During these large epidemics in the Americas," exact="ZIKV" post="infection resulted in severe pathological complications, notably microcephaly in"/>
   <result pre="through sexual or vertical route has also been confirmed, setting" exact="ZIKV" post="apart from most other flaviviruses 9. To date, there"/>
   <result pre="licensed vaccine or antiviral therapy available for the treatment of" exact="ZIKV" post="infection. The efficient transmission of this virus combined with"/>
   <result pre="combined with deficient antiviral strategies has exacerbated public panic over" exact="ZIKV" post="10. The mechanisms for the dissemination and pathogenesis of"/>
   <result pre="ZIKV 10. The mechanisms for the dissemination and pathogenesis of" exact="ZIKV" post="in developing fetuses, pregnant mothers, and adults remain largely"/>
   <result pre="in developing fetuses, pregnant mothers, and adults remain largely unknown." exact="ZIKV" post="is likely to invade a unique set of immune-sheltered"/>
   <result pre="of immune-sheltered tissues, including the brain, testis, and placenta. Several" exact="ZIKV" post="animal infection models have been previously established 11 to"/>
   <result pre="has not been possible to monitor the real-time patterns of" exact="ZIKV" post="infection through these methods 13. The collection of tissues"/>
   <result pre="methods 13. The collection of tissues and organs to evaluate" exact="ZIKV" post="infection requires the euthanasia of the animals, and important"/>
   <result pre="have been no successful attempts at the non-invasive detection of" exact="ZIKV" post="infection in vivo, which is warranted for characterizing the"/>
   <result pre="or therapeutic antibodies for ZIKV. In this study, a recombinant" exact="ZIKV" post="harbouring the Nluc gene (ZIKV-Nluc) was designed, recovered, and"/>
   <result pre="replicated well in cells with similar properties to the wild-type" exact="ZIKV" post="(ZIKVwt). The levels of bioluminescence were found to be"/>
   <result pre="viral loads in vitro and in vivo. The dynamics of" exact="ZIKV" post="infection in A129 (interferon (IFN)-Î±/Î² receptor deficient), AG6 (IFN-Î±/Î²"/>
   <result pre="is the first real-time non-invasive tracking of the progression of" exact="ZIKV" post="invading immune-sheltered tissues, as well as its vertical propagating,"/>
   <result pre="in the study of the replication, dissemination, and pathogenesis of" exact="ZIKV" post="in vitro and in vivo. Results Generation and characterization"/>
   <result pre="in vivo. Results Generation and characterization of a stable reporter" exact="ZIKV" post="To generate a bioluminescent ZIKV reporter virus, a Nluc"/>
   <result pre="characterization of a stable reporter ZIKV To generate a bioluminescent" exact="ZIKV" post="reporter virus, a Nluc gene was engineered into a"/>
   <result pre="engineered into a full-length infectious cDNA clone of an Asian-lineage" exact="Zika" post="virus, SZ-WIV01 10. As shown in Figure 1A, the"/>
   <result pre="ZIKV-Nluc and ZIKVwt. Using ZIKV-Nluc for the bioluminescence imaging of" exact="ZIKV" post="infection To investigate whether ZIKV-Nluc can be used as"/>
   <result pre="be used as a tool for the bioluminescence imaging of" exact="ZIKV" post="infection, A129 mice were inoculated with 1.2 Ã— 105"/>
   <result pre="II IFN in viral dissemination To determine the mechanisms of" exact="ZIKV" post="dissemination and pathogenesis in adults, pregnant mothers, and developing"/>
   <result pre="infected with 6 Ã— 104 IFU ZIKV-Nluc, or the parental" exact="ZIKV" post="as control, via intra-footpad injections. The resulting bioluminescent signal"/>
   <result pre="of viral infection. These results revealed the complete process of" exact="ZIKV" post="dissemination and showed that the ZIKV-Nluc virus primarily invaded"/>
   <result pre="mice (Figure 5 and Figure 6), highlighting the viscerotropism of" exact="ZIKV" post="in vivo. By contrast, only a weak bioluminescent signal"/>
   <result pre="at later time points, these results supported previous observations that" exact="ZIKV" post="preferentially replicated in both male and female reproductive tracts"/>
   <result pre="at E10 via intra-footpad injection to determine the transmission of" exact="ZIKV" post="from mother to offspring in mice. As shown in"/>
   <result pre="in an exact and effective bioluminescence (Figure 9B), indicating that" exact="ZIKV" post="was capable of crossing the maternal-fetal barrier to infect"/>
   <result pre="immune sera (neutralizing anti-ZIKV antibodies) were recommended for protection against" exact="ZIKV" post="infection 28, 33, it is unclear how these sera"/>
   <result pre="or antiviral compounds) suppress the progression of viral infection. Discussion" exact="ZIKV" post="is a pathogenic virus that causes microcephaly, diffuse calcifications,"/>
   <result pre="the first time, we report on the complete process of" exact="ZIKV" post="dissemination, as well as the identification of the ileocecal"/>
   <result pre="agreement with the findings reported by studies on JEV and" exact="DENV" post="reporter viruses 19, 24. Such properties of ZIKV-Nluc provide"/>
   <result pre="properties of ZIKV-Nluc provide a powerful means for further characterizing" exact="ZIKV" post="dissemination in living mice using bioluminescence imaging. Using the"/>
   <result pre="bioluminescence imaging. Using the ZIKV-Nluc virus, we visualized the real-time" exact="ZIKV" post="infection in A129, AG6, and C57BL/6 mice. ZIKV is"/>
   <result pre="the real-time ZIKV infection in A129, AG6, and C57BL/6 mice." exact="ZIKV" post="is known to directly infect neuronal progenitor cells and"/>
   <result pre="the peritoneal cavity may contribute to the quick dissemination of" exact="ZIKV" post="to the brain and other organs. Although ZIKV-Nluc was"/>
   <result pre="was consistent with a previous biochemical analysis that found that" exact="ZIKV" post="did not antagonize type I IFN response by promoting"/>
   <result pre="48, 49. After infection with a neurotropic virus, such as" exact="West Nile" post="virus, the induction of type I IFN expression in"/>
   <result pre="the function of type II IFNs in the control of" exact="ZIKV" post="infection. Compared with the singly-deficient A129 mice, AG6 mice"/>
   <result pre="side, indicating that type II IFNs contribute to limiting systemic" exact="ZIKV" post="infection in mice in the early stage. Neurons in"/>
   <result pre="to determine the exact mechanism of the non-cytolytic clearance of" exact="ZIKV" post="from infected neurons in the CNS. ZIKV is known"/>
   <result pre="non-cytolytic clearance of ZIKV from infected neurons in the CNS." exact="ZIKV" post="is known to preferentially replicate in the reproductive tract,"/>
   <result pre="However, whether the intestine is a potential target organ of" exact="ZIKV" post="infection remains to be further clarified. In this study,"/>
   <result pre="intestine is likely to serve as an important organ of" exact="ZIKV" post="infection. Previously, luciferase signals were also detected in the"/>
   <result pre="doubly-deficient AG129 mice infected with DENV-Fluc, suggesting that JEV and" exact="DENV" post="can replicate in gut-associated lymphoid tissues 19, 24. Nevertheless,"/>
   <result pre="chyme through the intestinal tract 56, 57. The fact that" exact="ZIKV" post="targets the ileocecal junction is consistent with a recent"/>
   <result pre="in mice 58. Our study elucidated the spatio-temporal dynamics of" exact="ZIKV" post="in pregnant mice and its subsequent vertical spread to"/>
   <result pre="proteins and nucleic acids, it has been previously suggested that" exact="ZIKV" post="can cross the placental barrier, being directly associated with"/>
   <result pre="61. However, the mechanism for the infection and dissemination of" exact="ZIKV" post="at the different stages of gestation remains unknown. In"/>
   <result pre="to other organs. The fetus may be highly sensitive to" exact="ZIKV" post="infection during the first trimester of pregnancy 62. However,"/>
   <result pre="consequences, as well as to determine the mechanism by which" exact="ZIKV" post="crosses the placental barrier at the different stages of"/>
   <result pre="AG6 mice have been used previously to mimic aspects of" exact="ZIKV" post="infection in humans. However, due to the lack of"/>
   <result pre="achieve better results in future studies. In summary, a novel" exact="ZIKV" post="reporter virus was established for the in vivo imaging"/>
   <result pre="study is the first to investigate the spatio-temporal dynamics of" exact="ZIKV" post="replication, the invasion of immune-sheltered tissues by ZIKV, and"/>
   <result pre="of immune-sheltered tissues by ZIKV, and the vertical propagating of" exact="ZIKV" post="during pregnancy. In addition to the brain and reproductive"/>
   <result pre="intestine was also demonstrated to be a potential target of" exact="ZIKV" post="dissemination, wherein the ileocecal junction may likely play a"/>
   <result pre="likely play a key role in the neuronal dysfunction of" exact="ZIKV" post="infection. The non-invasive imaging of ZIKV-Nluc is a powerful"/>
   <result pre="of antivirals and vaccines in vivo for the treatment of" exact="ZIKV" post="infection in humans. Materials and Methods Ethics statement All"/>
   <result pre="streptomycin maintained in 5% CO2 at 37 Â°C. The parental" exact="ZIKV" post="was rescued by transfecting Vero cells with the full-length"/>
   <result pre="data were defined as total flux in photons/second. Nano-Glo luminescence-based" exact="ZIKV" post="neutralization assay A Nano-Glo luminescence-based ZIKV neutralization assay was"/>
   <result pre="in photons/second. Nano-Glo luminescence-based ZIKV neutralization assay A Nano-Glo luminescence-based" exact="ZIKV" post="neutralization assay was developed for the measurement of the"/>
   <result pre="the editing of the final version of the manuscript. Abbreviations" exact="ZIKV" post="zika virus GBS Guillain-Barre syndrome Fluc firefly luciferase Rluc"/>
   <result pre="disease virus 2A sequence CCD charge-coupled-device NPCs neuronal progenitor cell" exact="WNV" post="West Nile virus CNS central nervous system ROI region"/>
   <result pre="virus 2A sequence CCD charge-coupled-device NPCs neuronal progenitor cell WNV" exact="West Nile" post="virus CNS central nervous system ROI region of interest"/>
   <result pre="nervous system ROI region of interest References 1CugolaFRFernandesIRRussoFBFreitasBCDiasJLGuimaraesKPet al.The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental modelsNature20165342677127279226 2DickGWKitchenSFHaddowAJZika"/>
   <result pre="Virus Vaccine: Progress and ChallengesCell Host Microbe20182412730008291 4BaudDGublerDJSchaubBLanteriMCMussoDAn update on" exact="Zika" post="virus infectionLancet2017390209910928647173 5TanZZhangWSunJFuZKeXZhengCet al.ZIKV infection activates the IRE1-XBP1 and"/>
   <result pre="Engl J Med2016374951826862926 9D'OrtenzioEMatheronSYazdanpanahYde LamballerieXHubertBPiorkowskiGet al.Evidence of Sexual Transmission of" exact="Zika" post="VirusN Engl J Med20163742195827074370 10LiPKeXWangTTanZLuoDMiaoYet al.Zika Virus Attenuation by"/>
   <result pre="Induces Sterilizing Immunity in Mouse ModelsJ Virol201892 11MorrisonTEDiamondMSAnimal Models of" exact="Zika" post="Virus Infection, Pathogenesis, and ImmunityJ Virol201791 12MaWLiSMaSJiaLZhangFZhangYet al.Zika Virus"/>
   <result pre="Male Infertility in MiceCell2016167151124.e1027884405 13DowallSDGrahamVARaynerEAtkinsonBHallGWatsonRJet al.A Susceptible Mouse Model for" exact="Zika" post="Virus InfectionPLoS Negl Trop Dis201610e000465827149521 14AliotaMTCaineEAWalkerECLarkinKECamachoEOsorioJECharacterization of Lethal Zika"/>
   <result pre="for Zika Virus InfectionPLoS Negl Trop Dis201610e000465827149521 14AliotaMTCaineEAWalkerECLarkinKECamachoEOsorioJECharacterization of Lethal" exact="Zika" post="Virus Infection in AG129 MicePLoS Negl Trop Dis201610e000468227093158 15Rameix-WeltiMALe"/>
   <result pre="and Tissue TropismCell Host Microbe2017211344228182948 33SapparapuGFernandezEKoseNBinCFoxJMBombardiRGet al.Neutralizing human antibodies prevent" exact="Zika" post="virus replication and fetal disease in miceNature2016540443727819683 34SongBHYunSIWoolleyMLeeYMZika virus:"/>
   <result pre="38GadeaGBosSKrejbich-TrototPClainEViranaickenWEl-KalamouniCet al.A robust method for the rapid generation of recombinant" exact="Zika" post="virus expressing the GFP reporter geneVirology20164971576227471954 39MutsoMSaulSRausaluKSusovaOZusinaiteEMahalingamSet al.Reverse genetic"/>
   <result pre="reporter viruses and packaged subgenomic replicon based on a Brazilian" exact="Zika" post="virus isolateJ Gen Virol20179827122429022864 40ShanCXieXMuruato AntonioERossi ShannanLRoundy ChristopherMAzar SashaRet"/>
   <result pre="40ShanCXieXMuruato AntonioERossi ShannanLRoundy ChristopherMAzar SashaRet al.An Infectious cDNA Clone of" exact="Zika" post="Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral"/>
   <result pre="Commun20134236924022374 44YuanLHuangXYLiuZYZhangFZhuXLYuJYet al.A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephalyScience2017 45TangHHammackCOgdenSCWenZQianXLiYet al.Zika Virus Infects"/>
   <result pre="interferon plays a crucial early antiviral role in protection against" exact="West Nile" post="virus infectionJ Virol20068053384816699014 55LasfarACookJRCohen SolalKAReuhlKKotenkoSVLangerJAet al.Critical role of the"/>
   <result pre="Risk of MicrocephalyN Engl J Med20163751427222919 63ZhaoHFernandezEDowdKASpeerSDPlattDJGormanMJet al.Structural Basis of" exact="Zika" post="Virus-Specific Antibody ProtectionCell201616610162727475895 64ZaitsevaMKapnickSMScottJKingLRManischewitzJSirotaLet al.Application of bioluminescence imaging to"/>
   <result pre="in vaccinia virus-infected miceJ Virol200983104374719656894 65LazearHMGoveroJSmithAMPlattDJFernandezEMinerJJet al.A Mouse Model of" exact="Zika" post="Virus PathogenesisCell Host Microbe2016197203027066744 66FayeOFayeODialloDDialloMWeidmannMSallAAQuantitative real-time PCR detection of"/>
   <result pre="Zika Virus PathogenesisCell Host Microbe2016197203027066744 66FayeOFayeODialloDDialloMWeidmannMSallAAQuantitative real-time PCR detection of" exact="Zika" post="virus and evaluation with field-caught mosquitoesVirol J20131031124148652 Figure 1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7256346\results\search\tropicalVirus\results.xml">
   <result pre="GessertSF, ChenY, et alPreparation of iron oxide silica particles for" exact="Zika" post="viral RNA extraction. Heliyon. 2018;4(3):e00572. [9]AliZ, LiangW, JinL, et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7256352\results\search\tropicalVirus\results.xml">
   <result pre="SimeonovA., HuangW., â€¦ TangH. (2016). Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_3\PMC7256510\results\search\tropicalVirus\results.xml">
   <result pre="the RNA-dependent RNA polymerase of RNA viruses such as Influenza," exact="Yellow fever," post="Chikungunya, Ebola [68], Norovirus, and Enterovirus [67]. Besides, in"/>
   <result pre="was initially developed to treat HCV, and its efficacy against" exact="Yellow fever" post="revealed its antiviral activity in preclinical studies against many"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
